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2 Chapter 1 
1.1 Introduction 
Pain is a significant part of growing up. It is a powerful stimulus that drives 
primitive survival behaviour and teaches children to avoid hann and danger. The 
most common sources of pain in children are the everyday incidents, averaging one 
incident per child every three hours [1]. Fortunately, few of these incidents result in 
serious injury and the pain associated with them is typically of short duration. 
When staying in a hospital, children, especially (premature) neonates, often 
experience pain as well. In this situation the most common sources of pain, apart 
from surgical intenrention, are invasive procedures, some for investigation and 
some for treatment. 
Pain during hospitalisation serves no purpose at all. For example, if pain is not 
adequately treated, it progressively increases responses of spinal dorsal hom 
neurons, a phenomenon that is called "wind-up". Large doses of opioids are then 
needed to suppress the established hyperexcitability, which could have been 
prevented by small doses given pre-emptively, i.e. before pain appears [2]. This 
hyperexcitability is most easily evoked in premature neonates [3]. Pain also causes 
physiologic stress, which in its turn may lead to metabolic instability, and finally 
may increase the risk of morbidity and mortality [4,5]. Because of greater body 
surface and energy needs, yet smaller reserves of protein, carbohydrate and fat, 
metabolic stability is more difficult to maintain in (premature) neonates than in 
older children [6]. Inadequately treated pain may also lead to behavioural problems 
at home [7,8], which may last 2 to 4 weeks longer than the duration of pain itself 
[9]. Finally, research findings suggest that pain exposure during early infancy results 
in a permanently altered neural circuitry, altered pain sensitivity, and probably also 
in behavioural sequelae [10-12]. 
Till the end of the 1980s the treatment of medically induced pain in children 
received little attention. Intramuscular administration of opioids on an if-necessary 
basis was the most common method of postoperative pain treatment, despite its 
demonstrated ineffectiveness [13], and the fear it raises in children [14]. Even more 
disturbing was the generally accepted notion that neonates could not feel pain and 
did not have any memory pertaining to painful stimuli [15]. In line with this notion 
less than 20% of the clinicians administered (systemic) opioids in neonates and 
infants following major surgery [16]. 
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The last decade has seen rapid changes in this malpractice of undertreatment and 
misconception. It is now generally acknowledged that even neonates can feel pain 
[17 -20]. Many instruments have been developed to assess pain in neonates, infants, 
and children [21,22] and a variety of analgesics, methods of administration, and 
protocols are applicable to neonates, infants, and children [23]. 
It is striking, therefore, that after more than 10 years of progress the attitude 
towards the management of procedural pain has not changed fundamentally [24-
26]. Procedures such as heel stick, arterial and venipuncture, or tracheal suction are 
consistendy performed without analgesia [24,27]. Most cynically, the children with 
the greatest risk of wind-up, metabolic instability, and oflong-term sequelae are 
most intensively subjected to these procedures [28]. Lack of time to administer 
drugs during emergency procedures, the risk/benefit ratio of administering drugs 
for very brief procedures, or fear for adverse consequences are common rationales 
put forward to justifY the failure to administer adequate pain relief [24]. 
Another striking finding is that the majority of the children in day care surgery 
suffer pain, most pronouncedly following circumcision [24,29] and 
(adeno)tonsillectomy [9]. Yet, clinicians as well as nurses describe these procedures 
as very painful and traumatic [24,30]. Fear of side effects of the analgesics used, or 
lacking the skills to apply local or regional anaesthesia might be explanations [29]. 
Incorrect assumptions about the pharmacokinetic aspects of analgesics could also 
explain the high incidence of pain after minor surgery. 
In contrast, postoperative pain following major surgery appears to be treated 
consistendy [27], primarily with opioids. Analgesic potency without a ceiling effect 
and maintenance of homeostatic stability even in critically ill neonates may explain 
this popularity. At present, recommended analgesic regimens have been defined 
which are based on the philosophy of pre-emptive analgesia rather than on the if-
necessary approach [23,31]. The dilemma, however, is that there is inter-individual 
as well as intra-individual variability in pain relief and analgesic needs [32-35]. 
Therefore, opioid dosages have to be adjusted according to the individual 
requirements. This can be achieved when opioid requirements are adjusted 
according to valid assessment of pain or when children participate in their own 
pain management program. 
In summary, the elimination and amelioration of medical induced pain is still 
capable of improvement. This can be achieved either by means of improving the 
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methods of pain assessment or by studying the efficacy of analgesic drugs, topics 
which are both addressed in this thesis. 
When studying pain in children, careful consideration must be given to the 
continuing process of maturation and development, both in the biological and the 
psychological dimensions of pain. For example, the transmission of pain differs 
between neonates and older children, the metabolism of medication varies with 
age, and the perception and understanding of pain depends on the children's 
cognitive development. The latter also restricts the applicability of pain assessment 
methods. 
1.2 Scope of this thesis 
This thesis focuses on how medically induced pain in children can be treated, 
evaluated, and on whether the administration of analgesics prevents neonates and 
infants from developing long-term sequelae. Various age groups were studied. The 
chapters 2 to 4 comprise studies in neonates and infants into the sensitivity and 
specificity of the face for the assessment of pain and into the development of long-
term sequelae. The chapters 5 to 7 describe studies in older children and 
adolescents evaluating various analgesic techniques for a variety of surgical 
interventions. 
1.2.1 Neonates and infants 
As neonates and infants are not able to tell if they are in pain, they have to rely on 
the knowledge and skills of nurses and clinicians. According to nurses and parents 
the most specific measure to assess the condition of the infant is the face. Chapter 
2, therefore, reviews the literature to determine whether this is true or not. As this 
measure is not validated for the assessment of postoperative pain, its validity for 
this purpose is assessed in chapter 3. Chapter 4 uses the face to assess whether the 
use of judicious analgesia has profound effects by reducing the vulnerability of 
children to develop long-term alterations in pain sensitivity. 
1.2.2 Children 
In this section pain is not assessed by means of facial expression but by other 
validated pain-related indices. This because nurses responsible for the evaluation of 
pain were not trained in analysing facial responses, and because self-report is 
considered the gold standard in older children. 
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Adequate pain relief during circumcision can be provided either by local or regional 
anaesthesia, or the administration of opioids. These techniques, however, are not 
preferred by many clinicians as local and regional anaesthetic techniques require 
special skills and opioids are known for their side effects. To gain clinical 
acceptability, alternative analgesic strategies have to meet tw"o criteria, i.e. easy to 
administer and few side effects. Whether application of EMLA cream can replace 
the difficult, highly skilled regional anaesthesia techniques is examined in chapter 5. 
Paracetarnol and diclofanac are the most commonly used analgesics for 
(adeno)tonsillectomy. Both are given pre-emptively, but there is no consensus 
about dose, time of administration and efficacy. Chapter 6, therefore, reviews all 
available papers on this subject to find out which of these two drugs should be 
preferred, not only from an efficacy point of view but also from that of side effects. 
Theoretically, pain management is optimal when, apart from pre-emptive analgesia, 
the children are allowed to self administer analgesics whenever necessary. Patient 
controlled analgesia (PCA) is a technique that satisfies these criteria. The efficacy of 
this technique in comparison with continuous infusion of morphine is examined in 
chapter 7. 
1.3.3 General discussion and summary 
Chapter 8 is the general discussion. In this part the results from the previous 
chapters are discussed in the light of developments within the field of pain 



























Measurement and long-term effects of pain 

Chapter2 
The value of the face to assess pain: a literature review 
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2.1 Abstract 
Background Neonates and infants lack the ability to report their pain and thus rely 
on nurses and clinicians skills to determine whether they are in pain or not. 
Objective To review the literature reporting on the sensitivity and specificity of the 
face for pain assessment. 
Design Systematic review. 
Methods A MEDUNE and PSYCUT search from 1966 through 2000 was carried 
out. Language restrictions were not applied. 
Results There are two coding systems to objectively code facial movements in 
neonates and infants: the Neonatal Facial Coding System and the Mmdmum 
Discriminative Facial Movement Coding System. The first was used in 34 of the 38 
original studies found. In general, facial movements have only been studied in 
relation to acute pain, using needle pain as the gold standard painful event. 
Conclusion The facial response to acute pain has good sensitivity and specificity, and 
is characterised by a constellation of seven well-defined facial actions that are 
different from expressions associated v.rith anger, fear, or sadness. 
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2.2 Introduction 
Pain is a subjective phenomenon and for that reason cannot be simply measured 
and quantified, especially not in children. The gold standard of measuring pain 
should be what one reports about one's experience, but infants and young children 
lack this ability. It is generally acknowledged that in this age group the non-verbal 
bio-behavioural alterations by pain constitute the infantile forms of self-report [36]. 
These alterations include: 1) cardiorespiratory responses, 2) neurochemical 
secretions such as adrenaline and noradrenaline, 3) paralinguistic vocalisations in 
the form of crying, screaming or moaning, 4) behavioural reactions including 
reflexive withdrawal of torso and limbs or purposeful action designed to ward off 
injury or to palliate pain, and 5) facial expression [37J. A broad range of need states 
and situations can also provoke most of these bio-behavioural alterations. Fatigue, 
hunger, discomfort from being soiled, pain, and other states of distress overlap in 
their behavioural manifestations [38]. The low specificity of most indices 
necessitates isolating those bio-behavioural responses within the complex of 
ongoing flow of children's activities that have limited signal-to-noise ratio. 
Several lines of evidence indicate that facial activity is particularly valuable for pain 
assessment. Facial activity serves primarily as a source of communication to others 
who may provide help [39]. It allows parents and other adults to differentiate 
beNTeen positive and negative emotions, motivational states, and cognitive states 
[40-42]. Several emotional facial expressions have a universal meaning, regardless of 
the culture in which one is raised [43,44]. These expressions differ from the facial 
response to pain, which also has unique characteristics [45-47]_ Finally, infants' 
facial responses to pain contribute more to adult judgements of the severity of pain 
than does crying [46,48]. 
The importance of the face has been acknowledged as all multidimensional pain 
assessment instruments have included the face (see Table 2.1). However, there is 
no consensus on what the face looks like when infants suffer pain. Descriptions 
range from a negative or marked contorted face to grimacing or frown, a 
withdrawn or disinterested face \vith quivering chin and clenched jaws and so forth. 
!vforeover, most of these descriptions are not made operational and in general we 
do not know what to look at. 
Table 2.1--- ~D~scripti~-=;;~=~f the fa~i~l ~;prc~;i~t~it;~;· i~ci~d~dTn -;~;Ifidi---;;-;~i;;;rp;ft; ;sse;~~~~t=~~-~-~~~"-~--~~~~· -~· 
instruments for infants 
Instrument 
Post Operative Pain 
Score [104] 
ClUES [105] 
Scale for Use in 
New-borns [106J 





0 = marked constant facial expression of pain; l = less marked intermittent facial expression of pain; 
2 = calm relaxed face 
0 = no facial expression; l = fr:imace; 2 = grimace/ gnmt 
0 = totally relaxed face, no tone or expression; 1 = reduced facial tone or expression; 2 = normal, neutral, 
no tension; 3 = increased tension, furrowed brow; 4 = contortion, grimace, vigorous cry 
1 = facial muscles totally relaxed; 2 = facial muscles normal; 3 = tension evident in some facial muscles; 
4 = tension evident throughout facial muscles; 5 = facial muscles contorted and grimacing 
0 = relaxed face, smiling; 1 = vny mouth; 2 = grimace (mouth and eyes) 
Riley Infant Pain Scale [109_1 0 =neutral face, smiling; l = frowning, grimacing; 2 =clenched teeth; 3 =full cry expression 
Nursing Assessment of 
Pain Intensity [109] 
FLACC [110] 
f..lills Toddler Pain 
Index [111] 
0 = smiling; 1 = neutral face; 2 = frowning, grimacing; 3 = clenched teeth 
0 = no particular expression or smile; 1 = occasional grimace or frmvn, withdrawn, disinterested; 
2 = frequent to constant quivering of the chin, clenched jaw 
Facial expressions may occur: frowning (grimacing); clenched ja\v; "0 " mouth (with movement, crying); 
fear (widened eyes), serious/ sad; or flinching 
J.iverpool Infant Distress 
Score [112] 
:i\Iodified Infant Pain 
Scale [113] 
Neonatal Infant Pain 
Scale f114] 
i\lodified Behavioural Pain 
Scale [115] 
Premature Inflnt Pain 
Profile [116] 
Early Verbal Pediatric 
Pain Scale [117] 
0 = eyes closed or relaxed; 1 = eyelids remain closed but face slightly screwed up with lines around mouth, 
eyes and brow; 2 = attentive, recepth'e expression, paying interest to environment; 3 = eyes partly closed 
with lines around, mild furrowing of brow, face slightly contorted into frown expression, chin quiver; 4 = 
moderately furrowed brow, eyes closed and screwed up tightly causing many lines around eyes, nostrils sharp 
and flaring, lips tightly held, jutting lower lip; 5 = expression held practically all the time without relief 
J-lacial expressions (brow bulge, open lips, chin quiver, stretch moutl1 vertical, stretch mouth hori?.ontal, 
naso-labial furrow, eye squeeze): 0 = marked; 1 = less marked; 2 = cahn 
0 = restful face, neutral expression; 1 = tight facial muscles, furrowed brow, chin, jaw (i.e. negative facial 
expression, nose, mouth, and brow) 
0 =definite positive expression; 1 =neutral expression; 2 =slightly negative expression (e.g. grimace); 
3 = definite negative expression (i.e. furrmved brows, eyes closed tightly) 
Brow bulge; eye squeeze; naso-labial furrmv: each facial action is scored for its presence: 0 = not present, i.e. 
0-9% of time; l = minimum present, i.e. 10-39% of time; 2 = moderate present, i.e. 40-69% of time; 
3 = maximum present, i.e. :::::70% of time 
0 = relaxed facial expression; 2 = grimacing (brows drawn together, eyes partially closed, squinting); 
4 = severe grimace (brows lowered, tightly drawn together, eyes tightly closed) 
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This led us to review the following topics regarding the sensitivity and specificity of 
the face as a means to communicate pain. 1) Which facial actions consistently 
accompany pain in neonates and infants? 2) Are there individual differences in the 
appearance of these facial actions? 3) Are these facial actions sensitive to change? 
4) Does the occurrence of these facial actions vary across several modalities of pain 
(e.g. acute vs. postoperative pain)? And 5) do these facial actions discriminate 
between pain and emotional states or distress? 
2.3Methods 
We aimed to identify all publications on facial expression of pain in infants. A 
MEDLINE and PSYCLIT literature search from 1966 through 2000 was 
conducted. The keywords used were pain, facial expression, infants and children. 
Language restrictions were not applied. After collecting the articles, all listed 
references were checked for additional relevant articles or books. 
2.4 Results 
2.4.1 Search 
This search resulted in a total of 38 original studies. These had been published in 
the following journals: Pain 11 times; [47,49-58], Pediatrics 4; [59-62], 
Developmental Psychology 3; [63-65], Journal of Pediatric Psychology 3; [66-68], 
Archives of Diseases in Childhood 3; [69-71], and other journals 15 times [72-84]. 
One original study was included in a book [85]. 
A noticeable fmding is that two distinct anatomy based facial coding systems are 
available that can be used in neonates and infants to describe changes in the face: 
the Neonatal Facial Coding System (NFCS) and the Maximally Discriminative 
Facial Movement Coding System (MAX). The NFCS is most accepted as 34 of the 
38 studies used this system. 
The NFCS [49,50] has been adapted from the Facial Action Coding System [86] 
and identifies action units representing discrete facial movements. These facial 
movements are derived from knowledge of the facial muscles that underlie skin 
movements. This system comprises ten well defined facial actions, i.e. brow bulge, 
eye squeeze, naso-labial furrow, open lips, horizontal and vertical mouth stretch, 
taut tongue, lip purse, chin quiver, and tongue protrusion (see Table 2.2). 
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The NFCS can be applied using fine graded video analysis [49,50] as well as in real 
time at the bedside [56,57,69,76]. 
The lvi:A.'C was initially developed to determine which muscles are responsible for 
various facial movements, i.e. appearance changes (ACs), involved in 
discomfort/ pain, and eight universal emotions, i.e. anger, fear, sadness, disgust, 
contempt, interest, joy, and surprise. These ACs are served by three separate 
branches of the facial nerve and by three relatively independent sets of muscles in 
three regions of the face: the Forehead/Eyebrows/ Nasal root (FEN) region, 
Eye/Nose/Cheek root (EN C) region, and the Mouth/Lips/Chin root (MLC) 
region. The FEN region has 6 ACs, the ENC region 7 ACs, and the MLC has 17 
ACs. Combinations of these ACs represent the presence of discomfort/ pain or one 
of the fundamental emotions [63,64,85]. Using fine graded video analysis, coders 
have to identify the offset and onset time of each AC. 






Horizontal mouth stretch 





Bulging, creasing, and vertical furrows above and between brows 
occurring as a result of the lowering and drawing together of the 
eyebrows. 
Squeezing or bulging of the eyelids. Bulging of the fatty pads about 
the infant's eyes pronounced. 
Primarily manifested by pulling upwards and furrow deepening of the 
naso-labial furrow. 
Any separation of the lips. 
Distinct horizontal pull at the corners of the mouth. 
Characterised by tautness at the lip corners (vertical) coupled 'W'ith a 
pronounced downward pull of the jaw. 
A raised, cupped tongue 'W'ith sharp tensed edges. 
Tongue visible between the lips extending beyond the mouth. 
The lips appear as an "oo" sound is being produced. 
An obvious high-frequency, up-down motion of the lower jaw. 
2.4.2 Facial actions accompanying pain 
Only nine studies report which of the ten facial actions appear or increase in 
intensity as a reaction to various modalities of acute pain. All studies identified the 
presence of brow bulge, squeezing of the eyes, naso-labial furrow, open lips and 
taut tongue when children were in pain [47,49,50,52,53,55,66,80]. Seven studies 
identified vertical mouth stretch as a pain-related facial action [47,49,50,52,55,66], 
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five identified horizontal mouth stretch [47,52,55,66], and two identified chin 
quiver [49,50]. In term-born infants tongue protruding was only observed in 
situations of discomfort but not during pain [49]. In preterm neonates at 32 weeks 
gestation, however, this facial action was observed in about 18°/o of the infants 
following lancing of the heel and in 25% during squeeze [56]. Lip purse has not 
been identified as a pain-related facial action. 
Si." studies have examined whether these facial actions are interrelated or act 
independently. High correlations (r > 0. 78) between brow bulge, eye squeeze, and 
naso-labial furrow suggest that these facial actions occur simultaneously when pain 
is present [50,67]. The correlation between these three facial actions and open lips, 
vertical mouth stretch, and taut tongue was moderate to low (r = .14 - .50) [50]. 
Principal component analysis yields the same findings as reported above 
[47,53,55,66]. Brow bulge, eye squeeze, naso-labial furrow, open lips, horizontal 
and vertical mouth stretch, and taut tongue loaded on one dimension; with the 
upper facial actions having higher factor loadings than the lower facial actions. 
These findings suggest that these facial actions form a facial composite of pain, and 
that the upper facial actions are the necessary components with the other features 
recruited thereafter, contingent upon the severity and specific sources of pain [47J. 
An example of this composite is presented in Figure 2.1 a. This expression is similar 
to the one defined by the MA.'C, i.e. lowered and bulged brows, bulge and/ or 
vertical furrows between the brows, eyes tightly closed and an angular and squarish 
mouth, though sometimes the mouth is wide open with the lips stretched tightly 
[87J. Moreover, this composite is the same as found in adults suffering from pain 
[46,88,89]. It thus appears that this expression has a universal meaning and is 
independent of cultural learning processes, thereby supporting Darwin's [90] claim 
that some facial expressions are inoate responses with an evolutionary history that 
originally had survival value for mankind. 
2.4.3. Individual differences 
Substantial variation within the facial expression has been observed which appears 
to be related to the behavioural state, i.e. sleeping or awake prior to a noxious 
event, and to the gestational age of the infant as well as to previous pain exposure. 
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Behaviottral state 
According to Prechtl, neonates and infants display prolonged and characteristic 
episodes of stable behaviour during the day. These episodes represent distinct and 
qualitative different modes of overall neural activity. Five distinct behavioural states 
can be distinguished, ranging from quiet sleep to alert crying [91 J. 
It is not clear whether the reactivity of the facial pain expression is dependent on 
the behavioural state. Gronau and Craig [50] found no association between 
behavioural state and the number of infants responding with brow bulge, eye 
squeeze, naso-labial furrow, or open lips following heelstick. The occurrence of 
taut tongue and vertical stretch mouth, however, was significantly related to 
behavioural state. The proportion of children responding with taut tongue and 
vertical mouth stretch was the largest in infants who were quiet awake prior 
heelstick; 85% and 55%, respectively, and the smallest for infants in quiet sleep; 
57% and 22%, respectively. Findings by Stevens eta!. [52] in preterm neonates 
suggest tbat the appearance of facial actions depend on the behavioural state. The 
proportion of time that brow bulge, eye squeeze and naso-labial furrow were 
present following heelstick was 64%, 55%, and 63%, respectively, in those who 
slept quietly prior to heels tick, and 91%, 7 4%, and 92%, respectively, in the active 
awake. 
Age 
Premature neonates respond to pain with the same facial actions as term-born 
babies do. However, the vigour of facial activity to noxious stimuli in premature 
neonates is significantly less than in term-born neonates [47,51,92]. Moreover, 
premature neonates may react to procedural pain with tongue protrusion [56], in 
contrast to term-born infants [49]. They also display more horizontal mouth stretch 
than neonates, who tend to react v.i.th vertical mouth stretch and taut tongue 
[49,50,52,92]. This difference in mouth stretch might be based on immaturity of the 
prematurely born neonate, as only soft tissue is involved in horizontal mouth 
stretch, whereas mandibular action as well as soft tissue are involved in vertical 
mouth stretch [51]. 
Using the MAX, some investigators [63,64,85] have demonstrated that after needle 
penetration the occurrence of the pain expression decreases with age, whereas the 
anger expression increases. Besides pain and anger, infants also display sadness as a 
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reaction to needle penetration. The occurrence of this latter expression seems to be 
independent of age. 
Using the NFCS, others have demonstrated that 4-month-old infants display less 
facial reactivity to noxious stimuli than 2-month-old infants do [51,53], but also less 
when compared with facial reactivity at the ages from si:< to eighteen months [53]. 
Early pain exposure 
Findings suggest that perinatal pain exposure, particularly when no adequate 
analgesia is given, alters the vigour of the facial reaction to subsequent pain [59,75], 
as well as its expression in later childhood [82,93-95]. For example, Gronau eta!. 
[75] reported that the facial actions were more extreme in infants who had 
experienced more stressful deliveries. Moreover, the duration of brow bulge, eye 
squeeze and naso-labial furrow to subsequent routine immunisation in circumcised 
infants was significantly greater compared with non-circumcised infants [82]. 
Others [59], by contrast, found that preterm infants of 28 weeks gestation age who 
had spent 4 weeks in a :t\iiCU and who had suffered a greater number of noxious 
procedures were less mature in their facial pain response than premature neonates 
of 32 weeks gestation age. In this study, the less mature facial responsiveness was 
associated with a higher number of painful procedures previously undergone. 
2.4.4 Ability to detect cbange 
To detect whether the facial reaction is sensitive to changes in pain severity, the 
NFCS facial actions were combined into a single index pain score. These indices 
were determined by summating the duration of the facial actions during the 
observation period. 
(Preterm) neonates and infants who are exposed to noxious stimuli display 
significantly more facial activity than when exposed to non-noxious stimuli, for 
example when subjected to rubbing the thigh or applying a non-noxious stimulus 
to the heel [47,49,50,52-54,59,60,66,68,74,77,79,92]. 
Neonates display less facial activity when undergoing venipuncture instead of 
heelstick, but more when compared with neonates exposed to non-noxious stimuli 
[62]. Facial activity during venipuncture is climinished when EMLA cream is pre-
emptively applied [78]. J\Jeonates, on contrary, who had received EMLA before 
circumcision displayed three times greater facial activity during surgery than before 
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at baseline [72,83]. This latter finding suggests that EMLA is contraindicated for 
this procedure as demonstrated by others [96,97]. Scott eta!. [80] demonstrated 
that preterm neonates who receive morphine display significantly less facial activity 
during heelstick compared with a placebo group. 
2.4.5 Different pain modalities 
There are no data on whether the facial actions described above also occur when 
(premature) neonates and infants experience subacute or longer lasting pain, e.g. 
postoperative pain or pain due to neonatal illness such as necrotizing entrocolitis, 
meningitis, or osteomyelitis. In contrast to acute short enduring pain, subacute pain 
has an inflammatory cytochemical or paractine basis initiating or continuing the 
pain [98]. The pain may not be obvious to observers and the response may be 
subtler and not continuously present. 
2.4.6 Discrimination between pain, emotional states and distress 
Pain versus emotional states 
As early as 1872, Darwin [90] pointed out that various facial expressions have a 
universal meaning, regardless of the culture in which people are raised. Thorough 
work of Izard eta!. [99] and Ekman eta!. [43,44] confirms Darwin's observations. 
They demonstrated that a total of si..--< facial expressions, i.e. the expression of anger, 
fear, sadness, disgust, shame, interest, joy and surprise seem to have a universal 
meaning. Some have argued that the expressions associated with interest and shame 
also have a universal meaning [99]. Others, on the contrary, believe that the 
position of the head provides clues for distinguishing these emotions [86]. Each of 
these expressions is clearly distinguished from the expression of pain. The core 
expression of anger is almost the same as that of pain, although in anger the eyes 
are narrowed instead of tightly closed. Fear is characterised by lifted brows and 
wide open eyes while the mouth is slightly opened, and sadness by raised and 
medially pulled brows, narrowed eyes, with the comers of the mouth drawn 
downward and slightly outward [87] (see Figure 2.1). These emotional expressions 
have also been observed in neonates and infants and can be distinguished from the 
pain expression as described earlier [63,65,85]. Like the facial display of pain and 
anger the expressions of interest, joy, and disgust can be identified at birth; sadness 
in 2-month-old, surprise in 4-month-old, and fear in 7 -month-old infants [63,64]. 
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Pain vers1-1s distress 
In one study [73] a considerable overlap was found in facial actions bet\Veen infants 
who suffered from colic pain (Wessel's colic infants) and healthy controls who 
cried before and after feeding. Before feeding, brow bulge and taut tongue were 
observed to appear slightly longer in infants who cried due to abdominal cramps, 
compared with crying healthy controls; i.e. brow bulge was present 118 vs. 110 
seconds, respectively, and taut tongue was present for about 70 vs. 42 seconds, 
respectively. With respect to eye squeeze and naso-labial furrow no significant 
differences were found bet\Veen both groups. These facial actions may also appear 
during distress, i.e. following heel rub [50], warming of the foot [52,92], sham 
heelsrick [77], and following the provocation of the withdrawal reflex by 
application of Von Frey hairs [84]. However, their occurrence is much shorter 
when the infant is in discomfort than when in pain [56,92]. 
2.5 Discussion 
The reviewed literature shows that when in pain, neonates and infants react with 
brow bulge, eye squeeze, naso-labial furrow, and open lips. Other facial movements 
such as mouth stretch and taut tongue may occur as well, probably providing 
information about the severity of pain. These pain-related facial actions are 
sensitive to change, demonstrated by comparing noxious stimuli with non-noxious 
stimuli but also following the administration of analgesics. Moreover, they form a 
constellation of pain that can be distinguished from the facial expressions 
associated 'With emotional states such as anger, sadness, or fear. These pain-related 
facial actions have also been observed in infants who suffer from distress due to 
hunger or discomfort. 
In this review we found that facial reactivity to a standardised pain stimulus is 
subjected to inter and intra-individual differences such as behavioural state, 
gestational age, and previous pain experiences. For example, the facial response to 
noxious procedures is greater in term-hom neonates than in neonates born at 
premantre age. Moreover, this response is more ·vigorous in term-bom neonates 
who have a history of pain exposure, but less vigorous in premature-born neonates 
with a comparable history. These findings, however, are in contrast with findings 
demonstrating that pain thresholds increase with increasing gestational age and that 
premature neonates and term-born neonates with a history of pain have lower pain 
thresholds than neonates without any history of pain [3,11]. 
Figure 2.1 Facial expressions of pain, anger, sadness, and fear 

The J)a/ue if the face 
It thus appears that the vigour and richness of the facial response should be 
interpreted in relation to some characteristics of the child such as gestational age, 
and history of perinatal pain exposure. 
In none of the 38 publications, facial activity was studied in situations of subacute 
pain. Whether the face is sensitive and specific enough for the assessment of 
subacute, longer-lasting pain such as postoperative pain or pain associated with 
neonatal illness is not known. This, however, is a more challenging complex 
question and of greater clinical importance than short, acute pain. The responses to 
subacute pain may be subtler. Infants may not display their pain continuously but 
may tend to go in a passive state to conserve their energy [59,100], as animals do 
when they cannot escape from a threat or stress (e.g. severe traumatic injury or 
repeated defeat in social encounters) [101]. Moreover, many of these infants have a 
history of frequent pain exposure [102], which might lead to hypersensitivity or 
allodynia [1 03]. In the end they may be too exhausted to communicate their pain. 
Sedatives may further influence the infant's ability to communicate pain. Further 
studies should explore whether infants use the same facial actions in situations of 
subacute pain as well as their sensitivity and specificity in these situations. 
The constellation of facial actions that emerges from the literarure is the same as 
Darwin [90] described more than a centuty ago. Darwin, however, defined this face 
as the face of suffering caused by pain, distress, and hunger. Darwin's observations 
still hold true. Recent studies have only led to refinements, i.e. the vigour and 
richness of the pain expression as well as tongue movements allow us to discern 
pain from discomfort, but not pain from hunger. 
As mentioned in the introduction, the variety of descriptions of the pain face in the 
multidimensional pain assessment instruments led us to undertake this review. 
These descriptions seem to be based on a-priori data without any reference to 
empirical data. Most instruments do not define which facial actions are involved in 
the facial display of pain or grimace [1 04-1 08]. This raises questions such as what is 
a pain face or when does a grimace appears. These v~oue descriptions increase 
subjectivity and may reduce reliability of the observation. Other instruments 
misinterpret what should be observed. For example clenched jaw is mentioned in 
four instruments [109-111], while others include chin quiver as a pain-related facial 
action [110,112,113]. In this review we did not find any evidence that clenched jaw 
or chin quiver can be regarded as pain-related facial actions. In another instrument 
[111] fear was included as a possible reaction to pain. To date fear has not been 
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observed as a common reaction to pain, unlike anger and sadness [64]. Hence, it 
would be more appropriate to include an objectively described facial response 
based on empirical findings, such as reviewed in this paper. 
In conclusion: the sensitivity and specificity of the infant's facial response to pain 
was reviewed in this paper. In general the available data demonstrate that the 
infant's face is remarkably plastic. The facial response to pain has good sensitivity 
and is characterised by a constellation of seven well-defined facial actions. This 
constellation can be distinguished from the facial expressions associated with 
emotional states such as anger, fear or sadness. In comparison 'W'ith other pain 
indices, the specificity of the facial actions is relatively high, although it remains 
difficult to discriminate between pain and distress due to discomfort. 
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3.1 Abstract 
Background The validity of the :\:eonatal Facial Coding System (l'FCS) has not 
been established yet for postoperative pain assessment. 
Objective To compare postoperative pain responses assessed by the ?\:FCS with 
those assessed by several valid pain-related indices. Secondly, to examine whether 
all ten :\:FCS facial actions are necessary for valid assessment of postoperative pain. 
Design Prospective observational study 
Methods Thirty-seven children (0-18 months old) undergoing major abdominal or 
thoracic surgery were included. The children's facial, behavioural (COC\1FORT 
'behaviour' and VAS) and physiological (blood pressure and heart rate) responses 
were assessed eight times during the first 24 hours. Catecholamine and morphine 
plasma concentrations were also determined. Random Regression Analysis served 
to assess the association between NFCS and the other pain indices. 
Multidimensional scaling was carried out to examine whether some facial actions 
could be combined. 
Results All ten facial actions were combined into a single index of pain. This index 
significantly associated with COMFORT 'behaviour', VAS, and with heart rate and 
blood pressure, but not with the catecholamine, morphine, and M6G plasma 
concentrations. Multidimensional scaling revealed that brow bulge, eye squeeze, 
naso-labial furrow, horizontal mouth stretch and taut tongue could be combined 
into a single measure of pain. The remaining five facial actions were not 
interrelated. r\lso this single measure significantly associated with COMFORT 
'behaviour', VAS, and with heart rate and blood pressure, but not v.~th the 
catecholamine, morphine, and M6G plasma concentrations. 
Conclusion The same facial actions that characterise acute pain are also valid 
indicators of postoperative pain. This study confirms previous findings 
demonstrating good reliability of the l':FCS. The reduction of the NFCS to five 
facial actions appears to increase the specificity for pain assessment without 
reducing the sensitivity and validity for detecting changes in pain. 
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3.2 Introduction 
Since the landmark publications of Anand eta!. (4,119], which demonstrated the 
adverse effects of untreated pain in neonates undergoing surgery, pain assessment 
in infants and young children has received great interest. Assessment of infant pain 
is challenging; because self-report is not available the presence of pain is inferred. 
\Xlhile pain assessment during acute pain-related procedures has been characterised 
extensively, the measurement of subacute pain, such as postoperative pain or pain 
associated with neonatal illness (e.g. necrotizing entrocolitis, meningitis or 
osteomyelitis), is even more complicated and has barely begun to be addressed in 
infants. In the postoperative period for example, the manifestation of observable 
behaviours by infants in pain may not be obvious, may be diminished (59] or even 
not (continuously) present (120]. Moreover, sedatives may alter the ability to 
express pain. 
At present, of all non-verbal pain indicators the facial response to pain appears to 
be the most specific for the expression of acute pain. Not only do facial responses 
differentiate pain/distress from other emotion states (63,64], for caregivers they are 
also more consistent than, for example, cry (121] and even more salient than cry 
(48]. Furthermore, following noxious procedures facial activity explains more 
variance than cry, body movements, or heart rate do (55,67]. 
Studies on the infant's facial response to pain have mainly used the Neonatal Facial 
Coding System (NFCS) (49,50,122]. This is an anatomy-based measure in which ten 
discrete facial actions are coded as present or not. Of these, seven are typically 
associated with acute pain: i.e. brow bulge, eye squeeze, naso-labial furrow, open 
lips, horizontal mouth stretch, vertical mouth stretch, and taut tongue. Chin quiver 
is less frequent, and lip purse never occurs during pain. The tenth facial action, 
tongue protrusion, has been found to be counterindicative of pain in term-born 
infants (49] but controversially was related to pain in preterm infants at 32 weeks 
gestation (56]. The NFCS has been validated for premature neonates (47,52,54,57], 
term-born neonates (49,50] as well as for older infants up to 18 months of age (53]. 
This instrument is sensitive to acute pain because it discriminates bernreen noxious 
(e.g. heel stick) and non-noxious stimuli (e.g. heel swab) (47,56,77] and also 
between infants receiving sucrose or morphine and controls during invasive 
procedures (25,71,76,80]. 
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Some investigators suggest that of the ten facial actions described only three, i.e. 
brow bnlge, eye squeeze, and naso-labial furrow, will suffice for valid pain 
observation [59,77,82,116]. The rationale for using only this subset of facial actions 
is that these are the most frequently observed in neonates and infants undergoing 
painful procedures and that each can distinguish between acute pain and non-pain 
states [54,66]. In contrast, Grunau et al. [56] argued against reducing the number of 
facial actions because those facial actions that are not universally observed may 
provide important information, e.g. about individual differences in pain experience. 
Furthermore, in case of subacute or chronic pain, subtle signs of ongoing 
discomfort might be missed if only the most common facial actions in response to 
acute procedural pain are assessed. The importance of evaluating the facial actions 
across development and in different situations has been underscored by the finding 
that tongue protrusion is associated with acute pain in preterm neonates younger 
than 33 weeks of gestation [56] but not in term-born infants [49]. 
It has not yet been established whether the NFCS is of clinical value for assessing 
pain in infants after major surgery. Determining the presence and severity of pain 
in the postoperative period is problematic, because of its subjective nature and the 
lack of gold standards. The present study has two main aims. The first aim was to 
compare responses obtained by using the NFCS with those obtained by using a 
modified version of the COMFORT-scale (COMFORT 'behaviour' scale) 
[107,118], the Visual Analogue Scale ry AS), as well as a number ofbio-
physiological pain indicators (i.e. heart rate, blood pressure, and catecholamine 
plasma concentrations), and morphine plasma concentrations. The second aim was 
to examine whether all ten facial actions included in the NFCS are necessary for 
valid assessment of postoperative pain in infants. To this aim a subset of facial 
actions was derived through multidimensional scaling. This subset was validated by 
comparing reactivity with COMFORT 'behaviour', VAS, bio-physiological 
responses as well as with morphine plasma concentrations. Additionally, this study 
addressed possible age, sex, and mechanical ventilation effects, as well as time trend 
effects and effects of method of morphine administration. 
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3.3 Materials and Methods 
33.1 Design 
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This prospective, observational study is part of a larger, pre-stratified double-blind 
randomised clinical trial assessing the efficacy of continuous morphine 
administration and intermittent morphine administration after major surgery in 
neonates and young children up to 3 years of age [123]. 
The inclusion criteria of the main trial were: I) neonates aged :>: 4 weeks \>lith a 
gestational age ~ 35 weeks and a body weight ~1500 grams; II) and infants \>lith a 
corrected postnatal age of at least 5 weeks up to 3 years; III) admitted to the ICU 
after thoracic or abdominal surgery. Patients were excluded if they 1) had received 
preoperative morphine or other opioids, 2) were given sedative drugs or muscle 
rela..'<ants, 3) had hepatic or renal dysfunction, 4) neurologic damage, 5) altered 
muscle tone, or 6) preoperative anaemia (hematocrit less than 30%). The hospital's 
medical-ethical committee approved the trial and parental consent was obtained. 
The infants were pre-stratified into three age groups because age differences in 
behavioural and physiological reactivity were expected to be of relevance, i.e. 
neonates, :>: 4 weeks old; young infants, 5 weeks to 6 months old; and infants, <: 6 
months old, respectively. 
Anaesthesia was standardised for all patients. After the induction of anaesthesia an 
arterial line was placed from which blood samples were drawn for measurement of 
catecholarnines and morphine plasma concentrations. 
After the operation all patients received morphine until they were pain free, defined 
as VAS < 4. For postoperative analgesia the patients received either a continuous 
morphine infusion 10 mcg.kg.h·1 or intermittendy morphine 30 mcg.kg·1 every 3 
hours (IM). In case of inadequate analgesia, defined as VAS ~ 4, patients received 
additional morphine (intravenous bolus dose 10 mcg.kg.1). 
The NFCS and video-recordings were added to the main clinical trial as new 
elements. Data generated by the main clinical trial, such as COMFORT 'behaviour' 
scale and VAS scores as well as bio-physiological data and morphine plasma 
concentrations were, also used in this additional study. 
33.2 Subjects 
All children who participated in the larger clinical trial in the period between 
28-06-97 and 11-08-98 and who were younger than 18 months were included in 
this study. 
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The background characteristics of these 37 children are presented in Table 3.1. 
Most children (76%) were younger than 6 months and most often had undergone 
an abdominal operation (73%) for a variety of reasons, mostly closure of entero- or 
colo-stoma (24%). Postoperative mechanical ventilation was necessary in 43% of 
the children for at least 24 hours and in 8% of the children for 12 to 24 hours. 
Table 3.1 Background characteristics 
Number of infants % 
Age group 
Neonates (0- 4 weeks) 11 30 
Young infants (4 weeks- 6 months) 17 46 
Infants (6 -18 months) 9 24 
Sex 
Male 19 51 
Female 18 49 
Surgery 
Abdominal high/low 27 73 
- Thoracic (with or without abdominal) 9 24 
Superficial 1 3 
Surgical procedU1'es 
Stoma closure 9 24 
:.vliscellaneous (diaphragmatic paresis, tumour, 6 16 
teratoma cyst, choledochal atresia, M 
Hirschsprung) 
T racheo-oesophagal atresia 4 11 
Lobectomy 4 11 
Septic gastro-intestinal (intussusception, 4 11 
perforation, ileus) 
Intestinal atresia/ malrotation 3 8 
Congenital diaphr~omatic hernia 3 8 
Gastroschisis 1 3 
Kephrectomy 1 3 
Nissen fundoplication 1 3 
Colon interposition 1 3 
Postoperative mechanical ventilation 
None 18 49 
12-24 hours 3 8 
> 24 hours 16 43 
33.3 Assessment measures 
The NFCS was used to provide detailed descriptions of facial activity. This 
anatomy based coding system focuses on changes in 10 discrete facial actions: i.e. 
brow bulge, eye-squeeze, nasolabial furrow, open lips, horizontal mouth stretch, 
vertical mouth stretch, taut tongue, lip purse, chin quiver, and tongue protrusion. 
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To compare facial activity with changes in pain-related indicators, the facial actions 
were combined into a single index score of facial activity (NFCS_total). Tbis index 
was determined by summating the duration of the observed facial actions and 
dividing the sum by 10. As the observation periods lasted 120 seconds, each facial 
action could in theory be present for a ma:dmum of 120 seconds. The index could 
thus range from 0 to 120. 
The COMFORT 'behaviour' scale [118] is an adaptation of the original 
COMFORT scale [107], adding the item 'crying', and removing the physiological 
items 'heart rate' and 'mean arterial blood' pressure. It thus comprises seven 
behavioural items, i.e. Alertness, Calmness, Muscle tone, Physical movement, Facial 
tension, Respiratory behaviour, and Crying. The item Respiratory behaviour is 
scored only in ventilated patients, Crying in non-ventilated patients. The resulting 
si-....:: items are scored on a 5-point scale, ranging from 1 to 5, so the total score can 
range from 6 to 30. The COMFORT 'behaviour' scale is reliable and valid for the 
postoperative pain situation [118]. In the main clinical trial, and thus also in this 
sub-study, COMFORT 'behaviour' ratings were obtained from trained nurses. 
The observational Visual Analogue Scale ry AS) is a horizontal continuous 10-cm 
line with the anchors 'no-pain' at the left side and 'extreme pain' at the right side. 
Nurses are asked to indicate on this line the extent to wbich they think the patient 
is in pain. Concurrent validity with other postoperative pain measures has been 
shown [124,125]. 
Heart rate and mean arterial blood pressure were measured with the Hewlett 
Packard Component Monitoring System (Boblingen, Germany). The raw data were 
used to calculate the mean and variability (i.e. standard deviation) of heart rate 
(HR_mean and HR_ var, respectively) and mean arterial blood pressure (BP _mean 
and BP _var, respectively), for each observational period. Concurrent validity of 
these physiological indicators has been established with the COMFORT 
'behaviour' scale [126]. 
Catecholamine plasma concentrations of adrenaline and nor-adrenaline were 
measured by HPLC using fluorometric detection [123]. 
Plasma concentrations of morphine and its metabolite M6G were assessed using 
the fluorometric immuno assay method. 
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3.3 .4 Procedures 
Procedure: measurements 
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All study subjects were observed by nurses for 120 seconds on admission to tbe 
intensive care unit, and every 3 hours, up to 24 hours postoperatively. During tbese 
bedside observations a nurse registered tbe patient's heart rate and mean arterial 
blood pressure every 20 seconds; tben at tbe end of tbe observation period tbe 
COMFORT 'behaviour" and VAS scores were assigned. 
At the same times, except 15 hours after surgery, continuous video recording was 
carried out for 120 seconds and providing a full view of tbe patient's face. 
Arterial blood samples for catecholamine and morphine plasma concentrations 
were taken at tbe end of surgery, and at 6, 12 plus 24 hours postoperatively. 
Video ana!Jsis 
NFCS coding was carried using video analysis by one primary coder [autbor JWBP] 
and one reliable coder [co-autbor MvD] who botb were not aware of tbe data of 
tbe main clinical trial. For each observation period separate video playbacks were 
used to code each facial action for presence or absence. Computer keyboard entries 
marked tbe onset and offset of each facial movement. The beginning of each 
observation period coincided when nurses started witb COMFORT 'behaviour' 
observations and lasted 120 seconds. 
Apparatus 
A VHS colour camera (Hitachi VM-S7200E) was used. A copy was made of each 
videotape and a Vertical Interval Time Code was added (Adrienne Electronics 
Corporation; Las Vegas, USA). This means tbat each frame of tbe video recording 
was marked witb a unique format (Hours: Minutes: Seconds: Frames) enabling 
selection and coding of specific sections of tbe videotape. A Videotape Analysis 
System was used which included: a computer witb a Vertical Time Code Reader 
(16-bits ISA-board), tbe Observer 3.0 Base Package for Windows and tbe Observer 
4.0 Sofrware Package for video analysis (Noldus: Wageningen, The Netherlands), a 
video cassette recorder (Panasonic AG 5700) witb remote control, stop action and 
slow motion feedback, and a 50 Hertz monitor. 
3.3 .5 Reliability 
Inter-observer reliability for tbe NFCS was assessed by using a random selection of 
10 video recordings in which tbe children displayed facial movements. Inter-
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observer reliability was calculated for each facial action in accordance with the 
conservative Facial Action Coding System reliability formula [50,66]. The 
agreement ranged from 0.84 for vertical mouth stretch to 1.0 for open lips. 
Nurses were trained in using the COMFORT 'behaviour' scale until they reached 
the criteria for inter-observer reliability, i.e. when linearly weighted Cohen's kappa 
for each item exceeded 0.40 [118]. 
3.3.6 Data analysis 
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To estimate the association between NFCS scores and COMFORT 'behaviour' and 
VAS scores, as well as with bio-physiological pain indices and morphine plasma 
concentrations, Random Regression Modelling (error covariance = unstructured) 
for continuous data [127] was carried out with SAS 6.12 for Windows. The 
following covariates were included in all analyses: (linear) time trend, morphine 
administration condition (CM and IM), age, sex, and mechanical ventilation (yes, 
no). With respect to age, two dummy variables were created: neonates (yes/no) and 
young infants (yes/no). Each random regression model incorporated random 
intercepts and random time slopes. 
To obtain a subset of facial actions, Multidimensional Scaling with phi-square 
measure was carried out with SPSS 9.0 for Windows. Distances :2:1.0 between 
stimuli co-ordinates were regarded as substantial. Each observational event of 120 
seconds was divided into 24 intervals of five-seconds in which the coder identified 
whether each separate facial action occurred. 
To assess whether NFCS-facial activity scores were affected by age, sex, or 
spontaneous versus mechanical ventilation, Random Regression Analysis was 
carried out repeatedly with one of these three variables dropped each time [128]. 
To achieve normal distributions, log transformations (natural logarithm) were 
carried out on VAS, HR_ var, BP _ var, adrenaline, and noradrenaline, morphine 
plusM6G. 
3.4 Results 
A total of 273 observations were performed. The median values for NFCS_total 
and the other pain-related behavioural and physiological indices of all these 
observations are presented in Table 3.2. The median NFCS-total score was highest 
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in the young infants; with a ma.'cimum score of 63.5. The median values for VAS, 
COMFORT 'behaviour', HR_var, and BP _var were also the highest in the young 
infants, compared with neonates and infants. 
Table3.2 Median ~~ values of the ;e:ain-related indicators 
I II III Statistical differences 
Neonates Young infants Infants 
Median,ranged Median(range) Median~ran(Te 
NFCS_total 12 0-38.4 12.5 0-63.5 12 0-46.5 !<!!" 
VAS 1.3 0.2-6.6 2.5 0.2-9.5 1.3 0.1-6.5 I< III; III<IP 
COMFORT 13.8 6.0-25.0 16.8 6.0-28.0 13.8 7.0-23.0 I < III; III<!!" 
'behaviour' 
HR_mean 144 113-185 155 110-206 159 104-193 
BP_mean 52 37-77 78 56-130 80 52-115 I < II'; II <IIf 
HR_var 3.5 0.6-24.5 6.3 0.8-22.4 4.7 0.6-20.8 I < II'; III <II" 
BP_var 1.6 0-6.4 3 0.4-14.6 2.4 0.6-9.6 I< II'; III<If; I<II!" 
Adrenaline 23 1-378 140 9-1463 336 16-2046 I < II'; II <III'; I <III" 
:N oradrcnaline 313 103-2091 431 106-1425 420 173-950 
Morphine 21.6 0-218.0 13.2 1.0-109.0 4.7 0-98 
M6G 18.0 0-85.0 9.0 0-52.0 4.5 0-17.4 
Notes: Differences between the three age groups were compared using the summary 
measurement approach. For testing overall differences the non-parametric Kruskal-Wallis 
test was performed. Mann-Whitney U test was used to assess pairwise differences. 
* p < .05; f"p <.OJ; tP <.001. 
3.4.1 Performance ofNFCS_total 
NFCS_total was significantly (p <.01) associated with VAS and COMFORT 
'behaviour' scores and also with HR_mean, BP _mean, HR_var, and BP _var (see 
Table 3.3). ;\;o significant associations were found between the NFCS_total scores 
and adrenaline, noradrenaline, morphine, and M6G plasma concentrations. 
The significant associations are depicted in Figure 3.1; only significant estimates 
(i.e. NFCS_total and covariates) are included (see Table 3.3). This figure shows that 
when NFCS_total increased from zero to ma.'cimum activity score (i.e. from 0 to 
60, see Table 3.2), the increase in VAS scores ranged between 1.3 to 4.1. The latter 
increase was influenced by two factors: the time of postoperative pain assessment 
and the need for mechanical ventilation. COMFORT 'behaviour' scores increased 
with 11 points, HR_mean with 35 beats, and BP _mean with 20 mmHg. With 
respect to HR_ var the increase was 2.3 and for BP _ var the increase ranged 
between 4.2 to 7.9. This latter increase was influenced by the age of the children 
and need for mechanical ventilation. Figure 3.1 further indicates that VAS scores in 
the early postoperative period were higher than 24 hours after surgery and were 
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lower in mechanically ventilated, compared with spontaneous breathing children. 
HR_mean was lowest in neonates. BP _mean and BP _ var, were lower in neonates 
compared with young infants and were also lower in mechanically ventilated 
children. 
3.4.2 Complexity of facial actions structure 
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Application of Multidimensional Scaling revealed a four-dimensional confi,ouration. 
Five of the ten facial actions had similar properties and could be grouped together, 
i.e. brow bulge, eye squeeze, naso-labial furrow, horizontal mouth stretch, and taut 
tongue. The other facial actions were not interrelated. The five related facial actions 
were combined into a single index of pain (NFCS_subset). This pain score was 
determined by summating the duration (total seconds) of the observed five facial 
actions and dividing the sum by 5. The other facial actions were considered to be 
independent. For each independent facial action the duration was used as a facial 
activity score. 
These NFCS facial activity scores are presented in Table 3.4. Young infants showed 
higher NFCS_subset scores than both the neonates and older infants. The median 
NFCS_subset score for the young infants was 2.4 with a maximum score of 98.7, 
for the neonates and young infants the median scores were 0.7 and 0, respectively, 
with ma:<imum scores of 49.4 and 69.0, respectively. 
Table 3.4 Median (range) values of the six indices of facial activity derived from 
Multidimensional Sc~ 
I II III Significant 
Neonates Young infants Infants differences 
Median (range) Median (range) Median (range) 
Subset BB, ES, :-;LF, I-L\1S, IT 0.7 0-49.4 2.4 0-98.7 0 0-69.0 III<!!" 
VMS 0 0 0-32.7 0 !<II; III<!!" 
TP 0 0-2.3 0 0-38.0 0 0-1.2 l<l( 
LP 0 0-1.5 0 0-73.3 0 !<II"; III<!( 
CQ 0 0-5.4 0 0-63.1 0 0-11.1 r <IIr·; m <II' 
OL 114.5 0-120 109.0 0-120 120 0-120 
Notes: Differences between the three age groups were compared using the summary 
measurement approach. For testing overall differences the non-parametric Kruskal-Wallis 
test was peiformed. Mann-Whitney U test was used to assess pain,vise differences. BB: brow 
bulge; ES: eye squeeze; NLF: naso-lahialfurrow; OL: open lips; HMS: horizontal mouth 
stretch; VMS: vertical mouth stretch: TT: taut tongue; TP: tongue protruding; LP: lip purse: 
CQ: chin quiver. * p < .05; tp < .01: I p < .001. 
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Table 3.3 Summary of Random Regression Analyses on pain 
indicators hr NFCS total :elus covariates 
Jl SE, df p Jl SE, df p 
LN(VAS) COMFORT 'behaviour' 
Intercept -.11 .47 32 .82 11.21 2.26 32 .00 
NFCS-total .02 .00 166 .00 .18 .02 167 .00 
Time -.03 .01 36 .00 -.13 .04 36 .73 
Condition -.10 .16 166 .53 -.15 .69 167 .83 
}Jconates '? .0- .26 166 .22 .87 1.11 167 .44 
Young infants .34 .20 166 .09 1.11 .86 167 .20 
Sex -.11 .08 166 .19 -.47 .89 167 .50 
V cntilation .38 .19 166 .05 1.51 .84 167 .07 
HR_mcan BP mean 
Intercept 166.88 13.57 32 .00 61.32 8.69 32 .00 
NFCS-total .58 .07 167 .00 .33 .05 152 .00 
Time -.00 .15 36 .99 .13 .10 36 .19 
Condition -2.57 4.43 167 .56 .00 2.87 152 .99 
='Jeonates -14.99 6.87 167 .03 -18.15 4.43 !52 .00 
Young infants -10.24 5.54 167 .07 -1.01 3.59 152 .78 
Sex -7.66 4.42 167 .09 -4.50 2.87 152 .12 
Ventilation -3.04 4.65 167 .52 8.40 2.94 152 .OJ 
LN(HR....var) LN@P var) 
Intercept 1.03 .51 32 .05 .22 .33 32 .52 
NFCS-total .01 .00 167 .OJ .02 .00 149 .00 
Time .00 .01 36 .93 .00 .01 35 .84 
Condition .03 .16 167 .86 -.02 .10 149 .83 
Neonates -.01 .25 167 .96 -.03 .16 149 .85 
Young infants .25 .20 167 .21 .27 .12 149 .03 
Sex -.17 .16 167 .27 -.10 .10 149 .34 
Ventilation .35 .18 167 .06 .36 .12 149 .00 
Notes: Time: time postoperative in hours, range 0-24 hours; Condition: method of morphine 
administration CM/IM, coded as 1 and 2, respectively; Neonates and Young infants entered 
as dummy variable no/yes, coded as 0 and 1, respectively; Sex: boys and girls, coded as 1 and 
2, respectively; Ventilation: mechanical ventilation versus spontaneous ventilation, coded as 
1 and 2, respectively. 


















?vfa.-x face act 
0 Spont-24hr 
¢Mech-24hr 
B 160 ~ 140 
~ 120 -----
Zero face act Ma.\: face act 













8:::::::::0····· ~ 60 
40~-------~ 
" 
Zero face act 
0 Sponi-Age(2,3) 
.6.MeclrAge(2,3) 




10 _ ..0 
~I 5 - ~;;;;;; :·, ~@;;·=·-;-;-:-;-:·:':~ 
OL------------------
Zero face act 
0 Spont-Age(2) 
,6. Mech--Age(2) 
?vfa."X face act 
OSpont-Age(1,3) 
(>Mech--Age(1,3) 
Notes: Only significant estimates (i.e. NFCS_total and covariates) were included (see Table 3.3). 
Zero face act: NFCS _total score equals 0; Max face act: NFCS _total score equals 60; Spont: 
spontaneous breathing; Mech: mechanical ventilation, 1 hr: 1 hour after surgery; 24 hr: 24 
hours after surgery; age( I): neonates; age(2): young infants; age(3): infants. 
Figure 3.1 Relations between NFCS_total and other pain indicators v.ithin the first 24 
hours postoperative 
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Table3.5 Summary of Random Regression Analyses on pain indicators 
by NFCS subset and inde:eendent facial actions :elus covariates 
B SEn df p B SE, df p 
LN(VAS) COYrFORT 'behaviour' 
Intercept -.06 .51 32 .90 14.5 1.92 32 .00 
Subset BB. ES. NLF, HMS, rr .01 .00 164 .00 .11 .01 165 .00 
CQ -.01 .00 164 .06 -.04 .02 165 .02 
OL .00 .00 164 .02 
Time -.03 .01 36 .00 -.03 .03 165 .32 
Condition -.09 .16 164 .58 -.56 .63 36 .37 
:::-Jconates .34 .26 164 .20 .19 1.02 165 .85 
Young infants .41 .20 164 .05 1.21 .80 165 .13 
Sex -.12 .08 164 .16 -.21 .32 165 .51 
Ventilation .36 .19 164 .06 .59 .77 165 .45 
HR mean BP mean 
Intercept 157.29 12.81 32 .00 61.06 7.58 32 .00 
Subset ss,ES,::-.:LF, I-L"\1$, rr .30 .04 166 .00 .20 .03 151 .00 
VMS .38 .20 151 .05 
OL .05 .02 166 .01 
Time -.03 .15 36 .84 .10 .10 36 .31 
Condition 2.76 4.48 166 .54 -.78 2.74 151 .78 
Neonates -15.15 6.95 166 .03 -19.59 4.26 151 .00 
Young infants -9.70 5.59 166 .08 -1.44 3.43 152 .67 
Sex -3.79 2.23 166 .09 -2.06 1.38 151 .14 
Ventilation -3.51 4.72 166 .46 7.19 2.87 151 .01 
LN(HR var) LN (!:>P var) 
Intercept 1.32 .37 32 .00 .89 .20 32 .00 
Subset BB, ES, NLF, HMS. rr .01 .00 166 .01 .01 .00 149 .00 
TP .02 .00 166 .06 
Time -.00 .01 36 .85 .00 .00 35 .95 
Condition .00 .12 166 .99 -.03 .07 149 .63 
Kconates -.05 .20 166 .81 -.05 .11 149 .67 
Young infants .17 .16 166 .28 .19 .08 149 .03 
Sex -.06 .06 166 .32 -.03 .03 149 .40 
Ventilation .24 .14 166 .09 .21 .08 149 .01 
Notes: Time: time postoperative in hours, range 0-24 hours; Condition: method of morphine 
administration CM/IM, coded as 1 and 2, respectively,· Neonates and Young infants entered 
as dummy variable no/yes, coded as 0 and 1, respectively; Sex: boys and girls, coded as 1 and 
2. respectively; Ventilation: mechanical ventilation versus spontaneous ventilation, coded as 
1 and 2, respectively. 
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Notes: Only significant estimates (i.e. NFCS _subset and covariates) were included (see Table 
3.5). Zero face act: NFCS _subset score equals 0; Max face act: NFCS _subset score equals 100: 
Spont: spontaneous breathing; Mech: mechanical ventilation, 1 hr: I hour after surgery; 24 hr: 
24 hours after surgery; age(I): neonates: age(2): young infants; age(3): infants. 
Figure 3.2 Relation betvveen NFCS_subset and other pain indicators within the first 24 
hours postoperative 
40 Chapter 3 
The young infants were the only ones who displayed vertical mouth stretch; they 
also had the highest scores on tongue protrusion, lip purse, and chin quiver. Open 
lips appears to have a low specificity for pain because this facial action was present 
during most of the observations and did not differ between neonates, young 
infants, and infants. To assess whether the NFCS_subset or any individual facial 
action was related to changes in other pain-related indicators, all indices were 
entered into Random Regression Analysis. To obtain only the relevant indices, 
stepwise back-ward elimination (one by one) was carried out (p-out was set at 
p> 0.10; see Table 3.5). 
Of these indices only NFCS_subset significantly estimated VAS, COMFORT 
'behaviour' HR_mean, BP _mean, HR_ var, and BP _ var, respectively. In addition, 
open lips was related with VAS (p = .02) and also with HR_mean (p = .01). 
Vertical mouth stretch was related with BP _mean (p = .05). In contrast, chin quiver 
was negatively related to COMFORT 'behaviour' (p = .02). Adrenaline, 
noradrenaline, morphine, and M6G plasma concentrations were not related to 
either the NFCS_subset or any of the independent facial actions. 
Figure 3.2 demonstrates that the association between i\lFCS_subset and VAS, 
COMFORT 'behaviour', HR_mean, BP _mean, HR_var, and BP _var equals that of 
NFCS_total. For example, when facial activity increased from zero to ma.'"-mum 
activity (i.e. from 0 to 99, see Table 3.4), the predicted increase in VAS scores 
ranged between 0. 7 to 2.3. The time of postoperative pain assessment and age of 
the children influenced this latter increase. COMFORT 'behaviour' scores 
increased with 11 points, HR_mean "~th 30 beats, and BP _mean with 20 mmHg. 
HR_var increased with 6.4 and the increase in BP _var ranged between 5.7 to 7.6. 
This latter increase was influenced by the age of the children and need for 
mechanical ventilation. 
Furthermore, VAS scores were higher in the early postoperative period than 24 
hours after surgery, and were higher in young infants compared Vlith neonates and 
infants. HR_mean was lowest in neonates. With regard to BP _mean and BP _ var, 
both physiological indices were lowest in neonates and in mechanically ventilated 
children. 
3.4.3 Sensitivity of facial activity in pain and no-pain situations 
In 48 of the 273 observations, a VAS score :::0 4 was assigued. Random Regression 
Analysis shows that NFCS-total scores and NFCS-subset scores were significantly 
greater when the subjects were judged to be in pain (p <.01) (see Figure 3.3). 
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The difference in mean facial activity scores in no-pain and pain situations was the 
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Figure 3.3 Error bars (SE) of facial activity 
stratified by pain level VAS 
3.4.4 Confounding 
The estimates of both NFCS_total and NFCS_subset did not change when age, sex 
or mechanical ventilation was eliminated from the analysis, indicating that the 
presence and vigour of NFCS facial activity does not depend on age, sex, or 
mechanical ventilation. 
3.4.5 NFCS total versus NFCS subset 
- -
To examine whether NFCS_subset provided better estimates of the pain-related 
indicators than NFCS_total, or vice versa, the models ofNFCS_total and 
NFCS_subset were compared by means of the difference in -2 Residual Log 
Likelihood ratio taking into account the degrees of freedom [129]. No significant 
differences were found between the models. Thus reducing the NFCS to five facial 
actions does not lead to a significant worse modelfit, pleading for reducing the 
NFCS to the content of the NFCS_subset. 
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3.5 Discussion 
We found that the :\:FCS was sensitive to changes in postoperative pain, and was 
associated with other behavioural and physiological indicators of pain in neonates 
and infants following major abdominal or thoracic surgery. Without unfavourable 
consequences for its sensitivity, the original NFCS can be reduced to a subset of 
five facial actions, i.e. brow bulge, eye squeeze, naso-labial furrow, horizontal 
mouth stretch, and taut tongue. These five facial actions are similar to those 
observed most frequently in acute pain situations. No adjustments have to be made 
for age, sex, or mechanical ventilation. 
Our analyses show that these five facial actions carry the bulk of information and 
are consistent across acute and postoperative pain sinrati.ons in infancy. Reducing 
the :\!FCS to five facial actions has several advantages, including a reduction in 
training time, workload, and thereby in coding costs. Moreover, only facial actions 
that are relevant for pain have to be taken into account. It has been suggested that 
dropping certain facial actions may increase the risk of missing subtle signs of 
ongoing discomfort [56]. However, our data show that these extra facial actions do 
not supply extra information. Open lips was only associated with VAS and 
HR_mean, probably because of low specificity. Others have also reported tbis low 
specificity [116,130]. Chin quiver was found to be negatively related with increasing 
COMFORT 'behaviour' scores, suggesting no sensitivity and specificity for pain. 
Lip purse was not associated "~th any of the pain-related indicators, consistent with 
previous studies in which it was dropped due to low occurrence [47,49,66]. The 
role of vertical mouth stretch in pain assessment is not clear yet. In (premature) 
neonates tbis facial action has been associated with acute pain, although the 
sensitivity is small compared "~th the upper facial actions [47,50,52,56,66,116], 
which is also the case in healthy term-born neonates [49,50]. For infants aged 2 to 
28 months, horizontal mouth stretch as well as vertical mouth stretch were 
eliminated from the NFCS because of infrequent occurrence [53]. Some studies in 
adults found vertical stretching of the mouth during pain [131,132] whereas others 
did not [45,133]. The lower facial actions are more likely to occur during severe 
pain [45,89,134] or are associated with the clinical syndrome being investigated 
[131]. In our study the incidence of severe pain was low, which may "-'plain why 
vertical mouth stretch occurred less frequently than the other five facial actions did. 
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To gain clinical acceptability of tbe subset of five facial actions, tbe validity and 
clinical utility for postoperative pain should be elucidated. In this study, content 
validity is established by tbe fact tbat brow bulge, eye squeeze, naso-labial furrow, 
horizontal moutb stretch, and taut tongue togetber form a facial display of pain. 
This finding is supported by many commonalties between this configuration and 
tbose widely accepted as indices of acute pain in neonates and infants [50,66, 134], 
of postoperative pain in children aged 1 to 6 years [130], and of acute or chronic 
pain in adults [131-133]. Independent of age, open lips was defined to be part of 
tbe configuration. This may be explained by tbe fact tbat in tbese studies tbe 
configuration was assessed using only the data following an acute procedure, 
whereas in our study all observational periods were used. 
Concurrent validity of tbe NFCS was evaluated from tbe perspective tbat pain is a 
multidimensional construct [135]. Strong relationships were found between 
NFCS_total, NFCS_subset, and COMFORT 'behaviour' scale. Changes in facial 
activity were paralleled by changes in HR_mean and BP _mean as well as in HR_var 
and BP _ var, and are tbus likely to reflect changes in pain. Some otber findings were 
unexpected. 
First, independent of (tbe vigour of) facial activity, VAS scores decreased over time 
and were lower in mechanically ventilated tban in spontaneous breatbing children. 
This raises tbe question whetber VAS scores completed by nurses are valid 
measures of pain severity [136]. Our findings suggest tbat nurses, apart from overt 
behaviour, take into account additional information when assigning VAS scores. It 
has been demonstrated that nurses use deductive and inductive reasoning to assess 
whetber tbe infant is in pain. Also characteristics and dia,onosis of tbe infant are 
taken into account [137-139]. Thus VAS scores may not reflect solely tbe severity 
of pain but ratber include nurses' confidence tbat an infant is in pain. 
Second, neonates normally have higher resting heart rates than infants have. In this 
study, however, tbe opposite was found. Morphine may be responsible as this drug 
is believed to produce dose dependent bradycardia caused by central stimulation of 
tbe vagal nucleus in tbe medulla. In this smdy neonates received tbe same amounts 
of morphine as (young) infants did, but due to lower clearance and longer 
elimination half-life [140] tbe neonates had tbe highest morphine and M6G plasma 
concentrations. 
Third, no association was found between facial responsiveness and stress hormone 
concentrations. Otbers support this observation [141,142]. Facial reactivity and 
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catecholamine responses appear to have different levels of sensitivity and specificity 
for pain assessment. Both are blunted by appropriate pain relief [4,76,80,143, 144]. 
Catecholamine plasma concentrations, however, may be subject to many influences 
other than pain [145, 146] and pain-related behaviours are not always displayed 
when in pain [120,147,148]. The absence of pain-related behaviour does not imply 
absence of high catecholamine concentrations elevated by pain [144]. Thus, facial 
activity and catecholamine responses appear to be relatively independent indices of 
infants~ reactivity to pain. 
Construct validity is the most difficult and challenging task in instrument 
development. The difference in facial activity between pain and non-pain states was 
greater for J\iFCS_subset than NFCS_total, suggesting that NFCS_subset is a more 
specific measure for postoperative pain. In this study we did not examine whether 
facial activity decreased after the administration of analgesics. Guinsburg eta!. [76] 
did so and demonstrated that morphine decreases NFCS scores in mechanically 
ventilated premature neonates less than 33 weeks gestational age, as did Scott et al. 
[80] in neonates 24 to 39 weeks who were undergoing noxious procedures. 
A bunaing question concerns the added value of the NFCS. In contrast with other 
mainly multidimensional pain assessment instruments the NFCS is very detailed 
and the facial actions are well defined. The facial configuration of pain can be 
distinguished from emotional states such as anger, fear, or sadness [63]. In contrast 
with the other behavioural measures, the child need not be disturbed, for example 
taking off the blanket, as the face is normally visible. Apart from fine graded video 
analysis, there is evidence that the l':FCS can be used in real time at the bedside 
[56,57,76], with high inter-observer reliability. Moreover, our findings demonstrate 
that sex, age, or mechanical ventilation does not affect facial activity. The NFCS 
facial actions are well defined, in contrast to the global and va,oue definitions of 
facial activity and other pain-related behaviours in most of the multidimensional 
pain assessment instruments. We are aware that the NFCS only includes overt 
facial mOvements, while many multidimensional pain assessment instruments, apart 
from overt behaviours, also include physiological pain indices. However, in two 
studies the authors concluded that in the postoperative period physiological 
measures do not add extra information to the behavioural findings and for that 
reason can be dropped from the instrument [113,118]. For these reasons we 
suggest that the NFCS may be a good alternative. 
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In summary, this is the first study demonstrating that the same facial actions that 
characterise acute pain are also valid indicators of postoperative pain. Content and 
current validity for the postoperative period were established as well as a first phase 
of construct validiry. This study confirms previous findings demonstrating good 
reliability of the l':FCS. Reducing the NFCS to five facial actions appears to 
increase the specificity for pain assessment without reducing the sensitivity and 
validity for detecting changes in pain. 
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Major surgery within the first three months of life and subsequent 
bio-behavioural pain responses to immunisation at later age: 
a case comparison study 
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Background Pain exposure during early infancy alters the pain perception beyond 
infancy into childhood. 
Objective To examine if major surgery within the first three months of life in 
combination with pre-emptive analgesia, alters infants' pain responses to 
immunisation at toddler's age. Secondly, so assess whether these alterations are 
greater in toddlers with a larger number of negative hospital experiences. 
Design Case comparison study 
Methods Two groups of 50 toddlers each were compared: index and control group. 
All index toddlers had participated within the first three months of their life in a 
random clinical trial evaluaring the efficacy of pre-emptive morphine administration 
for postoperative analgesia. The control group consisted of matched controls. Pain 
reactions were recorded at routine immunisation at either 14 months (J\1]v.fR 
immunisation) or 3 years and 9 months (DTT immunisation) of age. Outcome 
measures were facial reaction, coded by the Ma.'Ximum Discriminative Facial 
Movement Coding System, heart rate, and cortisol saliva concentration. Negative 
hospital experiences included: number of operations requiring morphine 
postoperatively, cumulative TISS scores, and 1) number of days mechanically 
ventilated, 2) length of stay in ICU, or 3) total hospitalisation days. 
Results No differences were found between the index and control group in the facial 
display of pain, anger, or sadness, or in heart rate, and cortisol concentrations. 
Intra-group analyses of the index group showed that following MMR the number 
of operations and total TISS score correlated positively with the facial 
responsiveness, r =.72 and .61, respectively. Conversely, the number of operations, 
total TISS score, days of mechanical ventilation, and length ofiCU stay correlated 
negatively with heart rate responses, r = -.58 to -.76. No effect was seen after DTT 
immunisation. 
Conclusion Major surgery in combination with pre-emptive analgesia within the first 
months of life does not alter pain responses to subsequent pain exposure in 
childhood. Exposure to (non-)noxious procedures during hospitalisation influences 
the pain responses for a prolonged period. These, however, diminish after a 
prolonged period of non-exposure. 
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4.2 Introduction 
It has been well established that the nociceptive pathways, (sub)corrical centres, 
and neurochemical systems necessary for pain perception and transmission are 
intact and functional from an early stage of foetal development [149]. However, in 
new-borns this neural system is still very immature and requires rime to mature into 
childhood. Experimental data suggest that during this "critical period of 
immaturity" alterations in normally occutring activity patterns, e.g. due to frequent 
pain exposure, make this system more susceptible to perturbation than at any other 
rime of life [10,11,150,151]. 
New-borns admitted to neonatal ICUs will be exposed to noxious interventions 
associated with life-saving high technology care [28]. In (premature) neonates this 
results in a decreased pain threshold [103,152], and a prolonged period of sensory 
hypersensitivity [153,154]. These decreases in pain threshold coincide with clinically 
significant bio-beha"Vioural changes in pain reaction, i.e. in facial reaction, 
cardiovascular response, and saliva cortisol response [59,75,155-157]. 
Emerging evidence suggests that these bio-behavioural changes will persist after 
discharge from the hospital. At corrected ages of 4 and 8 months premature infants 
born with extreme low birth weight (ELBW) show less facial activity but higher 
heart rate in response to subsequent pain than term-born infants do [60,158]. This 
effect is most pronounced in infants who seemed to be sicker at birth, stayed 
longer in the NICU, experienced more painful procedures, and received greater 
amounts of morphine [60]. Parents' reports suggest that ELBW neonates at 18 
months corrected age are less reactive to everyday pain than term-born toddlers 
[94]. At the age of 8-10 years, ELBW children rated pictures of medical events as 
more painful than pictures of psychosocial pain events, unlike term-born peers 
[159]. In this latter study it was found that, apart from pain sensitivity, also the 
affective aspects of the pain experience were altered. At the age of 12 to 16 years, 
however, no significant differences on a pain questionnaire could be demonstrated 
between ELBW and term-born adolescents [160]. 
The few reports on healthy, full-term infants' responses to pain over rime also 
suggest prolonged increased pain sensiti-vity as a consequence of early pain 
experience. Circumcision without any form of analgesia increased the infants' hie-
behavioural pain responses to subsequent immunisation at the age of 4 to 6 months 
[82,93]. Also, stressful conditions at birth, i.e. assisted delivery versus elective 
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caesarean section, were associated with increased salivary cortisol responses to 
immunisation at 2 and 6 months of age [161,162]. 
At present, the effects of major surgery on the immature nervous system and 
subsequent pain response in childhood are unknown. In contrast with a decade 
ago, neonates now receive pre-emptive analgesia for postoperative pain relief [16]. 
Experiments in animals suggest that appropriate doses of morphine may prevent 
the development of altered pain sensitivity [1 OJ. In humans, however, it is not 
known whether effective dosages of morphine diminish the iatrogenic effects of 
pain. 
This is why we set up a case comparison study to answer the question: does major 
surgery within the first three months of life, under the condition of pre-emptive 
analgesia, alters the pain responses to immunisation at toddler's age? 
We also were interested whether the number of negative hospital experiences 
during infancy alters pain responses to immunisation at toddler's age. For example, 
infants born with congenital abnormalities often undergo more than one surgical 
intervention and are hospitalised for a long period during which they are subjected 
to many noxious procedures. In contrast with pain following major surgery, many 
noxious procedures are still carried out without any form of analgesia [25]. 
4.3. Methods 
4.3.1 Design 
A prospective case comparison study in a number of community health care 
centres in the Netherlands was undertaken. This study includes part of a cohort of 
(young) children who have participated in a large double blind randomised clinical 
trial, which was carried out in the ICU of the Sophia Children's Hospital, the 
Netherlands, between April 1996 to August 1999. The aim of the larger trial was to 
assess the efficacy of pre-emptive continuous versus intermittent morphine 
administration following major abdominal or thoracic surgery, e.g. stoma closure 
diaphragmatic paresis, teratoma cyst, choledochal atresia, or M. Hirschsprung. 
Additional postoperative analgesics were given when nurses assigned Visual 
Analogue Scale scores~ 4 ern [123]. 
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4.3.2 Subjects 
All children who have participated in this larger trial are prospectively being 
followed. Those who had to receive either their routine Measles, Mumps, and 
Rubella (MJ\1R) or Diphtheria, Tetanus, and Trivalent polio (DT1) immunisation 
between January 1998 to July 2000 and who had participated within the first three 
months of their life in the larger trial were included in this underlying case 
comparison study (index children). The immunisation was given at each toddler's 
own community health care centre. 
At each centre matched control toddlers were selected. The match variables were 
community health care paediatrician and type of immunisation. Inclusion criteria 
for these matched controls were no history of abdominal or thoracic surgery and 
undergoing either 11J'\1R or DIT immunisation. To prevent selection bias, the 
toddler closest in time to the immunisation of the index child was selected. When 
parents refused consent, the toddler next in time was selected. 
Exclusion criteria for the index as well as the control group were 1) mental 
retardation, 2) deafness, 3) blindness, and 4) overt signs of illness at the day of 
immunisation. The Medical Ethical Committee of this hospital approved this study 
and informed parental consent was obtained. 
According to routine schedules for immunisation in infancy and childhood, the 
MMR was given at the age of 14 months and the DTT at the age of 3 years and 9 
months. 
4.3.3 Assessment measures 
Alterations in pain responses were assessed from a bio-behavioural perspective. 
The behavioural responses to immunisation were assessed by the Ma.~um 
Discriminative Facial Movement Coding System (MAX) [63,64]. This coding 
system was selected to assess whether early pain experiences alter pain sensitivity 
and/ or the affective aspects of the pain experience [159]. The MAX is an anatomy 
based facial coding system that focuses on facial movements (appearance changes 
(AC)). These ACs are served by three separate branches of the facial nerve and by 
three relatively independent sets of muscles in three regions of the face: the 
Forehead/Eyebrows/ Nasal root (FEN region), Eye/Nose/Cheek root (ENC 
region), and the Mouth/Lips/Chin root (MLC region). The FEN region has 6 ACs, 
the ENC region 7 ACs, and the MLC has 17 ACs. 
52 Chapter4 
Combinations of these ACs represent the presence of pain/ distress or discrete 
emotions, e.g. anger, sadness, or fear [87]. 
Heart rate (HR) and salivary cortisol concentration were the bio-physiological pain 
indicators. HR was registered by a pulse oximeter (Ohmeda Biox 3700, Ohmeda, 
Boulder, Colorado, USA). Cortisol in saliva was assessed using a coated tube radio 
immuno assay method (Diagnostic Products Corporation, Los Angeles, USA) 
[163]. 
Negative hospital experiences were understood to be: total number of minor 
surgical procedures (i.e. not requiring morphine for postoperative analgesia), major 
operations (i.e. requiring morphine postoperatively), (N)ICU related procedures as 
evaluated by the Therapeutic Intervention Scoring System (TISS) [164], total days 
mechanically ventilated, length of stay in the (N)ICU, and length of hospital stay. 
TISS is a well-established and validated parameter that can be regarded as a 
measure of the care and treatment given to a patient [164-166]. TISS scores are 
daily calculated by the nurses. For this study for each patient all TISS scores were 
summed up into an index of illness. 
4.3.4 Procedures and apparatus 
ImmtJnisation 
The child was placed in the parent's lap. The parent was instructed to hold the 
child in a tight hug. The paediatrician, according to a protocol standardised for all 
participating community health care centres (see Figure 4.1), then gave the 
immunisation. The protocol did not allow for (non-)pharmacological pain 
intewentions such as Efvf.LA, distraction, or given the toddler control over the 
situation [167], i.e. choosing the limb and moment of immunisation. 
Data sampling 
The facial response to immunisation was recorded by an 8 mm video camera 
(Hitachi VM-H90E). This camera was handheld to get a close up of at least two 
thirds of the children's face. A same type of camera was put on a tripod to record 
i.a. the display of the pulse oximeter (see Figure 4.1). To get an impression of each 
toddler's neutral face, video recordings lasting at least 60 seconds were made before 
immunisation. 
Figure 4.1 Standard immunisation procedure 
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Two saliva samples were taken, one before and one 20 to 30 minutes after 
immunisation [156,168]. To stimulate saliva flow, 0.3 ml of a citric acid solution 
(1.5%) was administered orally. The saliva was sampled witb a cotton-bar on which 
a nonwoven swab was fixed. At least 0.5 ml. of saliva was collected during a 
maximum period of 5 minutes. After swabbing, saliva was squeezed from tbe 
nonwoven swab in a syringe and stored in a vial at -20°C. A duplicate analysis of 
cortisol was done in each saliva sample. To avoid inter-assay variation, samples of 
one individual were analysed in tbe same assay. 
Video ana!Jsis 
MAX and HR were coded by one of tbe two coders [autbor JWBP or co-autbor 
JBdeMJ. Witb respect to tbe MAX, video playbacks were used to code separately 
tbe brow, eye and moutb regions of tbe face. One specific code was given for each 
A C. Coding of tbe face spanned tbe period from needle insertion up to 60 seconds 
thereafter. Several measures as a reaction to immunisation were created: 1) sensory 
reaction, i.e. duration of pain/ distress expression, 2) affective reactions, i.e. 
duration of anger, sadness, or fear expression, and 3) overall facial response, i.e. 
duration of sensory plus affective reactions. 
Heart rate data were coded from tbe videotapes on a second by second basis 
starting from 60 seconds before to 60 seconds after immunisation. These data were 
used to calculate baseline heart rate (HR_base; i.e. mean heart rate during 30 
seconds preceding needle insertion), heart rate after immunisation (HR_mean; i.e. 
mean heart rate of tbe 60 seconds after immunisation), and heart rate response 
(HR_change; i.e. HR_mean minus HR_base). 
Apparatus 
To mark onset and offset of tbe ACs in a chronological order and to register heart 
rate response with exact one second intervals, a copy was made of each videotape 
and a Vertical Interval Time Code was added (Adrienne Electronics Corporation; 
Las Vegas, USA). This means tbat each video frame (picture) was marked witb a 
unique format frame (Hours: Minutes: Seconds: Frames) enabling selection and 
coding of various segments of tbe tape. A Videotape Analysis System was used 
which included: a computerwitb a Vertical Time Code Reader (16-bits ISA-board), 
tbe Observer 3.0 Base Package for windows and tbe Observer 4.0 Software 
Package for video analysis (Noldus: Wageningen, The Netherlands), a video 
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cassette recorder (Panasonic AG 5700) with remote control and stop action and 
slow motion feedback, and a 50 Hertz monitor. 
4.3.5 Reliability training 
Inter-observer reliability had previously been obtained by using the MA,'( manual 
and training videotape. Each coder independently coded the training tape. Inter-
observer reliability was assessed with the master code and was computed following 
Izard's [87] indications in the M:AX manual: agreements / (agreements + 
disagreements). Reliability was above the required 80%, i.e. 86% and 88% for the 
two coders. 
4.3.6 Data analysis 
The facial responses were analysed with the Mann Whitney U-test because of 
highly skewed data. Multiple linear regression analyses were used to assess 
differences in heart rates and cortisol concentrations. These analyses were adjusted 
for Ml\1R or DTT immunisation and with respect to the cortisol data also for 
circadian rhythm; i.e. time of immunisation. To achieve normal distributions, log 
transformations (natural log) were carried out on the variables cortisol 
concentrations after immunisation and changes in cortisol concentrations. 
Missing values were replaced by predicted mean matching method [169]. Spearman 
rank correlation was used to assess the association between negative hospital 
experiences and pain responses. 
4.4 Results 
Both the index and control group consisted of 50 children, distributed over 44 
community health care centres. Thus si-...::: centres were visited twice. Patient 
characteristics are presented in Table 4.1. Overall, 28 children received MMR and 
72 the DTT immunisation. Sex did not differ significantly between the index and 
control group. 
With respect to the index group the majority of children had undergone only one 
major and one minor surgical procedure. The median number of days of 
hospitalisation and (N)ICU stay was 42 and 13 days, respectively, and the median 
total TISS score was 115. 
With respect to the control group 16 toddlers had stayed in a hospital and 7 of 
them had undergone minor surgery, mainly because of birth circumstances, e.g. 
Long~term consequences 
forceps delivery or vacuum extraction and day care surgery such as adenotomy or 
myringotomy. The control children were at least 1 year and 6 months old when 
undergoing these minor surgical procedures. 
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Notes:§: opioids were administered for postoperative pain relief;§§: no opioids were 
administered for postoperative pain relief; #: 7 children had undergone minor surgical 
procedures, i.e. adenotomy or myringotomy; ##: 16 children had stayed in a hospital; median 
number of days of hospitalisation was 2, ranging from 1 to 14. 
4.4.1 Differences in painfulness between MMR and DTT immunisation 
First we assessed whether the two immunisations differed in painfulness. The 
proportion of toddlers reacting with a pain expression to l\11ffi was greater than 
that reacting to DTT, 89% and 33%, respectively. Anger and sadness were also 
more prominently present in the MMR group. In addition, the times of occurrence 
of each of these facial expressions as well as those of the overall facial response 
were longer following MMR than followiog DTT immunisation (see Figure 4.2 and 
Table 4.2). Because MMR evoked greater pain responses than DTT immunisation 
we decided to stratify to type of immunisation. 
4.4.2 Differences between index and control group 
The index and control group did not differ '>lith regard to the presence of 
pain/ distress, sadness or anger expression. Moreover, no differences were found in 
the overall facial response (see Figure 4.2). 
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HR_base and HR_mean values are presented in Figure 4.3. :-;)o differences in 
HR_base before immunisation were found between the index and the control 
group. As expected, HR_base was significandy (p <.01) lower in children of the 
DTI group. Following immunisation, HR_mean was similar between the index 
and control group. Again this value was significandy lower (p <.01) in children of 







Number of subjects showing the pain/ distress and 
emotional facial expressions 
~\1R (n- 28) 
25 (89%) 
20 (71 %) 
23 (82%) 
2 (7%) 





Cortisol concentration before immunisation did not differ between the index and 
control group. No difference was found between the index and control group in 
the amount of change in cortisol concentration before and after immunisation. 
Children in the DTI group had lower cortisol concentrations (p = .02) than those 
in the M:\1R group (see Figure 4.4). After immunisation, no difference in cortisol 
concentration was found between the index and control group. Again the DTI 
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Figure 4.4 Salivary cortisol responses to inununisation 
4.4.3 Effects of negative hospital experiences 
59 
Significant Spearman rank correlation coefficients between measures of pain 
sensitivity and negative hospital experiences are presented in Table 4.3. For the 
index children receiving .'v!MR a greater number of operations and higher total 
TISS score were associated with increased facial pain/ distress and overall facial 
response. Length of hospital stay, total TISS score, number of operations and days 
of mechanical ventilation were negatively associated with HR_mean. Total number 
of operations and len.,o-th of stay at the (N)ICU were also negatively related with 
HR_change. No association was found between the other pain measures and 
number of negative hospital experiences. 
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For the control children who received MMR, no correlations were found between 
pain indices and number of days hospitalised or number of minor surgical 
procedures. For the control children receiving the DTT, only HR_mean was 
negatively associated with number of minor surgical procedures. Heart rate before 
immunisation was also negatively associated with number of minor surgical 
procedures. 
IT able 4.3 Significant Spearman rank correlations between measures of negative 
i; hospital e,_--periences and pain sensitivity indicators 
I Pain/ distress Total facial HR._ base HR_mean HR_change 
e.'\:pression activity 
"' !:: "' 
t: ~ !:: 1':0 !:: ~ 
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4.5 Discussion 
We found that major surgery in combination with pre-emptive morphine 
administration within the first three months of life does not alter the behavioural 
and physiological pain response to intrusive immunisation, neither at the age of 14 
months, nor at the age of 3 years and 9 months. However, in the index group 
negative hospital experiences, as evidenced by higher number of major surgical 
procedures and a higher total nss score, were positively associated v.1th greater 
facial pain but with a reduced heart rate response to immunisation at the age of 14 
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Experimental studies in animals have demonstrated that nociception during a 
distinct period of life changes the neuroanatomical architecture as well as pain 
sensitivity [150,151,170]. It has been suggested that these alterations may be 
ma.'<imal in rat pups at 6 to 9 days after birth [11]; after 14 days there is still an 
effect, but less pronounced [150]. The central nervous system (CNS) of a 7 -day-old 
rat functions like that of a full term human neonate, and that of a 14-day-old rat 
corresponds to that of an infant 1 year of age [149]. The specific mechanisms by 
which these alterations in neuroanatomy and pain sensitivity are induced have not 
fully been established. It is assumed that activation of the l':-methyl-D-aspartic acid 
receptor ion-complex produces an increase in intracellular calcium and other 
second messengers, which stimulate protein kinases and new gene expression 
[10,11 ,171]. We therefore theorised that major surgery in early infancy induces 
structural alterations in children's central neural processing of painful stimuli 
[82,93]. 
In this study, however, no differences in pain responsiveness were found between 
the index and control group. This suggests that appropriate and standardised 
analgesic protocols following major surgery prevent the development of alterations 
in pain sensitivity. Others, on the contrary, have found that pre-emptive analgesia, 
i.e. EN!LA before neonatal circumcision, does not prevent infants from developing 
increased pain sensitivity [83]. ENILA, however, has only mild to moderate 
analgesic properties for circumcision [97,172]. Oberlander et al. [60] found that 
infants who had received greater amounts of morphine during their stay at the 
NICU were more sensitive to pain; whether judicious doses of morphine were 
administered is not clear. Inadequate doses of morphine (i.e. either too low or too 
high) also induce neuroanatomical changes, which may give the same outcome as 
nociception [1 OJ. 
Our data show that greater numbers of negative hospital experiences alter the pain 
responses to immunisation at the age of 14 months but not at the age of 3 years 
and 9 months. A possible explanation is that the plasticity of the young infant's 
CNS may lead to compensation that minimises permanent changes when allowing 
sufficient time between previous pain exposure and subsequent pain stimulus. This 
was evident for the children with few negative hospital experiences receiving MMR 
and for all who received the DTT immunisation. Experimental studies in animals 
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also suggest that time "heals" as the altered pain thresholds rerum to normal values 
at adult age [170,173]. 
Another explanation for the absence of associations between negative hospital 
experiences and pain response at the age of 3 years and 9 months may be that at 
this age the phenomenon pain has increased in complexity. At this age, factors 
other than the tissue damage influence children's pain perception and hence their 
reaction to immunisation. These are cognitive factors such as memory for pain and 
cogritive development, as well as sociological factors such as family and cultural 
learning. [17 4]. A third explanation might be that, in contrast with MMR, the pain 
following DTI is not severe enough. 
An unexpected finding was the diminution in heart rate accelerations with 
increasing number of negative hospital experiences. From a psychological 
perspective, heart rate deceleration can be regarded as a process that facilitates 
environmental intake; heart rate acceleration, on the contrary, filters irrelevant 
stimuli out that have distraction-value for the performance of internalised cogritive 
elaboration [175]. From this perspective, it thus appears that with increasing 
number of negative hospital experiences children become less effective in filtering 
nociceptive input. On the other hand, the less vigorous acceleration in heart rates 
can also be regarded as an adaptive response of the body as it reduces, among other 
things, overall oxygen consumption. 
It is obvious that for ethical reasons we were limited in the selection of a 
representative and standardised pain stimulus. One may question whether 
immunisation is a valid ill.tervention to assess long-term sequelae. For e.."\:ample, the 
area of the body to which the immunisation is applied is not the same as the area of 
perinatal pain exposure. In other studies, however, this intervention was effective 
to demonstrate alterations in pain response [93,161,162]. A possible explanation for 
these latter findings is that neuroanatomical changes of the C:-JS due to nociception 
are not only restricted to the dorsal hom but also extend to higher levels of brain 
development [11]. 
Experimental studies in animals show that repetitive neonatal pain, apart from 
alterations in pain thresholds, may lead to vulnerability to stress disorders and 
an..--ciety-mediated adult behaviour [170]. Grunau et al. [159] found that in former 
ELBW born children the duration ofNICU stay after 8 to 10 years was related to 
small increases in pain affect ratings in recreational and daily living settings, but not 
for medical and psychological pain. We, therefore, investigated whether major 
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surgery or negative hospital experiences would alter the affective dimension of the 
pain experience. An.'Ciety was found in three children, of which two had a history of 
major surgery. However, this emotion was fleeting, as the ma...'cimum time of 
occurrence was no more than rnro seconds. Moreover, no differences in occurrence 
were found between the inde." and control group with respect to the other affective 
pain reactions, such as anger and sadness. N"either was there a relation between 
these emotions and number of negative hospital experiences. 
In summary, this is the first clinical study demonstrating that major surgery in 
combination with an appropriate and standardised analgesic protocol within the 
first months of life does not result in an altered pain response to subsequent pain 
exposure in childhood. However, it appears that chronic exposure to (non-)noxious 
stimuli during hospitalisation contributes to an altered pain response. The inherent 
plasticity of the young infants' CNS after a prolonged period of non-exposure may 
lead to compensation that diminishes this long-term effect. Whether in humans 
structural neuroanatomical alterations are still apparent after a prolonged period is 
not known, but it seems highly likely. New achievements in neuroima.,oining such as 
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Pre and postoperative application of EMLA cream is not a suitable 
replacement for caudal block in children undergoing circumcision: 
a randomised controlled trial 
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5.1 Abstract 
Background Many boys suffer pain following circumcision even when performed in 
the hospital. 
Oijective To evaluate the efficacy ofEMLA cream for analgesia in children 
undergoing circumcision compared with a caudal block and placebo. 
Design Random clinical trial. 
Methods Shty-four boys aged 1 to 12 years scheduled for elective circumcision in 
day care. Circumcision was carried out under standardised general anaesthesia. The 
efficacy of pre as well as postoperative application of EMLA was compared with 
that of caudal block, and placebo cream for peroperative as well as postoperative 
pain relief. Peroperative efficacy parameters were blood pressure, heart rate, 
respiratory rate, and inspiratory halothane concentration. Postoperative efficacy 
was assessed by Visual Analogue Scale scores assigned by the nurses, three times in 
the first 120 minutes postoperatively, and by the patient's need for additional 
analgesics. 
Results Peroperative blood pressure, respiratory rate, and inspiratory halothane 
concentrations were highest in those who had received placebo. Compared with 
the caudal block, children who had received preoperative EMLA cream had lower 
heart rates but higher inspiratory halothane concentrations at the end of surgery. 
The Visual Analogue Scale scores did not differ between the treatruent methods. 
However, boys who received either EMLA or placebo cream were 6 and 14 times, 
respectively, more likely to receive rescue analgesics within the first 120 minutes 
postoperatively compared with the Caudal group. No differences were found in the 
number of children needing analgesics for the first 24 hours at home. 
Conclusion EMLA cream is less effective than caudal block and thus can not be 
considered a suitable alternative. 
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5.2 Introduction 
In many societies, boys are subjected to circumcision during infancy or childhood. 
Not only the procedure is painful, boys will suffer pain for some time thereafter 
[178]. Nevertheless, even when performed in a hospital many clinicians withhold 
appropriate pain treatment. The common reasons for this obsolete practice are 
"concern about adverse effects", "not familiar \Vith the technique", and "takes too 
much time". Other reasons are "procedure does not warrant it", and "infants do 
not remember pain" [29]. 
To provide adequate analgesia during and after circumcision, caudal block in 
combination with general anaesthesia is commonly used. The alternative is Eutectic 
Mi'<tUie of Local Anaesthetics (EMLA), a topical anaesthetic cream containing 
2.5% lidocaine and 2.5% prilocaine in water, providing efficient penetration of the 
local anaesthetics through the skin [72,179]. The use ofEMLA cream as an 
anaesthetic has several advantages: the application technique is simple and does not 
cause a motor blockade, which takes away a major concern of parents [180]. 
Secondly, there is no risk of systemic toxicity or pain due to unsuccessful blockade 
[181]. 
Several studies in awake neonates have claimed efficacy and safety of EMLA cream 
for circumcision [72,83,182]. However, in these studies the behavioural and 
physiological responses during the procedure were significantly greater compared 
with baseline. Whether these are due to distress from being restrained or due to 
inadequate analgesia is not clear. Performing circumcision under general 
anaesthesia may exclude this confounder. No data are available about the efficacy 
of EMLA during circumcision under general anaesthesia. 
With respect to postoperative analgesia the efficacy of topical anaesthesia has been 
claimed in two studies (183,184] but contradicted by others (185]. 
The aim of this study was to assess whether application of EMLA cream could 
adequately replace a caudal block for circumcision. 
5.3 Methods 
5.3.1 Design 
A randornised placebo controlled trial was carried out. Sixty-four boys aged 1 to 12 
years with American Society of Anaesthesiologists (ASA) status 1 to 2 (186] and 
scheduled for elective circumcision in day care surgery were included. Exclusion 
criteria were a known allergy for local anaesthetics, neurological disorders, 
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methaemoglobinaemia, a clinically obvious phimosis, and the use of 
sulphonamides. The :vledical Ethical Committee of this hospital approved the 
study. Parents were informed of the purpose of the trial and their written informed 
consent was obtained. 
5.3 .2 Assessment measures 
Peroperative analgesia was assessed by cardiorespiratory responses to surgery, i.e. 
systolic and diastolic blood pressure (SBP and DBP, respectively), heart rate (HR), 
respiratory rate (RR), and inspiratory halothane concentration. These parameters 
were recorded at induction of anaesthesia, at incision, and at 2, 5, and 10 minutes 
thereafter. 
The Visual Analogue Scale (y AS) was used to assess differences in postoperative 
analgesia. The VAS is a horizontal continuous 1 0-cm line with the anchors 'no-
pain' at the left side and 'e:<treme pain' at the right side. Nurses were asked by 
placing a mark on this line to estimate the extent to which the child was in pain. 
The reliability and validity of the VAS for pain assessment has been established 
[124,125]. The VAS forms the commonly used pain assessment instrument in our 
clinic. 
The number of children receiving rescue analgesics within the first 120 minutes 
after surgery also served to assess the efficacy of postoperative analgesia. 
5.3.3 Study medication 
Four different packages were prepared i.e. 1) EMLA pre- and postoperatively 
(group EE); 2) placebo cream pre- and postoperatively (Caudal group); 3) EMLA 
preoperatively and placebo cream postoperatively (group EP); or 4) placebo cream 
preoperatively and EMLA postoperatively (group PE). These packages were 
provided by ASTRA (Sodertilje, Sweden) and contained two tubes of sterile cream 
marked as either 'preoperative' or 'postoperative' and a sealed envelope which 
contained an instruction to apply caudal block or not. The EMLA tubes contained 
a five-gram dose of EMLA cream; the placebo tubes were identical to the EMLA 
tubes and contained cosmetically identical Miglyil R 012 oil. A computer-generated 
randomisation was used to randomise these packages; the randomisation code was 
broken after inclusion of all study children. 
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5.3.4 Procedure 
The patients were allocated to a study package in order of their appearance. Forty-
five minutes before circumcision the cream marked 'preoperative' was applied to 
both the external and internal surfaces of the foreskin of the penis and covered 
with an occlusive dressing, i.e. a finger condom. 
Anaesthesia was completely standardised. Induction of anaesthesia was achieved 
with intravenous thiopentone 5 mg.kg·' or diprivan 3 to 4 mg.kg·', or by inhalation 
of halothane in a Oz/N20 (2:1) mi'Oture followed by maintenance via a face mask 
with 0 2/N20 (2:1) and halothane. After removal of the cream, any local skin 
reactions were recorded. The anaesthesiologist opened the envelope to find out 
whether a caudal block had to be given. Caudal block with bupivacaine 0.25%, 2 
mg.kg·' was given to children in the Caudal group only; in all other patients only 
iodine tincture was applied to the skin at the coccygeal bone. Halothane was 
continued at 1 MAC (corrected for age), in Oz/N20 (1:2) by facemask. Incision 
was carried out after a 15-minute pause. After incision, halothane was decreased in 
steps of 0.5% every minute as long as SBP, DBP, or HR did not change. Halothane 
was increased in steps of 0.5% every 30 seconds in case of inadequate anaesthesia, 
defined as an increase in HR and/or increase in SBP or DBP > 10%, or in case of 
involuntary movements. All children were anaesthetised by the same 
anaesthesiologist. 
After surgery, the cream marked 'postoperative' was applied to the wound and 
covered with a bandage. 
VAS scores were assigned at arrival at the day care unit, and 60 and 120 minutes 
after surgery. Alfentanil 10 to 20 mcg.kg·' iv plus paracetamol 30 to 50 mg. kg·' 
rectally was used as rescue analgesics and admlnistered at nurses' VAS scores ;?: 4 
em. Muscle weakness, vomiting, duration of procedure, and time of urination were 
recorded. 
At discharge all children received a prescription of paracetamol suppositories (90 
mg.kg.day·') for the next three days. The day after the operation, parents were 
asked by telephone about presence of pain, need for pain relief, urination pattern, 
and any incidence of vomiting. 
5.3. 5 Data analysis 
The summary measurement approach [187] was used in this study, taking the mean 
cardiorespiratory responses and nurses' VAS scores of each child as outcome 
variables. Differences across groups were tested using linear regression analysis for 
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the continuous variables; with age as covariate. In each analysis the Caudal group 
served as the reference group. The Kruskal-Wallis Test and the Mann \Xlhitney U 
Test were used in case of highly skewed data. Odds-ratios (95% confidence 
intervals) were calculated to assess differences in the number of children needing 
additional analgesics postoperatively. 
Before start of tbis study, sample size had been calculated from pilot data in other 
children (n = 15) who had received caudal block before circumcision (the gold 
standard group in tbis study). The mean SBP at incision was 93, with a standard 
deviation of7. To estimate the sample size, the effect size approach was used [188]. 
An increase of> 10% of the mean was defined as a clinical significant difference, 
y1elding an effect size of 1.3. Using an alpha of 0.05 and a beta of 0.05 yields a 
sample size of 16 for each group. 
5.4 Results 
At baseline the four groups were comparable with respect to age and weight. (Table 
5.1). Two patients from group EP and two from the Caudal group were excluded 
from analysis because of unscheduled additional surgery (n = 2), the development 





Group EE Group EP 
n=16 n=14 
3 (1-8) 4 (1-10) 
16 (10-30) 17.5 (11-37) 
Note: Values are median (range). 
5.4.1 Peroperative efficacy 
Group PE 







Logarithmic transformations were carried out on diastolic blood pressures as well 
as on inspiratory halothane concentrations. No differences were found between 
group EE, EP, and the Caudal group in mean systolic and diastolic blood 
pressures, and respiratory rates (see Table 5.2). However, in groups EE and EP the 
mean heart rate responses were significantly lower than those in the Caudal group 
(p = .01 and .04, respectively). 
Children who had received placebo (group PE) had significantly greater systolic 
and diastolic blood pressures, and respiratory responses to circumcision than those 
in the caudal group (p = .01; .01, and .04, respectively). The mean heart rate 
responses did not differ between these two groups. 
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Five and ten minutes after incision, the halothane concentrations were significantly 
greater in group PE compared with the caudal group (p = .01 and .01, respectively). 
Ten minutes after incision, children in group EE and PE needed also significantly 
more halothane than the caudal group (p = .01 and .04, respectively; see Table 5.2). 
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Notes: Groups EE, EP and PE were entered as dummy variables in the regression analysis. 
The regression coefficients in this table are dispersions from the mean cardiorespiratory 
responses and the mean inspiratory halothane of the Caudal group. Intercept equals the 
values of the Caudal group. 
5.4.2 Postoperative efficacy evaluation 
The first 120 minutes after surgery no differences were found between the four 
groups in mean VAS scores (i.e. scores assessed at arrival at the day care unit, and 
at 60 and 120 minutes after surgery). However, during this first 120 minutes, rescue 
analgesics were administered to 8/16, 10/14 and 7/14 of the children of group EE, 
EP and PE, respectively, compared with 2/14 of the Caudal group. The odds-ratio 
for rescue analgesics between group EE and the Caudal group was .17 (95% CI: 
.028- .997); between group PE and the Caudal group .17 (95% CI: .027- 1.036). 
When comparing all EMLA treated children ~.e. group EE plus PE) with those of 
the Caudal group, the odds-ratio for rescue analgesics was .17 (95% CI .032- .877). 
The odds-ratio between the placebo group and the Caudal group was .067 (95% 
CI: .010- .443). These findings demonstrate that children who had received 
EMLA or placebo were 6 and 14 times, respectively, more likely to receive 
additional analgesics postoperatively, compared with the Caudal group (see Figure 
5.1). 
No differences were found in the numbers of children needing analgesics at home, 















EE PE EP EE+PE 
Group 
Note: Children in groups EE and PE received EMLA after 
circumcision, children in group EP, on the contrary. received 
placebo cream. 
Figure 5.1 Odds-ratios (95% CI) for the need of additional analgesics 
5.43 Side effects 
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None of the children had clinical signs of methaemoglobinaemia. One child in each 
group vomited postoperatively. No urinary retention was observed. Five patients in 
the Caudal group had clinical signs of muscle weakness as revealed by the 
anaesthesiologist. 
5.5 Discussion 
We found that EMLA cream has mild analgesic properties. However, it appears to 
be insufficient when used alone, because higher halothane concentrations were 
recorded at the end of circumcision compared with the caudal block. Furthermore, 
children who had received EMLA for postoperative analgesia were 6 times more 
likely to receive rescue analgesia during the first two hours following surgery. These 
Hndings thus indicate that EMLA is not a suitable analgesic to replace caudal block. 
A surprising Hnding was that children in the Caudal group had significantly higher 
heart rates during circumcision compared with both EMLA groups. We doubt 
whether this is due to intra-operative stress, because systolic and diastolic blood 
pressures and respiratory rates did not significantly differ between these groups. 
i\J.though this is very uncommon observation in this age group, we assume that the 
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administration of bupivacaine had caused vasodilatation, which was compensated 
for by an increase in heart rate. 
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Recently published guidelines suggest that regional anaesthesia and EMLA are both 
appropriate and effective techniques for circumcision [190,191]. In many cultures, 
however, circumcision is carried out in neonates or children who are awake. Our 
findings show that EMLA alone is not completely effective for circumcision, as 
additional pain relief was necessary to diminish peroperative stress. Others 
demonstrated that regional and local anaesthesia in awake neonates is more 
effective than EMLA alone [96,189]. Furthermore, Benini eta!. [192] showed that 
EMLA is only effective for about one tbird of the circumcision time span. It thus 
appears that EJ\1LA does not penetrate deeply enough to be very effective during 
circumcision and that it is contra-indicated when used in neonates or children who 
are awake. 
The efficacy of lidocaine as a topical anaesthetic for postoperative analgesia 
follo'Wing circumcision was demonstrated by Tree-Trakarn eta!. [183,184]. They 
found that lidocaine spray (10 to 20 mg), ointment (25 to 50 mg), or jelly (10 to 20 
mg) produced similar pain relief as morphine (0.2 mg.kg"1) or dorsal penile nerve 
block. Moreover, also the duration of pain relief did not differ between these 
techniques. Apart from lidocaine, EMLA contains also prilocaine. As this drug has 
a faster onset time than lidocaine, we expected that EMLA would be effective 
directly after application. N evertbeless, EMLA was found to be ineffective for 
postoperative pain relief compared with caudal block. Lee [185], who compared a 
two-gram dose of EMLA cream with dorsal penile nerve block, reported similar 
findings. It could be argued that lidocaine may have induced vasodilatation [193] 
and subsequent may have increased systemic absorption of the local anaesthetics 
from the mucosa [194]. This, however, cannot explain both our and Lee's findings 
as Lee applied similar doses of lidocaine as Tree-Trakarn did, i.e. 50 mg. The 
ineffectiveness of EMLA for postoperative pain relief may also be due to the fact 
that both in our and in Lee's study the wound was covered with a bandage. This 
may have increased the absorption of water from the EMLA cream and thereby 
decreased penetration into the skin. In the lidocaine studies, on the contrary, either 
the wound was left open or covered with petroleum jelly and surgical gauze. When 
the wound is left open, lidocaine jelly forms a thin film of coating over the wound 
which is similar to protective plastic wound coating [183]. 
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We found that 40 to 60% of the children needed analgesics at home, independent 
of the analgesic technique used. This problem has been described before by Knight 
eta!. [178], who found that following circumcision about 85% of the children 
needed additional analgesics for at least 36 hours. Others suggest that this need 
may even last four days [184]. Inadequate analgesia on the day of surgery may cause 
behavioural problems which may last up to 3 to 4 weeks, in many cases longer than 
the pain itself [7,9]. Neonates who suffer pain from circumcision develop an 
increased pain sensitivity which persists several months after the event [82,93]. It is 
important, therefore, that analgesia should be continued at home and not stopped 
at discharge from the hospital. 
With respect to circumcision, topical anaesthesia in the form of EMLA applied pre 
and/ or postoperatively can not be considered a suitable replacement for a caudal 
block. 
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Postoperative pain management in children following (adeno )tonsillectomy: 
efficacy, pharmacokinetics and safety of paracetamol and diclofenac 
Based on: 
J .W.B. Peters, A. G. Vulto, R. Grobbee, A.E.E. Meursing 
Clin Drug Invest 1998;17:309-19 
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6.1 Abstract 
Background There is doubt about the optimal analgesic regimen for postoperative 
pain management following (adeno)tonsillectomy. 
Oijective To assess efficacy of paracetamol (acetaminophen) and diclofenac in 
children aged 3 to 12 years for postoperative pain relief following 
(adeno)tonsillectomy. Pharmacokinetics and adverse effects of the two agents are 
also addressed. 
Design Systematic review. 
Methods A MEDLI:\:E search from 1966 through 1998 was carried out. Language 
restrictions were not applied. 
Results In general, systematic and practise-based research on these drugs for this 
indication is scarce. 
Concfttsion Paracetamol 20 mg.kg-1 administered orally, 60 minutes preoperatively, 
and diclofenac 2 mg.kg·' administered rectally at induction seem to achieve 
satisfactory pain relief in the majority of children during the first few hours 
postoperatively. 
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6.2 Introduction 
(Adeno)Tonsillectomy ((A)TE) is one of the most common otolaryngologic 
surgical procedures performed in children, and is routinely done in an ambulatory 
setting [195]. Both children and physicians describe (A)TE as very painful and 
traumatic [30]. 
Following (A)TE, the patient has an open pharyngeal wound that after 24 hours is 
covered with a granulation membrane, which is replaced by peripheral mucosa 
within 3 weeks [196]. The child's crying, associated with increased vascular 
congestion of the head and neck, may segregate the granulation membrane with 
subsequent bleeding. Furthermore, untreated throat pain may prevent the child 
from drinking, thereby increasing dehydration risk. It is believed that adequate 
postoperative pain relief will reduce such sequelae and promote the child's well 
being. 
Analgesics commonly used after (A)TE include opioids, local anaesthetics and 
nonsteroidal anti-inflammatory drugs (NSAIDs); opioids and local anaesthetics, 
however, carry the potential risk of (severe) complications. For instance, vomiting, 
as enhanced in the use of opioids, may induce bleeding. Inhibited laryngeal reflex 
mechanisms, such as occur with the use of local anaesthetics, may increase 
aspiration risk. It is our experience that with the commonly recommended NSAID 
dosages pain relief is inadequate, since many children are still in pain and restless 
and uncooperative after surgery. This, therefore, was the incentive for reviewing 
the rationale behind recommended doses of the different analgesics, and this paper 
reviews the literature from this perspective. 
It was observed that the literature contains predominantly studies on paracetamol, 
diclofenac and ketorolac. Ketorolac is not included in the present review because a 
significant increase in the incidence of postoperative haemorrhage has recently 
been reported in children receiving ketorolac before and afrer (A)TE [197-199], 
thus precluding its use for this indication. Therefore, this review concentrates on 
paracetamol and diclofenac, with particular focus on efficacy, pharmacokinetics and 
tolerability. 
6.3 Methods 
We aimed to identify all primary published, randomised, clinical trials focusing on 
pain in post-tonsillectomy in children. A MEDLINE literature search from 1966 
through 1998 was conducted. No language restrictions were applied. The keywords 
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were: (postoperative) pain, tonsillectomy and child(ren) aged 3 to 12 years. After 
collecting the articles, all the listed references were checked for additional relevant 
articles. 
6.4 Results 
This search resulted in a total of 11 original studies. Three had been published in 
Anaesthesia· [200-202] two in Paediatric Anaesthesia· [203,204] and five in other 
' ' ' ' 
journals [205-209]. One original study was published in a thesis [21 OJ. Variation in 




Paracetamol is a p-aminophenyl derivative that was first introduced into clinical 
medicine in 1893 as an antipyretic agent. Later, the drug was also used as a mild to 
moderate analgesic, probably because of its capacity to inhibit the nociceptive 
response in the central nervous system (CNS) [211]. 
The therapeutic plasma concentration was defined as 10 to 20 mg.L·1 [212]. 
Whether a dose of 10 to 20 mg.kg"1 in children, shown to be effective in reducing 
fever [213-215], provides sufficient pain relief is not clear. Findings in children 
following (A)TE have shown variable results. In one study [205], a dose of 10 
mg.kg·', administered rectally at the end of the operation, failed to provide 
sufficient pain relief because 37 of the 42 children e:-operienced pain and needed 
additional opioids. This finding was corroborated by Gaudreault eta!. [206], who 
concluded that administration of even 20 mg.kg·' paracetamol rectally at the 
induction of anaesthesia did not prevent immediate postoperative pain, i.e. all 12 
children receiving paracetamol needed supplemental doses of opioids. 
In three other studies, therefore, higher rectal doses of up to 30 to 50 mg.kg·' were 
given. However, immediate postoperative pain could not be prevented [207], most 
children required additional opioids postoperatively [208], or reported too much 
pain [210]. Even the combination of rectal paracetamol30 to 50 mg.kg·1 with 
intramuscular fentanyl 1 mcg.kg"1 did not improve pain relief [21 OJ. Recent findings 
[203,216] have demonstrated that not only the riming of administration but also the 
chosen route may be critical. Mather and Peutrell [203] administered a dose of 20 
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mg.kg·' paracetamol orally 60 minutes before induction. These authors concluded 
that a single preoperative dose of paracetamol provides satisfactory pain relief in 
the majority of children: only nine of their 24 patients needed additional 
postoperative morphine. 
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Pharmacokinetic studies have shown that paracetamol 20 mg.kg·' orally provides 
higher plasma concentrations within a shorter period than a dose of 35 mg.kg·' 
rectally (see Table 6.1). It thus is reasonable to assume that Mather and Peutrell's 
findings may have contributed to higher plasma concentrations. Anderson et a!. 
support this hypothesis [209], demonstrating that pain relief after TE was superior 
when plasma concentrations exceeded 14 mg.L·'. In this study 100 children were 
randomly assigned to 40 mg.kg·' paracetamol either orally 40 minutes 
preoperatively or rectally after induction of anaesthesia. Although the authors used 
double the oral dose that Mather and Peutrell administered, rescue opioids 
remained necessary in 10 of the 50 children who had received paracetamol eli:ill 
compared with 23 of the 50 children of the rectal group. 
These efficacy results have to be carefully interpreted as only four studies used 
validated measurement instruments to assess pain [207 -21 OJ. In the other studies 
rescue opioids were given based on subjective judgement of the nurses. 
Additionally, in none of these cited studies adequate doses of opioids were pre-
emptively administered to prevent children from suffering pain during surgery; only 
nitrous oxide and inhalation anaesthetics were given. Such suffering can cause 
"Vlind-up" and may consequently influence the effectiveness of postoperative pain 
relief. Therefore, at the induction of anaesthesia opioids should be administered to 
provide adequate prevention or suppression of pain during surgery and the early 
recovery period. 
Diclofenac 
Diclofenac belongs to the phenylacetic acid derivatives and was specifically 
developed as an anti-inflammatory agent. In contrast to paracetamol, this agent 
inhibits the prostaglandin synthesis in peripheral tissues, although some of its 
analgesic action may also be elicited within the CNS [217]. Diclofenac was 
introduced into clinical medicine in 1970; its efficacy for postoperative TE pain was 
established in 1984 in adults receiving diclofenac 1 to 3 mg.kg·' rectally after 
surgery [218]. 
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Watters et al. [200], however, found that diclofenac (1 mg.kg-1) administered at 
induction provided inadequate pain relief in a majority of children, i.e. 52% (i.e. 13 
out of 25) needed rescue analgesics at awakening. A lower incidence in the use of 
rescue analgesics was found by Tbiagarajan et al. [201]. In this study, 183 cbildren 
received, at induction, either diclofenac (1 mg.kg-1) intramuscularly or papaveretum 
(0.2 mg.kg-1) intramuscularly; the incidence of rescue opioids was 25 and 16%, 
respectively. In comparison, Bone and Fell [202], in 60 cbildren, administered at 
induction either a higher dose of diclofenac (2 mg.kg-1 rectally) or a similar dose of 
papaveretum (0.2 mg.kg·1 intramuscularly). Rescue analgesics were not necessary in 
any of the children at awakening. This finding was corroborated by Mendham and 
Mather [204], i.e. none of the 25 children who had received diclofenac (1 mg.kg·1 
rectally) at induction needed rescue opioids at recovery. 
These efficacy results are difficult to interpret because study findings were 
divergent. This might be attributed to the fact that the rescue opioids were given at 
the discretion of the nursing staff, rather than on guidance of reliable and validated 
pain measurement tools. 
Sufficient pain relief was provided in the majority of the children, although 
peroperatively no opioids were given in either of the studies. Nevertheless, the 
combination of diclofenac (1 mg.kg'1 rectally) plus fentanyl (0.75 mcg.kg·1 
intravenously) at induction provides an overall better postoperative pain relief, 
compared with diclofenac (1 mg.kg"1 rectally) alone [204]. 
6.4.2 Pharmacokinetics 
There is generally a relationship between plasma concentrations and effect with 
considerable intra-individual variation in both kinetics and dynamics. In order to 
understand the analgesic efficacy and duration of an administered drug, it is useful 
to study its pharmacokinetics and pharmacodynamic relationships. Relevant data 
are limited and some information needs to be inferred from research in adults. 
P aracetamo! 
Bioavailability of paracetamol in children is not known. In adults, the oral 
bioavailability of paracetamol increases with increasing dose [219 ,220], being 63% 
after a dose of7 mg.kg·1 and 88% after a dose of 14 and 28 mg.kg·1 [219]. 
Bioavailability of rectally administered paracetamol is, in contrast, not dose-
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dependent [221], and is less than after oral administration, ranging from 40 to 93% 
[221,222]. 
Because of the poor solubility of paracetamol, the rate of uptake with the rectal 
route is lower and shows a wider variation compared with the oral route. 
Moolenaar et al. [221 ,222] showed that this might be due to various aspects of the 
formulation. The bioavailability of rectally administered aqueous suspensions ::0: 10 
ml, in contrast to suppositories [222], is similar to that found after oral 
administration, but decreases with decreasing volume of the suspension [221 J. For 
suppositories, the particle size, volume and the nature of the excipient may all have 
an impact on the pharmacokinetics [213,214,221-224]. For example, bioavailability 
from lipophilic-based suppositories is greater than that from hydrophilic-based 
suppositories [213,214]. Moreover, bioavailability from lipophilic-based 
suppositories increases with finer paracetamol particles as well as with increasing 
suppository size [221]. 
In children, the peak plasma concentration (e=.) following the administration of 
paracetamol elixir appears between 30 and 60 minutes [215,220,225-228]. The em,, 
after 12 mg.kg·' paraceramol eli.-cir was 15 mg.L"1 [220,225,228]. High plasma 
concentrations were reached after administration of 20 mg.kg-1 paracetamol eli.xir; 
19.6 mg.L"1 and 16.5 mg.L"1 at 60 and 240 minutes, respectively. When 
administered rectally, em,, is reached after 100 to 180 minutes 
[206,213,216,227,229,230], which is lower and more erratic. The reported em,, after 
administration of a rectal paracetamol solution of 20 mg.kg·1 was 11 mg.L·1 
[206,230], and with suppositories of 40 to 45 mg.kg·', it was 13 to 17 mg.L"1 
[216,231]. Table 6.1 provides an overview of these pharmacokinetic findings. 
Plasma protein binding of paraceramol does not occur when therapeutic doses are 
administered, i.e. when plasma concentrations remain below 60 mg.L·' [232,233]. 
Paracetamol distributes well through the body, as is reflected by the hypothetical 
volume of distribution (V J, which is about 0.7 to 1 L.kg·1 in children [220,234,235]. 
Inactivation of paraceramol occurs through hepatic metabolism and subsequent 
renal excretion. Only 5 to 10% is excreted in the urine as the parent compound 
[236,237]. The major pathways of inactivation are sulphation, glucuronidation, and 
oxidation. 
T;bf~6. i -~~p;;dTat;ic -Ph~;~;-~oki~~ti~ studi~~~ -2ar~C~ta~~l~~~~~~~~~~--~~~-~~~-------~-~,~~~~~-~~-~ ,==~~~~·-~~--~~-"-~·"-~>~~-~~~"~· 
Authors No. of Route Formulation Dose (mg.kg.1) T,=~ (min) C= (mg.L.1) TYzG (min) 
atients 
Gaudreault et al. [206] 20 rectal Liquid solution 20 Mean 120 Mean 10.9 
SD 1.7 
Cullen et ai.l213] 28 rectal Hydrophilic Range 15-20 Mean 120 Mean 7.7 
suppository 
lO rectal Lipophilic Range 15-20 f..lean 120 Mean 9.6 
su )eositn!:r 
Windorfer & Vogel [215] 12 oral Elixir 5 i\fean 30 Mean 3.7 
SD l.l 
12 oral Elixir lO :!\Jean 30 Mean 11.9 
SD 2.5 
12 oral Elixir 20 Mean30 Mean 19.7 
SD4.6 
Anderson et al. [216] 20 rectal Polythidine glycol 40 Mean 137 Mean 17 
base contained in SD 72 SD 7.2 
glycogclatine 
capsules 
Wilson et al. [220) 10 oral Tylenol elixir 9 Mcan42 Mean 9.3 Mean 184 
SD 25.2 SD 3.9 
8 oral Tylenol elixir 12 1\fean 33 i\fcan 14.6 Mean 149 
SD 18.7 SD 9.0 
Nahata et al. [225] 6 oral Tylenol elixir lhnge 12-14 Range 9.9-19.6 
4 oral Tylenol eljxir Range 22-27 Range 18.4-40.1 
_, ____ ,,_ 
Wa1son et al. [226] 40 oral Tylenol ellxir lO Mean 54 Mean 6.8 
SD2.2 
Hopkins et al. 1990 [227) 5 oral 
9 rectal 
Kelley et al. [228] 18 oral 
Kolliifel eta!. [230] 4 rectal 
i\fontgomery et al. [231} 10 rectal 
Birmingham ct al. (287] 9 rectal 
9 rectal 
10 rectal 
Notes: Tmar:.' time to maximum concentration, 
Cmax: maximum plasma concentration, 
T'hjJ: elimination ha!f-life, 
SD: standard deviation, 









vegetable oil base 
1 Iydrogenated 
vegetable oil base 
llydrogenated 
vegetable oil base 
Mean 14.5 Mean 114 
CI 13.9-15.1 CI75-153 
Mean 15.3 .Mean 153 
CI 13.0-17.6 CI 77-229 
.Mean 11.6 Mean 27 
SD0.7 
20 .Mean 96 
45 .Mean 180 
10 .Mean 107 
Range 30-120 
20 il1ean 288 
Range 150-480 






















The capacity for sulphation and oxidation appears to be larger in children than in 
adolescents and adults; both metabolise paracetamol mainly via glucuronidation 
[236-239]. The overall rate of elimination in children is similar to that in adults 
[236]. The reported elimination half-life (tv,ol ranges from 1.2 to 2.9 hours 
[220,225,227,228,240], for both the oral and the rectal route [227]. The clearance is 
about 5 to 6.6 ml.min.kg·1 [220,234]. 
Dicloftnac 
Bioavailability of diclofenac after oral or rectal administration is unknown. 
In contrast to paracetamol, diclofenac is soluble and therefore rapidly absorbed. In 
adults, time to ma.-:imum concentration (T rna.") after rectal administration varies 
from 30 to 60 minutes [241-243]. In children, however, Tm"' and em"' are not 
knov.TI after rectal administration. The T ma.x and cm:LX' after intramuscular 
administration of 1 mg.kg·', are reported to be between 15 to 45 minutes [244] and 
4 nmol.g"', respectively [244]. This em,, is considerably lower than the em,, reported 
in adults (6 nmol.g-1) who had received the same intramuscular dose [244]. With 
oral administration a similar trend is seen. After oral administration of 1.5 mg.kg·', 
the em,, was 1.6 mg.L"1 [245], while in adults this e~" was obtained following 
administration of 0.8 mg.kg·' [246,247]. This age-related discrepancy in plasma 
concentration is reflected by a 5-fold higher (0.9 L.kg-1) v, in children [248] 
compared with adults (0.17 L.kg-1) [246]. 
In adults diclofenac is highly protein bound (>99%) [242,243]; the amount of 
plasma protein binding in children is unknown. Furthermore, in adults 80% of the 
diclofenac is metabolised [241 ,242] and is excreted in the form of glucuronide and 
sulphate metabolites, 65% in urine and for 35% in bile [241,242]. It has been 
suggested that the renal elimination in children is similar to that found in adults 
[245]; evidence for this is lacking. The ty,8 in children is reported to be 78 minutes 
[248], the same as in adults [247,249]. Systemic clearance (eL) in children (!.7 
ml.min.kg-1) is twice as high as in adults [244,248]. 
The greater V, and eL in children could be due to a lesser degree of protein 
binding than in adults [250,251]. Because only the unbound drug can cross the 
blood-brain battier [243], a lower protein binding in children increases eNS 
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penetration, thereby possibly inhibiting the nociceptive neurotransmission in the 
CKS. 
6.43 Safety 
In order to determine whether paracetamol and diclofenac are safe to administer 




The adverse effects of paracetamol are uncommon at therapeutic doses [252], 
defined in children as a ma."<imum of 90 mg.kg.day1, in four to six doses [253,254]. 
Elevated aspartate transaminase serum values (SGOT), consistent with 
hepatotoxicity, have been reported after ingestion of > 150 mg.kg"1 within 1 day 
[255-257]. Symptoms include vomiting, anorexia, and epigastric pain. Hepathic 
encephalopathy may develop, leading to coma and death. Paracetamol plasma 
concentrations associated with hepatotoxicity are usually> 200 mg.L"1 at 4 hours 
and > 50 mgL1 at 12 hours after ingestion [255,256]. 
Hepatotoxicity is rare when therapeutic doses are administered. There have been a 
total of ten published cases of children diagnosed with hepatotoxic effects 
following the administration of< 90 mg.kg.day1 for 1 day to 1 week [258,259]. 
This raises the question whether paracetamol was the sole cause of the observed 
hepatotoxic reaction [260]. Keady all these children were febrile and were probably 
malnourished. According to Heubi eta!. [258], reductions in caloric or protein 
intake combined with multiple doses of paracetamol might lead to reduced 
amounts of sulphated and glucuronate metabolites. However, paracetamol-
associated hepatic failure and extrahepatic organ dysfunction might also be 
responsible [261]. 
Paracetamol-induced hepatotoxicity results from accumulation of a reactive 
intermediate: N-acetyl-p-benzoquinone (NAPQI). At therapeutic doses, 
paracetamol is mainly metabolised by sulphation and glucuronidation, whereas the 
mi..;;ed-function oxidase system (cytochrome P450) inactivates small amounts of 
paracetamol to NAPQI. Kormally, NAPQI is detoxified by conjugation with 
glutathione. In case of (acute) overdose, the sulphation and glucuronidation 
pathways may get saturated, subsequently increasing the metabolism through the 
oxidation pathway. If this is not matched by a sufficient supply of glutathione, 
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NAPQI will bind to hepatocellular proteins thereby causing oxidative stress [262], 
eventually leading to liver necrosis. 
This process can be rectified with the drug N-acetylcysteine G\'AC), which 
replenishes glutathione stores, providing a glutathione substitute and slightly 
enhancing disposition by non-toxic sulphate conjugation [255,263]. The outcome 
of NAC treatment, however, depends on the paracetamol plasma concentrations 
and the time interval between paracetamol ingestion and the institution of antidote 
therapy [264-267]. 
Paracetamol overdose in children~ 12 years of age has a distinctly different pattern 
than that in adults, i.e. a lesser degree of hepatotoxicity and minor increases in 
SGOT levels were found in children compared with adults following overdose 
[233,256,264,268]. 
Rumack [256] calculated that adolescents and adults were SL'< times more likely to 
develop SGOT level> 1000 IU.L'1 following :-lAC treatment compared with 
children~ 6 years of age. In another prospective study [268], a total of 2231 
children~ 12 years and 2637 adults, admitted to a poison control centre for 
paracetamol overdosage, were evaluated. The adults had considerably more serious 
consequences from paracetamol exposure than the children did. While prolonged, 
severe or life-threatening effects were found in 0.3% of the children, in adults this 
incidence was 5.2%. None of the children died, whereas 10 deaths were reported in 
the adult population. 
One might argue that the lower incidence in children results from differences 
between the time course of paracetamol ingestion and NAC therapy or from higher 
toxic plasma levels in adolescents and adults; however, this seems not to be the 
case. In children ~ 6 years old, with plasma concentrations > 200 mg.L·' at 4 hours 
and 50 mg.L'1 at 12 hours after ingestion, only 5.5% (i.e. 3 out of 55) developed 
SGOT levels> 1000 IU.L·'- The children with abnormal SGOT levels received 
NAC treatment> 16 hours after paracetamol ingestion [256]. In adolescents and 
adults, with plasma concentrations ranging from 200 to 300 mg.L'1 at 4 hours and 
50 to 75 mg.L'1 at 12 hours after ingestion, SGOT levels> 1000 IU.L'1 occurred in 
11% of those who received NAC therapy within 10 hours after overdose. \XIhen 
NAC therapy was instituted within 10 to 16 or 16 to 24 hours after paracetamol 
ingestion, 29% and 62%, respectively, developed hepatotoxicity reactions [267,269]. 
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Experiments in mice and rats revealed similar age-related differences. Several 
possible explanations for tbese differences have been put forward, e.g. differences 
in microsomal protein binding [270] or a more rapid glutathione (re)syntbesis in tbe 
younger animals [271-273] compared witb adult animals [270]. The extrapolation of 
tbese findings to humans is not simple, because mice and rats differ in tbe severity 
of paracetamol-induced hepatic necrosis and tbe extent of hepatic glutathione 
depletion [27 4J. 
In summary, paracetamol administered in therapeutic doses is a well-tolerated 
analgesic. Moolenaar's findings [221] from comparing different volumes of 
paracetamol suspensions, provide indirect evidence tbat rectal absorption is 
prolonged but complete. Moreover, a lower bioavailitbility was associated witb a 
significantly higher ratio of free paracetamol/ paracetamol-glucuronide, such as 
after rectal administration, partly as a result of increased first-pass metabolism. It is 
unknown whetber this first-pass metabolism contributes to glutathione-store 
depletion. 
Dic!ofenac 
Current guidelines recommend a ma...amum diclofenac dose of 2 to 3 mg.kg.day-1 
[275]. Witb this dose, mild and transient adverse effects occur in 30% of adults and 
adolescents [218,276,277]; this is in tbe same range as adverse effects on placebo 
[218,276]. No data are availitble in children. In clinical practice tbere is some 
concern whetber or not diclofenac increases tbe incidence of primary ( < 24 hours 
postoperative) and secondary bleeding(> 24 h postoperative), because prolonged 
skin bleeding times [278,279] have been reported. Diclofenac inhibits tbe enzyme 
cycle-oxygenase, an enzyme essential in platelets for tbe production of 
tbromboxane A2, which is an important mediator of platelet aggregation and 
vasoconstriction. These are processes constituting the primary haemostatic 
response to vessel injury [278]. 
Postoperative haemorthage following (A)TE occurs more frequently in adults tban 
in children and adolescents [280]. Chronic infection of tbe tonsil may be 
responsible. Comparison among studies in children, reporting various frequencies 
of postoperative bleeding, is difficult due to tbe indistinctness of what is regarded 
as serious postoperative bleeding. Secondly, findings were not differentiated for 
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either TE or (A)TE [281-283], although the incidence of postoperative 
haemorrhage following (A)TE doubles that ofTE alone [281]. 
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The reported frequencies of serious primary bleeding in children following TE and 
(A)TE, requiring operative arrest for haemorrhage, vary between 0 to 0.9% 
[198,280] and 0 to 2.7%, respectively [199,208,284,285]. The incidence of 
secondary bleeding, demanding reoperation, was found to vary between 0.9 to 
2.5% [198,280] and 0 to 1.03%, respectively [199,284]. These incidence rates 
comprise only those children who did not receive 1\:SAIDs. 
There are three publications involving children that provide incidence figures 
regarding primary and secondary bleeding after the administration of diclofenac. 
Tbiagarajan et al. [201] in 183 randomised children, found no increased incidence in 
primary bleeding; only 1% of those who had received diclofenac (1.0 mg.kg·' 
intramuscularly) at induction had to return to the operating theatre, compared with 
2% of those who had received papaveretum (2 mg.kg·' intravenously). In a more 
recent study [204], primary haemorrhage occurred in 5% (i.e. 3 of 58) of the 
children who had received diclofenac (1.0 mg.kg·' rectally) at induction compared 
with 3.2% (2 of 63) who had received tenoxicam (0.4 mg.kg·' intravenously) at 
induction. Tewary and Curry [286] reviewed 363 records; 232 children underwent 
(A)TE and 131 had adenotomy alone. All children received 25 mg diclofenac 
rectally at induction. Primary bleeding was reported in 1.6% (i.e. SL'< of 232) of the 
patients; four of these patients needed to return to the operating theatre. Between 
the second and the eighth postoperative day, 1.3% (i.e. four of 232) of the children 
returned to the hospital with bleeding. 
6.5 Discussion 
Postoperative pain management (efficacy, pharmacokinetics and tolerability) in 
children after (A)TE was reviewed in this paper. In general, available data on pain 
medication for this indication are scarce. The published trials were essentially 
limited to two drugs: paracetamol and diclofenac. The question is whether it is 
possible to make a well-founded choice between these two options. 
Postoperative pain relief is desirable both from the point of prevention of 
postoperative complications and the patients' favourable recovery and well being. 
Adequate pain relief can be achieved with both drugs in most children. As children 
are required to have an empty stomach at induction, the oral route may be 
disadvantageous. 
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To reach adequate pain relief, paracetamol has to be administered orally at least 60 
minutes before the procedure in order to obtain adequate plasma concentrations. 
This may give rise to some residue in the stomach at the time of induction of 
anaesthesia. When administered rectally, paracetamol should be administered about 
3 hours before surgery because of the slower absorption from suppositories; this 
can be impractical. Diclofenac, however, is rapidly absorbed from the rectum: 
suppositories can be inserted at induction of anaesthesia, allowing for adequate 
pain relief once the procedure is over and anaesthesia is terminated. 
For paracetamol, findings suggest that adequate pain relief can be obtained with 
plasma concentrations> 14 mg.L-1 [209]. To obtain such plasma concentrations, 
paracetamol doses of at least 20 mg.kg-1 orally [215,225] or> 40 mg.kg-1 rectally 
[209,216] are necessary. However, more data regarding plasma concentration in 
relation to pain score and anaesthetic technique are required. An initial rectal dose 
of 40 mg.kg-1 is almost half the recommended daily maximum dose of 90 
mg.kg.day\ which means there is little room for supplementary doses when the 
plasma concentration declines after the first dose and pain returns; 
supplementation of other drugs such as diclofenac may be necessary. 
There is, however, evidence that for the short-term use a ma.."'illnum daily dose not 
exceeding 150 mg.kg-1 may be acceptable, with little risk of developing 
hepatotoxicity. Unfortunately, the evidence for the efficacious and safe use of 
paracetamol for this procedure at such dose is not conclusive. 
Pharmacokinetic studies on diclofenac in children are scarce; therefore we have to 
draw conclusions from efficacy studies only. From those studies, 1 to 2 mg.kg-1 
administered rectally or intramuscularly at induction apparenrly seems to provide a 
satisfactory course postoperatively, although the scientific rigor of the published 
trials is disappointing. Because of some inhibitory effect on platelet aggregation, the 
major concern when using cliclofenac as a postoperative analgesic is the risk of 
primary and secondary bleeding. Published evidence regarding this adverse effect 
suggests that there may be a tendency towards a higher bleeding risk. The practical 
relevance for this indication and these patients is not clear and needs further study. 
In conclusion, the available data suggest that adequate postoperative pain relief can 
be achieved with rectal administration of diclofenac at induction of anaesthesia; the 
same cannot be said for paracetamol. The timing of a rectal dose of paracetamol is 
bound to lead to some failures. In addition, the required dose is relatively high, 
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leaving little scope for additional doses when the analgesic effect diminishes. The 
risk for developing liver toxicity in some predisposed patients cannot be excluded 
[257-259]. 
\Jilhen the possibility of a small increase in the risk of postoperative bleeding seems 
of minor clinical significance, rectal diclofenac in a dose of 2 mg.kg'1 at induction 
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7.1. Abstract 
Background There are no data about the efficacy of Patient Controlled Analgesia 
(PCA) when a background infusion is added, in comparison with continuous 
infusion of morphine (C\1) only. 
Objective To assess the efficacy ofPCA (background infusion of 15 mcg.kg.h-1 and 
bolus doses of 15 mcg.kg-1 with a lockout interval of 10 minutes) with that of 
continuous infusion of morphine (20 to 40 mcg.kg.h-1; CM) in terms of pain relief, 
morphine needs and side effects. 
Design Stratified randomised clinical trial. 
Methods Forty-seven children aged 5 to 18 years undergoing major elective 
lower/upper abdominal or spinal surgery were allocated. The magnitude of surgery 
was assessed by the Severity of Surgical Stress scoring system (SSS). Differences in 
postoperative pain were determined by children's self-report on the Visual 
Analogue Scale every three hours up to the second day postoperatively. Side effects 
compatible with morphine were recorded. 
Results No differences were found in pain scores between both groups. However, 
morphine intake in the PCA group was significantly higher than in the CM group. 
Moreover, greater morphine intake was associated with higher SSS scores, 
independent of the technique of administration. Despite a greater morphine intake 
in the PCA group side effects did not differ between both groups. 
Conclusion PCA with a background infusion and CM only provide similar, moderate 
pain relief. Research is indicated to find out why children do not use the PCA 
device to diminish their pain. 
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7.2 Introduction 
Patient Controlled Analgesia (PCA) and continuous infusion of morphine (CM) 
are well-established methods of relieving postoperative pain in children 
[13,35,288]. Theoretically, PCA meets the prerequisites for effective pain relief, i.e. 
the opioid dosage is adjusted to the individual requirements and plasma 
concentrations are maintained at a constant level [289]. This technique can be 
applied with or without a continuous background infusion (BI). 
Studies in children comparing PCA without a BI (PCA-BI) with CM only reported 
divergent results. In one study PCA reduced the morphine intake without 
decreasing pain relief [290]. Others demonstrated that PCA increased the 
morphine needs but also improved pain relief in 9 to 15-year-old children but not 
in children aged between 5 and 8 years [34,291]. Further evidence indicates that 
pain relief [35] and sleeping patterns [292] improve when a BI is added to PCA. At 
present, there are no studies in children that have compared PCA plus a BI 
(PCA + BI) with CM. We hypothesised that postoperative pain scores on the Visual 
Analogue Scale of children who receive PCA+BI would be 15 mm lower than 
those of children treated with CM. Secondly, morphine intake of children receiving 




A randomised controlled clinical trial was performed. The inclusion criteria were 
age 5 to 18 years, physical status ASA 1 or 2 [186], and hospitalised for elective 
lower/upper abdominal or spinal surgery. Postoperatively the children remained in 
a normal or medium care environment. Developmental retardation, caudal or 
regional blockade, and inability to feel pain in the area of operation (e.g. 
meningomyelocele) were the exclusion criteria. The Medical Ethical Committee of 
this hospital approved this study. Written parental informed consent was obtained 
before the patients were entered into the study. 
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7.3 .2 Assessment measures 
The Severity of Surgical Stress scoring system (SSS) was used to assess the 
magnitude of the surgical stress. This system takes into account seven factors that 
contribute to the stress of surgical trauma [119]: blood loss, superficial dissection, 
visceral trauma, site and duration of surgery, associated stress factors, and cardiac 
surgery. In this study, SSS scores tend to be relatively low, because cardiac surgery 
was not included. 
The Visual Analogue Scale (VAS) was used to assess differences in postoperative 
pain. The VAS is a horizontal continuous 1 0-cm line with the anchor 'no-pain' at 
the left side and 'extreme pain' at the right side. The children were supposed to put 
a mark on this line indicating the extent of pain. This scale has proven to be 
adequately understood by 5-year-old children, and has satisfactory supportive data 
on validity [293]. The children assigned VAS scores hourly for the first four hours 
and next once every three hours, except when asleep. Total registration period was 
the day of surgery and the first two days thereafter. 
Morphine intake of the PCA group was registered by the PCA pump, and for the 
CM group by the nurses' registration on medication charts. 
Side effects such as nausea, vomiting, urinary retention requiring bladder 
catheterization, slow and/ or superficial breathing, and itching were assessed and 
registered by a nurse, every three hours. 
7.3 .3 Procedure 
The day before surgery, children were instructed by one of the first two authors 
how to use the VAS and the PCA device. 
Preoperatively midazolam was administered on an if-necessary basis. Peroperative 
anaesthesia was standardised; fentanyl was the only analgesic administered. At the 
end of the operation children were randomly assigned to either PCA + BI or CM. 
Before randomisation all children were stratified into three age groups (5 and 6, 7 
to 11, and 12 to 18 years), based on Piaget's stages of cognitive development [294]. 
To guarantee equal group sizes, random permuted blocks of four patients' 
assignment were used [29 5]. 
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After surgery the anaesthesiologist completed the SSS score system. All patients 
received morphine until they were pain free. Thereafter, PCA or CM was started. 
The PCA pump (Graseby 3300®, Watford, UK) was adjusted for bolus doses of 15 
mcg.kg·1, with a lockout interval of ten minutes. The BI was set at 15 mcg.kg.h·1• 
This BI dose represents 50% of average hourly requirements of children receiving 
PCA for postoperative pain [35,292]. The CM device (Brown perfusor®, 
Melsungen, Germany) was set between 20 and 40 mcg.kg.h"', which has been 
proven to be effective in children [288]. 
A consultant paediatric anaesthetist visited the patients every morning to check 
whether the technique was working satisfactorily and to readjust the BI or CM 
amounts according to the child's pain reports and general condition. PCA bolus 
dose amounts and the lockout interval were not changed during the study. 
7 3.4 Data analyses 
The Mann Whitney U-test was used to compare the demographic data and SSS 
scores bet\veen both groups. The serial measurement data, i.e. pain scores and 
morphine intake, were analysed using the summary measurement approach [187] 
and stepwise multiple linear regression analysis. For the purpose of the analyses, 
intervention was coded as 1 for PCA + BI and 2 for CM. 
Power analysis was based on the comparison of two independent means [296]. A 
mean difference of 15 mm was defined as clinically relevant. It was expected that 
95% of the mean reported pain scores would range between 0 and 80 mm, 
resulting in a standard deviation of 20 mm. One-sided testing with an alpha of 0.05 
and a beta of 0.20 yielded a sample size of 44 patients. To correct for dropouts it 
was decided to include at least one more patient in each group. 
7.4 Results 
Patients' data are presented in Table 7.1. Forty-seven children were included, 24 of 
them received PCA+ BI and 23 CM. Most of them (57%) were between 7 and 11 
years of age. There were no significant differences between the groups for age, 
weight, sex or ethnic background. Surgery was performed for a wide variety of 
indications, mostly laparotomy of the upper abdomen (n=14), laparotomy of the 
lower abdomen (n=11), and lumbotomy (n=9) (see Table 7.2). 
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Type of surgery was equally divided bet\Veen both groups. No significant 
differences (median (range)) in SSS or loading dose morphine amounts were found 
bet\Veen the CM and PCA group. 
Table 7.1 Background characteristics 
5-6 7-11 12. 18 Ethnic Age Weight Loading sss 
years years years background (years) (kg) dose 
(mcg.kg·') 
Median Median Mean Median 
~ ~ 0 
-" ~ (range) (range) (SD) ~ " u " " 
-a ¥ -B 
"" 
5 :§ E -a E u 
- " 
"' "' "' "' "' "' 
Q 0 
PCAgroup 2 4 7 6 3 2 18 6 8.5 34 117 
(n = 24) (5-16) (18-71) (JO) 
CMgroup 3 0 7 7 5 19 4 9.0 31 110 
(n=23) (5-18) (17-71) (72) 
Total 5 4 14 13 4 7 37 10 
7.4.1 Pain 
The mean pain scores for each child each day (see Figure 7.1) were categorised as 
mild(< 3 em), moderate (2: 3 and< 6 em), or severe(<: 6 em) [35]. On the day of 
surgery, PCA and CM resulted in mild pain scores in only 32% and 24% of the 
children, respectively. At days 1 and 2, mild pain scores were obtained in about 
50% of the children of both groups (see Figure 7.1). To evaluate the overall 
efficacy of the PCA and CM techniques, stepwise multiple regression analysis was 
carried out. Intervention, morphine intake, SSS and age were entered as the 
predictor variables, and postoperative pain as the outcome variable. None of these 
variables were statistically significant predictors of reported pain intensity. 
7.4.2 Morphine intake 
The mean morphine intake for each day in both study groups is presented in 
Figure 7.2, showing that on all days the PCA group consumed more morphine 
than the CM group. The overall difference was assessed using multiple regression 
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Table 7.2 Distribution of surgical interventions according to expected amount of postoperative pain 
________ ,_ 
Type of Surgery PCA Cl 
-------------------------Major postoperative pain 
Thoracotomy 
Laparotomy upper abdomen 
I ,aparotomy lower abdomen 
Other 
Moderate postoperative pain 




Minor postoperative pain 
Laminectomy 
I .obectomy (2) 
Splenectomy (2), Adrenalectomy (l), 
Gall bladder surgery (1), Bladder surgery (I), 
Intest1nal resection (2) 
Ureteral rcimplantation (6), Uterus amputat1on (1) 
Pyeloplasty (I), Partial nephrectomy (2), 
Pectus excavahtm correction (3) 
Open lung biopsy (I) 
Excision liquor cyst (1) 
Note: numbers in parentheses are numbers of cases. 
Lobectomy (2) 
Splenectomy(!), Liver-cyst (I), Adrenalectomy (I) 
Bladder surgery(!), Imliana Pouch (I), 
Intest1nal resection (1), Stoma (1) 
Nephrectomy (l) 
Ureteral reimplantat1on (4) 
Pyeloplasty (3), Partial nephrectomy (2), Elevation 
urethrostomy (1) 
Pectus excavatum correction (2) 
Excision bone tumour (1) 
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Stepwise multiple regression analysis was carried out. Intervention, SSS, age, and 
pain were entered as predictor variables. Age and pain, however, were excluded 
from the regression analysis because of partial F-values of 0.76 and 0.09, 
respectively. Hence, the final regression model contained only the variables 
intervention and SSS. Together they accounted for 62% of the variance; the F-
value was 34.81 (p < .01). The final regression model can be described as: Log 
(.\1orphine intake (mcg.kg.h.1)) = 3.37- 0.45 (intervention) + 0.53 (SSS). The 95% 
CI (p-value) for the two predictors ranged between e·0·57 - e·0·32 (p < .01) and e0··3 -
e0·7 (p < .01), respectively. Thus, when controlling for SSS, the morphine intake of 
children with PCA + BI is about 57% greater than with CM. Moreover, morphine 
intake increases exponentially with increasing SSS, independent of the technique of 
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Note: mild pain is defined as a VAS < 3, moderate pain as a VAS 2:: 3 but 
< 6, and severe pain as a VAS 2:: 6 em. 
Figure 7.1 Distribution of daily mean individual pain scores 
One patient, aged 5 years, receiving PCA, with an SSS of 6 and a morphine intake 
of 10.77 mcg.kg.h·\ was omitted from statistical analysis, because of standard 
residual of> 3.0. In this case the BI infusion was stopped as early as day one, and 
PCA was stopped at day two; this trend was uncommon compared with all other 
cases. 
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Figure 7.2 Distribution of cumulative daily morphine requirements 
7.4.3 Side effects 
Nausea and vomiting were noted atleast once in 11 (46%) and 8 (33%) patients of 
the PCA group, respectively; and in 7 (30%) and 4 (17%) children of the CM 
group, respectively. Itching was observed in two (8%) patients of the PCA group, 
but in none of the CM group. Urinary retention was found once in each group 
(4%), and superficial breathing was noted in one (4%) patient of the PCA group. 
There were no statistically significant differences between the two groups for any 
of these side effects. 
7.5 Discussion 
In this study we found that while PCA+BI (15 mcg.kg.h·1 with bolus doses of15 
mcg.kg.1) was associated with an increased morphine intake, it did not provide 
better pain relief than CM (20 to 40 mcg.kg.h.1). Despite a greater morphine intake, 
PCA + BI did not increase the incidence of side effects. Moreover, morphine intake 
appeared to be related to the severity of surgical stress. 
The incidence of mild pain was low in both groups. An explanation might be that 
the paediatric anaesthetist could have underestimated the severity of the 
postoperative pain as shown by the findings in the CM group (see Figure 7.2), i.e. 
although morphine doses up to 40 mcg.kg.h·' could be administered, only two 
children received > 30 mcg.kg.h·'. Findings in the PCA group suggest that most 
children did not use the device to diminish their pain, even when instructed to self-
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administer more morphine. Similar observations have been reported in children> 
5 years [35,291,297] and in adults [298,299]. It is not clear why children and adults 
do not self-administer morphine to diminish their pain at a level of sufficient pain 
relief. Perhaps the use of multimodal analgesia (e.g. addition of paracetamol or 
NSAIDs) might improve pain relief. 
In this study, pain scores did not differ between the groups, although higher 
morphine amounts were used in the PCA group. We hypothesised that the higher 
morphine intake is related to the fact that PCA treated children used the PCA 
device to reduce pain caused by activity due to nursing or physiotherapy. In this 
study, however, pain was not assessed during activity. Additionally, psychological 
factors may also be held responsible. For instance, anxiety, neuroticism, depression, 
family environment as well as the patient's type of locus of control are related to 
the efficacy of postoperative pain treatment in adolescents and adults [300-305]. 
Further studies are indicated to assess which of these psychological factors 
influence effective use of PCA in children. 
The use of a BI of 15 mcg.kg.h·1 seems to be controversial. Studies in children 2: 6 
years [306,307] and adults [308] indicate that a concurrent BI does neither reduce 
the frequency of self-administration of morphine nor improve pain relief. 
However, in a series of studies in children undergoing appendicectomy 
[306,307 ,309] a BI of 4 mcg.kg.h·' with bolus doses of 20 mcg.kg·', and a lockout 
interval of five minutes, appeared to be the most efficacious adjustment for PCA. 
PCA without a BI was associated with inadequate sleeping pattern, background 
infusions > 4 mcg.kg.h·1 increased the incidence of side effects, and bolus doses of 
10 mcg.kg"1 resulted in higher pain scores during activity. Others [35,292], however, 
did not observe any differences in morphine intake or side effects, when comparing 
PCA only with PCA + BI. In these latter studies, however, bolus doses were smaller 
in those receiving PCA+BI. In the present study, the BI of 15 mcg.kg.h·1 did not 
increase the incidence of side effects, compared with C\1. Whether a lower BI 
would decrease the incidence of side effects, without altering pain relief, is not clear 
and needs to be further investigated. 
Another significant finding in our study relates to the positive association bet\Veen 
SSS scores and morphine intake. The SSS scoring method, however, was developed 
for neonates [119]. It was found that SSS scores discriminated between minor, 
moderate, and severe hormonal stress responses (e.g. plasma adrenaline, 
noradrenaline). Additionally, increasing SSS scores are associated with greater and 
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more prolonged changes in hormonal plasma concentrations during and after 
surgery [119]. In neonates, peroperative administration of opioids decreases the 
ma,onitude of stress hormone secretion and improves postoperative morbidity and 
mortality outcome [4,143]. In adult patients, similar hormonal stress responses and 
outcome values have been obtained [31 0,311 J. For example, the release of stress 
hormones is lower after laparoscopic cholecystectomy than after conventional 
cholecystectomy. In adults the magritude of this stress response was found to be 
associated with postoperative morphine requirements [310]. Hence, the neonatal 
stress response to surgery is the same as in adults. It seems valid, therefore, to 
adapt the SSS scoring system for children and adolescents. In our study, stress 
hormones were not detertnined, which calls for careful interpreting of the SSS 
scores and increasing morphine requirements. 
In children, PCA+BI (15 mcg.kg-1 bolus dose+ 15 mcg.kg.h-1) and CM of20 to 40 
mcg.kg.h-1 provide similar, moderate postoperative pain relief. More studies are 
needed to clarify why children do not use the PCA device to relieve pain. 










The elimination and amelioration of pain is a difficult task. It is aimed at preventing 
sensitisation [2], physiologic and metabolic disturbances [6], pathological 
complications [23,312], and long-term sequelae [11]. 
In children this task is even more difficult, because it is not always clear when they 
suffer from pain. While children of 4 years and older are able to report their pain 
themselves, the measurement of pain in neonates and toddlers must of necessity 
rely on other methods. In the very young the assessment of pain crucially depends 
upon either behavioural observation, or measuring of physiological indices that are 
not necessarily related with the pain condition [126]. We are thus often confronted 
with the dilemma: is pain present or not, and if so, to what degree. 
Age-related differences in neurophysiology [149,313], pharmacokinetics 
[31,314,315], and cognition of pain [167] make the elimination and amelioration of 
pain even more difficult. For example, due to differences in neurophysiology 
sensitisation can be produced by repeated tacrile stimulation in premature neonates 
rather than by injury as in older children, and contralateral inhibition is achieved by 
tacrile stimulation rather than by pinch [3]. This means that stimuli that are non-
noxious to adults may be perceived as pain by neonates, or may become painful 
because of sensitisation as a result of prolonged exposure to ICU-related stress-
inducing interventions. Neonates who are being chronically exposed to ICC-related 
(non-)noxious procedures, may thus in fact be subjected to "chronic pain" [98]. 
Besides, it is not known whether the behavioural and physiological alterations in 
response to, for example, mechanical ventilation, endotracheal suction, or 
nasogastric tube insertion should be considered as consequences of either pain or 
stress. Stress, in this context, is defined as a disturbance in the dynamic equilibrium 
called homeostasis [23]. Some authors have argued that one should take care not to 
treat the stress responses but the pain itself, because pain and medically induced 
stress responses are not always interrelated [316], and the long-term effects of 
treatment with analgesics in the absence of pain are unknown [19]. Others, 
however, have expressed a contradictory opinion [144,317]. 
In this thesis studies are described that provide a contribution to the problem how 
to assess, to eliminate, and to relieve pain as well as its effects in infants and 
children. Evidence is given that the face is valuable for assessing whether neonates 
and infants are in pain. The efficacy of some pain-related interventions as well as 
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their benefits and consequences at the long term were studied. The validity of the 
various findings is discussed in the respective chapters. The aim of this general 
discussion is to integrate the results from the previous chapters with the 
developments of the last years and to provide suggestions for further research. 
8.2 Measurement of pain 
Tbis thesis shows that movements in the face resulting from pain can be reliably 
assessed, not only by the Neonatal Facial Coding System (:"FCS) but also by the 
Ma:<imum Discriminative Facial Movement Coding System (MAX). These facial 
movements form a specific configuration that is similar for acute and subacute pain 
and does not change during one's life span. The latter suggests that the facial 
display of pain is independent of cultural learning, supporting Darwin's hypothesis 
that several facial expressions are innate and universal [90]. 
Using the :\:FCS we demonstrated that changes in facial activity are related with 
changes in VAS and COMFORT 'behaviour' scores, heart rate, and blood pressure. 
As expected, several facial actions could be omitted from the NFCS, as these did 
not contribute to its specificity. Theoretically reducing the number of facial actions 
increases the applicability of the KFCS. 
In this thesis the clinical applicability of the NFCS was not studied, but it has been 
demonstrated by others who showed that facial movements can be reliably assessed 
in real time [56,57,76]. Coding facial movements in real time is easier than from 
videotape. The coder's view in real time is 3-dimensional, making movements such 
as bulging above and between brows, or bulging of the eyelids, more easy to detect 
than by 2-dimensional video analysis. Moreover, the coder can move to 
accommodate changes in the infant's position and the observation is not affected 
by extraneous factors such as recording quality, e.g. variation in lighting causing 
shadows. Clinical applicability, however, does not mean clinical utility, because the 
latter applies to the needs of the individual patient, specially to the basis for 
decisions regarding medical and nursing management of pain [56]. 
Clinical utility requires cut-off points that indicate the presence of pain and that 
provide a basis to adjust analgesic regimens. Theoretically, for postoperative pain 
the cut-off point could be an :\:FCS facial activity score of 25 (see chapter 3). 
However, if a cut-off score is taken as a signal of pain, the irony is then that those 
who need pain relief most urgently are left unattended. Premature neonates, for 
example, have a lower pain threshold and have more difficulties in maintaining 
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metabolic stability [6] than term-born neonates have. Their facial response to 
noxious stimuli, on the contrary, is less vigorous than that of term-born neonates 
(see chapter 2). Moreover, although premature neonates are more easily sensitised 
[3], they are also more often exposed to painful (non-)noxious ICU-related 
procedures than term-born neonates are [28]. However, in these infants frequent 
pain exposure diminishes the responsiveness to subsequent pain, but in term-born 
neonates increases the responsiveness. 
The difficulty of defining an optimum cut-off point not only applies to the NFCS 
but to nearly all observational pain assessment instruments described up till now. 
Further research should clarify which influencing factors should be taken into 
account and whether we can adjust for them as is done for instance in the PIPP 
[116]. In this instrument higher scores are assigned to neonates '>lith younger 
gestational ages and to those who are asleep in comparison with active-awake ones, 
independent of their facial activity. 
The VAS is a commonly used instrument to assess the severity of pain by 
observation and self-report. In this thesis a VAS score 2 4 signalled the need of 
extra analgesics. This cut-off score is not empirically based, but agreed upon by 
clinical experts. Chapter 3 shows that nurses' VAS-scores decreased during the 
postoperative period, irrespective of the amount of facial activity. It thus appears 
that the observational VAS is not a measure of pain severity per se, but is 
associated '>lith nurses' confidence whether a child is in pain or is not. Evidence 
shows that nurses take additional information such as health, di~onosis, or 
gestational age into account to assess the presence of pain [137-139]. The question 
is whether all their assumptions are correct. The observational VAS has the 
advantage of allov.-ing nurses to adjust for contextual cues and characteristics of the 
child such as gestational age, pain history, etc. Its disadvantage, however, is 
uncertainty about the pain behaviours that were actually taken into account and 
how these were weighed. Combining the NFCS or other observational measures 
'>lith the VAS may overcome the disadvantages of both instruments. 
With regard to the VAS as a self-report measure, findings in chapter 7 show that 
children and adolescents report pain scores ~ 4 points, even when they can 
administer additional morphine themselves by Patient Controlled Analgesia (PCA). 
This suggests that the VAS cut-off point of 4 is too low and that children may 
endure more pain before needing additional analgesics. Additionally, we must gain 
more understanding of what children regard as pain. Not clinical experts, but 
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children themselves should be asked to define cut-off points on the VAS. Using a 
faces-scale ranging from 0 to 6, Gauthier et al. [318] demonstrated that children 
wanted treatment for postoperative pain at a mean score of 3.2 (±1.2). Others [319] 
found a slightly lower mean treatment threshold of 2.3. While perhaps a VAS<: 4 is 
too low, it prevents the child from developing sensitisation, or physiological and 
metabolic disturbances, because nurses and clinicians are urged to undertake action 
at an early stage. 
8.3 Management of pain 
The attitudes towards procedural pain and minor surgery in children, especially in 
neonates and infants, have started to alter over the last years [16]. This has resulted 
in four Cochrane collaborations on neonatal analgesia [182,320-322]. In addition, 
two international consensus meetings to develop guidelines for routine 
management of procedural pain and minor surgery in neonates and infants were 
held recently [190]. The final result is an exhaustive list of all possible interventions 
(e.g. sucrose in combination '>lith a pacifier, opioids, or local anaesthetics) that may 
diminish pain responses to a range of noxious procedures, such as heelstick, central 
line placement, chest tube insertion, or circumcision. 
These guidelines aim at improving evidenced-based medicine, i.e. the 
"conscientious, explicit, and judicious use of current best evidence in making 
decisions about care of individual patients" [323]. For this reason it is not clear why 
interventions were suggested without any evidence of their efficacy. Moreover, no 
recommendations were given on preferable interventions, even when there is 
enough evidence to do so. For e.-xample, sucrose with a pacifier, E11LA, or regional 
anaesthesia were suggested for circumcision. Sucrose with swaddling reduces cry 
duration during circumcision but has no positive effect on postoperative cortisol 
levels [324]. In this thesis (see chapter 5) it was found that EMLA has some 
analgesic properties for circumcision, as is supported by others [72,83]. However, 
EMLA alone cannot be considered a suitable replacement for regional anaesthesia. 
Because children who had received EMLA needed higher halothane concentrations 
peroperatively and were more likely to receive additional analgesics in the 
postoperative period compared '>lith caudal block. Others have drawn similar 
conclusions in awake neonates [96,325,326]. 
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Moreover, apart from systemic analgesics and local anaesthetics, interv~entions such 
as sucrose with a pacifier or Elv!LA are suggested for central line placement or 
chest tube insertion. Whether these latter two techniques provide adequate 
analgesia under these conditions is not known. Theoretically, systemic analgesics 
can also be administered for these procedures. ~ultiple boluses, however, may lead 
to adverse side effects, because of the higher plasma concentrations achieved. With 
the doses adjusted to age and to the amount of pain, the risk of side effects is 
similar to that in older children and adults [31]. 
These guidelines demonstrate that clinicians and researchers measure by two 
standards when dealing with pain relief in infants and children. For instance, 
interventions that reduce screaming or cursing with about 30% [72] would be 
considered as unethical, inhuman, and clinically irrelevant in adults. Such 
interventions, however, are still advised and applied in neonates and infants. For 
ethical and medical considerations the same standards that are accepted as humane 
in adults should also be applied in children. 
In chapter 3 we found that in neonates and infants pain relief is not always 
adequate with either continuous infusion of morphine 10 mcg.kg.h·1 or intermittent 
morphine administration 30 mcg.kg·1 three hourly. Some children needed additional 
morphine on the basis of a VAS score 2: 4 and although NFCS, COMFORT 
'behaviour' and VAS scores were relatively low at the pre-defined observation 
moments, high scores were occasionally measured. In clilldren and adolescents (see 
chapter 7) we also found that the extent of pain relief differed between the 
subjects, independent of the technique of morphine administration and total 
amount of morphine consumption. Others have obtained similar findings 
[33,35,292,327,328]. It thus appears that there is gross variation in morphine needs 
with varying results in the efficacy of pain relief. 
An explanation for this phenomenon might be that each individual has its own 
therapeutic analgesic plasma concentrations. Austin et a!. [329] for example, 
demonstrated that the therapeutic analgesic plasma concentration for meperidine 
varied among patients, i.e . .46 ± .18 mcg.l-1. Concentrations above .70 mcgX1 were 
calculated to provide 100% pain relief. Large variability in morphine 
pharmacokinetic values between children [327,330-333] is another explanation for 
the variation in morphine needs. Intra-individual differences in effective plasma 
concentrations and metabolic differences may be due to heterogeneity in pain 
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receptors and metabolic patterns. Perhaps DNA analysis may provide some 
answers. 
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Another explanation might be that surgical pain is often associated with 
inflammation [98]. Addition of NSAIDs, such as diclofenac or paracetamol, may 
help to improve efficacy, and decreases the risk of common side effects. In day-
care surgery, high doses of paracetamol [334] and diclofenac [204] were shown to 
reduce morphine intake and pain scores, respectively, in older children. As found in 
chapter 6, paracetamol and diclofenac administered in therapeutic doses are well-
tolerated analgesics; the recommended ma.'<imum daily dose is 90 mg.kg·1 and 3 
mg.kg·t, respectively. There are no data concerning the optimum dosages and their 
safety following major surgery in small infants. Because data regarding 
pharmacokinetics, pharmacodynamics, and safety of diclofenac are lacking, this 
drug is contra-indicated in neonates and infants. Up till now, paracetarn.ol has been 
demonstrated to be effective and safe in this age group [227,335,336]. 
8.4 Long-term effects 
Neuroanatomy studies in experimental animals show that even a simple skin 
wound at birtb will distort the maturation of the central nervous system, leading to 
permanent alterations. Nerve damage not only results in the death of sensory nerve 
cells, but other sensory nerve terminals sprout extensively and occupy areas 
normally exclusively devoted to the damaged nerve [151]. These new sprouts form 
inappropriate connections with spinal nerve cord cells in areas far outside their 
normal termination region [150,337,338], causing the nervous system to become 
permanently distorted. Parallel to these findings are the observations that rats 
develop altered pain sensitivity after perinatal pain exposure [339]. It is thought that 
such changes also occur in humans. 
In this thesis (see chapter 4) no differences were found in bio-behavioural pain 
responses at immunisation between toddlers with a history of major surgery in early 
infancy and controls. Peroperative and postoperative surgical pain were always 
managed by opioids in combination with validated pain-related indices. It thus 
appears that judicious use of analgesics prevents the infant from developing an 
altered pain sensitivity. On the other hand, it could equally be argued that the 
inherent plasticity of the young nervous system might lead to compensation that 
minimises permanent change [1 0]. Perhaps new achievements in neuroimagining 
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such as l\1JU [176] or contrast PET scan [177] may help to disclose this 
phenomenon. 
ChapterS 
Findings in this thesis suggest that medically induced pain and stress cause an 
increase of pain sensitivity lasting beyond the period of exposure and gradually 
extinguishing after a long period of non-exposure. Others have demonstrated 
alterations in pain responses and sensitivity in former extreme low birth weight 
infants [60,94,158] and term-hom neonates [82,93] who were exposed to pain in 
early infancy. These findings, however, are less convincing than those from 
experiments in animals are [10,151,170,340]. In this thesis as well as in those other 
clinical studies, alterations in pain were evaluated by bio-behavioural responses to 
immunisation, or by subjective parents' reports [60,82,93,94,158]. In the animal 
studies, however, rats were subjected to well-defined pain experiments such as the 
hotplate test. One may question whether immunisation is the most appropriate 
intervention to study alterations in pain sensitivity and perception. The stimulus 
may not be severe enough, or may be influenced by the paediatrician who gives the 
immunisation, and it does not allow comparison of differences in pain thresholds 
or pain tolerances. In nearly all studies bio-behavioural measures were used, these, 
however, do not allow to discriminate bet\1leen pain sensation and affective 
feelings. Furthermore, when using immunisation it is very difficult to control for 
parent, child and doctor interaction effects. 
Apart from postoperative situations, neonates and infants also receive morphine 
during mechanical ventilation or extracorporeal membrane o:-..-ygenation. In the 
latter case, however, morphine administration is aimed at reducing stress rather 
than pain. Experiments in animals suggest that morphine administration in the 
absence of pain may also mediate permanent alterations in the CNS [10,341]; these 
alterations are the same as those resulting from perinatal pain exposure [1 0]. It is 
not known whether this applies to humans. 
Besides alterations in pain sensitivity, prolonged hospitalisation and repeated 
medical intervention may also lead to other long-term sequelae, such as clinically 
greater somatization scores [342]. Other long-term sequelae are thought to be 
increased an.~ety, stress disorders, hyperactivity in combination with attention 
deficit disorder, and self-destructive disorders [343]. Am:iety disorders or 
alterations in pain affect, i.e. in anger or sadness reaction patterns, could not be 
demonstrated in this thesis. However, these emotions were only assessed directly 
after immunisation and not as the development of psychopathology. Further 
General discttssion 
studies are indicated to assess the effects of pain, stress, and morphine intake in 
early infancy. 
8.5 Overall conclusions and remaining questions 
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There is no uniform technique for the measurement of pain in children. 
Measurement techniques can be classified as self-reports, behavioural observations, 
or physiological measures. Self-report is regarded as the gold-standard technique in 
older children. A silver standard appears to be the face, because the facial reaction 
to pain is the same in acute and subacute pain situations and it allows to distinguish 
between the sensory and affective dimensions of pain, i.e. pain-related emotions 
such as anger or sadness. Moreover, the facial display of pain is the same for 
infants, children and adults. 
Under certain conditions the face is worthless for the assessment of pain, for 
example in case of induced muscle paralysis, excessive sedation, or when the face is 
excessively plastered to fi..'<ate the tube. In the first two instances physiological 
measures may provide an outcome. The value of autonomic responses in subacute 
pain situations is not clear and further research is indicated. 
Despite substantial evidence that pain can be reliably assessed in the clinical setting, 
paediatric pain is not routinely assessed in most settings [344]. Such practices lead 
to randomness and cannot form the basis for the current striving for evidenced-
based medicine. Implementation of standardised pain assessment is a more 
complex activity than simply selecting an instrument. Therefore, research is 
indicated to define strategies for successful implementation of pain measures. 
For ICU-related procedures, or following minor surgical procedures, pain 
management is often inadequate. \Vhen clinical care is aimed at preventing 
sensicisacion, morbidity and long-term sequelae, current best evidence should be 
used in making decisions which intervention is most effective. For circumcision 
this means that EMLA is out of the question and is not a suitable replacement for 
regional anaesthesia. With respect to (adeno)tonsillectomy, paracetamol and 
diclofenac when given in appropriate dosages and at appropriate rimes appear to 
provide adequate pain relief following this surgical procedure in the majority of 
children. In our clinic a double blind, randomised clinical trial is underway to 
confirm the conclusions of our review and to assess which of these two analgesics 
provides better analgesia. 
Following major abdominal or thoracic surgery, morphine dosages have to be 
adjusted to age-related differences in pharmacokinetics. Still the efficacy of pain 
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relief will be subject of intra-individual differences in pain thresholds and 
metabolism of analgesics. Recommended analgesic regimens therefore can only be 
considered as initial guidelines. The study of heterogeneity of pain receptors and 
metabolism patterns may provide an answer to the question which doses should be 
administered to a particular patient. 
Pain exposure during critical developmental windows may lead to higher pain 
sensitivity. These appear to diminish after a prolonged period of non-exposure, but 
more importandy, they can be effectively prevented by the use of judicious 
analgesics. Further studies are indicated in which subjects are exposed to pain tests 
that have a high degree of standardisation, i.e. always producing similar pain, having 
a relation between stimulus and pain intensity, allowing repeatability with minimal 
temporal effects, and allowing quantification of the different qualities of pain. 
Integration of neuroima,oining techniques such as MRI or contrast PET scan may 
help to increase our understanding of the long-term effects of tissue damage and 
pain exposure in early infancy. 
While optimal management of stress-inducing procedures such as mechanical 
ventilation prevents the development of adverse sequelae, it is essential to ensure 
that the iatrogenic effects of stress are not replaced by the iatrogenic effects 
resulting from opioid therapy. Other aspects that have to be addressed are the 
effects of hospitalisation on the development of pathophysiologic disorders, such 
as emotional and behavioural disturbances, or somatic complaints. 
In summary, in the last decade pain management has changed from an intuition-
based to an evidenced-based approach. This means that current best evidence 
should be taken into account, not only to select initial analgesic doses but also to 
use well-validated pain assessment instruments. Only then we will be able to 
objectively evaluate the efficacy of treatment and to adjust for intra- and inter-
individual differences in analgesic needs. The face is the most promising instrument 
to achieve this goal. Apart from the short-term effects of pain relief, clinicians 
should be abreast of the long-term consequences of pain exposure and use of 
analgesics in neonates and infants. 
References 
118 References 
1. Fearon I, YlcGrath PJ, Achat H. 'Boo boos': the study of everyday pain among 
young children. Pain 1996;68:55-62. 
2. Woolf CJ. Recent advances in the pathophysiology of acute pain. Br 1 Anaesth 
1989;63:139-46. 
3. Fitzgerald M, Andrews K. :--Jeurophysiological and neurobiological correlates of 
supraspinal pain processing measurement techniques. In: Finley GA, McGrath 
PJ, eds. Progress in pain research and management. Seattle: IASP Press, 1998: 
21-46. 
4. Anand KJS, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl 
anaesthesia in preterm babies undergoing surgery: effects on the stress response. 
Lancet 1987;31:243-8. 
5. Anand KJS. Relationships between stress responses and clinical outcome in 
newborns, infants, and children. Crit Care Med 1993;21:S358-9. 
6. Anand I<JS, Carr DB. The neuroanatomy, neurophysiology, and neurochemistry 
of pain, stress, and analgesia in newborn and children. Pediatr C!in North Am 
1989;36:795-823. 
7. Richards MP, BernalJF, Brackbill Y. Early behavioral differences: gender or 
circumcision? Dev Psychobio/1976;9:89-95. 
8. Kotiniemi LH, Ryhanen PT, Yloilanen IK. Behavioural changes following 
routine ENT operations in two-to-ten-year-old children. Paediatr Anaesth 
1996;6:45-9. 
9. Kotiniemi LH, Ryhanen PT, Moilanen IK. Behavioural changes in children 
following day-case surgery: a 4-week follow-up of 551 children. Anaesthesia 
1997;52:970-6. 
10. Dickenson AH, Rahman W, eds. Mechanisms of chronic pain and the 
developing nervous system. In: McGrath PJ, Finley GA, eds. Chronic and 
recurrent pain in children and adolescents. Progress in pain research and 
management, Vol. 13. Seattle: IASP press, 1999:5-38. 
11. Anand KJ, Scalzo PM. Can adverse neonatal experiences alter brain 
development and subsequent behavior? Bioi Neonate 2000;77:69-82. 
12. Grunau RVE. Long-term consequences of pain in human neonates. In: Anand 
KJS, Stevens BJ, McGrath PJ, eds. Pain in neonates, 2nd revised and enlarged 
edition. Amsterdam: Elsevier, 2000:55-76. 
13. Bray RJ. Postoperative analgesia provided by morphine infusion in children. 
Anaesthesia 1983;38:1075-8. 
14. PeutrellJM, Wolf AR. Pain in children. Br 1 HospMed 1992;47:289-93. 
References 119 
15. Schechter NL. The undertreatment of pain in children: an overview. Pediatr Ciin 
NorthAm 1989;36:781-94. 
16. Lima D J, Lloyd-Thomas AR, Howard RF. Infant and neonatal pain: 
anaesthetist's perceptions and prescribing patterns. BM] 1996;313:787. 
17. Burrows FA, Berde CB. Optimal pain relief in infants and children. BMJ 
1993;307:815-6. 
18. Stratton Hill jr C. When will adequate pain treatment be the nottn? JAMA 
1995;274:1881-2. 
19. Aynsley-Green A. Pain and stress in infancy and childhood- where to now? 
Paediatr Anaesth 1996;6:167-72. 
20. Zacharias M, Watts D. Pain relief in children. Doing the simple things better. 
BM] 1998;316:1552. 
21. Champion GD, Goodenough B, Baeyer von CL, Thomas W. Measurement of 
pain by self-report. In: Finley GA, McGrath PJ, eds. Progress in pain research 
and management. Seattle: rASP Press, 1998:123-60. 
22. Bours GJJW, Huijer Abu-Saad H, Hamers JPH, Dongen van RTM. Pain 
assessment in neonates: state of the art study: University of Limburg, 1996. 
23. Anand KJS, Menon G, Narsinghani U, Mcintosh N. Systemic analgesic therapy. 
In: Anand KJS, Stevens BJ, McGrath PJ, eds. Pain in neonates, 2nd revised and 
enlarged edition. Amsterdam: Elsevier, 2000:159-88. 
24. Porter FL, WolfCM, Gold], LotsoffD, MillerJP. Pain and pain management 
in newborn infants: a survey of physicians and nurses. Pediatrics 1997;100:626-
32. 
25. Johnston CC, Collinge JM, Henderson SJ, Anand KJS. A cross-sectional survey 
of pain and pharmacological analgesia in Canadian neonatal intensive care 
units. Ciin J Pain 1997;13:308-2. 
26. Sabrine :\f, Sinha S. Pain in neonates. Lancet2000;355:932-3. 
27. Johnston CC, Collinge JM, Henderson SJ, Anand KJ. A cross-sectional survey 
of pain and pharmacological analgesia in Canadian neonatal intensive care 
units. Ciin J Pain 1997;13:308-12. 
28. Barker DP, Rutter N. Exposure to invasive procedures in neonatal intensive 
care unit admissions. Arch Dis Child Fetal Neonatal Ed 1995;72:F4 7-8. 
29. Stang HJ, Snellman LW. Circumcision practice patterns in the United States. 
Pediatrics 1998;101:E5. 
30. Kokke FT, Heide van der DH, Boelen-van der Loo WJ. Postoperative analgesia 
in 3 Dutch hospitals: a pilot study. Tijd.rchr Kindergeneeskd 1993;61:48-51. 
120 Reftrences 
31. Kart T, Christrup ll, Rasmussen M. Recommended use of morphine in 
neonates, infants and children based on a literature review: Part 2--Clinical use. 
Paediatr Anaesth 1997;7:93-101. 
32. Dijk van M, Bouwmeester 1\:, Duivenvoorden HJ, et al. Efficacy of continuous 
versus intermittent morphine administration after major surgery in 0 to 3-year-
old infants: a double-blind randoruised controlled trial. subl7litted. 
33. Lynn .AJ.\1, ~especa M, Bratton SL, Shen DD. Intravenous morphine in 
postoperative infants: intermittent bolus dosing versus targeted continuous 
infusions. Pain 2000;88:89-95. 
34. Bray RJ, Woodhams Ac\1, Vallis CJ, Kelly PJ. Morphine consumption and 
respiratory depression in children receiving postoperative analgesia from 
continuous morphine infusion or patient controlled analgesia. Paediatr Anaesth 
1996;6:129-34. 
35. Berde CB, Lehn BM, Yee JD, Sethna NF, Russo D. Patient-controlled analgesia 
in children and adolescents: a randomized, prospective comparison with 
intramuscular administration of morphine for postoperative analgesia. J Pediatr 
1991 ;118:460-6. 
36. Anand KJS, Craig KD. New perspectives on the definition of pain. Pain 
1996;67:3-6. 
37. McGrath PJ, L'nruh Ac\1. Measurement and assessment of paediatric pain. In: 
Wall PD, Melzack R, eds. Textbook of pain. third ed Edinburgh: Churchill 
Livingstone, 1994:303-13. 
38. McGrath PA, Seifert CE, Speechley ~, et al. A new analogue scale for 
assessing children's pain: an initial validation study. Pain 1996;64:435-43. 
39. Prkachin KM. Pain behaviour is not unitary. Behav Brain Sci 1986;9:754-5. 
40. Camras LA, Su1livanJ, Michel G. Do infants express discrete emotions? Adult 
judgements of facial, vocal and body actions. J Nonverbal Behavior 1993;17:171-
86. 
41. Izard CE. Innate and universal facial expressions: evidence from developmental 
and cross-cultural research. Psycho/ Bu//1994;115:288-99. 
42. Oster H, Begley D, Nagel L. Adult judgements and fine-grained analysis of 
infant facial expressions: testing the validity of a priori coding formulas. Dev 
Psycho/1992;28:1115-31. 
43. Ekman P, Sorenson ER, Friesen WV. Pan-cultural elements in facial displays of 
emotion. Science 1969;164:86-8. 
Refermces 121 
44. Ekman P, Friesen WV. Constants across cultures in the face and emotion. 1 Pers 
Soc P!J!cho/1971;17:124-9. 
45. Patrick CJ, Craig KD, Prkachin K..l\1[. Observer judgements of acute pain: facial 
action determinants. 1 Pers Soc P!J!cho/1986;50:1291-8. 
46. LeResche L, Dworkin SF. Facial expressions of pain and emotions in chronic 
TMD patients. Pain 1988;35:71-8. 
47. Craig KD, Whitfield MF, Gronau RVE, Linton], Hadjistavropoulos HD. Pain 
in the preterm neonate: behavioural and physiological indices. Pain 
1993;52:287 -99. 
48. Craig KD, Gronau RE, Aquan-Assee]. Judgement of pain in newborns: facial 
activity and cry as determinants. Can 1 Behav Sci 1988;20:442-51. 
49. Gronau RVE,Johnston CC, Craig KD. 1'-ieonatal facial and cry responses to 
invasive and non-invasive procedures. Pain 1990;42:295-305. 
50. Gronau RVE, Craig KD. Pain expression in neonates: facial action and cry. Pain 
1987;28:395-410. 
51. Johnston CC, Stevens BJ, Craig KD, Gronau RVE. Developmental changes in 
pain expression in premature, full-term, two- and four-month-old infants. Pain 
1993;52:201-8. 
52. Stevens BJ, Johnston CC, Horton L. Factors that influence the behavioral pain 
responses of premature infants. Pain 1994;59:101-9. 
53. Lilley CM, Craig KD, Gronau RVE. The expression of pain in infants and 
toddlers: developmental changes in facial action. Pain 1997;72:161-70. 
54. Johnston CC, Stevens BJ, Yang F, Horton L. Differential response to pain by 
very premature neonates. Pain 1995;61:471-9. 
55. Hadjistavropoulos HD, Craig KD, Gronau RVE, Whitfield MF. Judging pain in 
infants: behavioural, contextual, and developmental determinants. Pain 
1997 ;73:319-24. 
56. Gronau RE, Oberhnder T, Holsti L, \'V'hitfield MF. Bedside application of the 
1\:eonatal Facial Coding System in pain assessment of premature neonates. Pain 
1998;76:277 -86. 
57. Guinsburg R, de Araujo Peres C, Branco de Almeida MF, et al. Differences in 
pain expression between male and female newborn infants. Pain 2000;85:127-
33. 
58. Johnston CC, Stremler RL, Stevens BJ, Horton LJ. Effectiveness of oral 
sucrose and simulated rocking on pain response in preterm neonates. Pain 
1997;72:193-9. 
122 References 
59. Johnston CC, Stevens BJ. Experience in a neonatal intensive care unit affects 
pain response. Pediatrics 1996;98:925-30. 
60. Oberlander TF, Grunau R, \"Vhitfield MF, et al. Biobehavioral pain responses in 
former extremely low birth weight infants at four months' corrected age. 
Pediatrics 2000;105:£6. 
61. Porter FL, Wolf CM, :\1iller JP. The effect of handling and immobilization on 
the response to acute pain in newborn infants. Pediatrics 1998;102:1383-9. 
62. Larsson BA, Tannfeldt G, Lagercrantz H, Olsson GL. Venipuncture is more 
effective and less painful than heel lancing for blood tests in neonates. Pediatrics 
1998;101:882-6. 
63. Izard CE, Hembree EA, Dougherty LM, Spizzirri CC. Changes in facial 
expressions of 2- to 19-month-old infants following acute pain. Dev Psycho! 
1983;19:418-26. 
64. Izard CE, Hembree EA, Huebner RR. Infants' emotion expressions to acute 
pain: developmental change and stability of individual differences. De~; Psycho! 
1987;23:105-13. 
65. A.--cia G, Bonichini S, Benini F. Attention and reaction to distress in infancy: a 
longitudinal study. Dev Psycho/1999;35:500-4. 
66. Craig KD, Hadjistavropoulos HD, Grunau RVE. A comparison of two 
measures of facial activity during pain in the newborn child. J Pediatr Psycho! 
1994;19:305-18. 
67. Hadjistavropoulos HD, Craig KD, Grunau RV, Johnston CC. Judging pain in 
newborns: facial and cty determinants.] Pediatr Psycho/1994;19:485-91. 
68. Sweet SD, McGrath PJ. Relative importance of mothers' versus medical staffs' 
behavior in the prediction of infant immunization pain behavior. J Pediatr 
Psycho/1998;23:249-56. 
69. RushforthJA, Griffiths G, Thorpe H, Levene :'0.1. Can topical lignocaine 
reduce behavioural response to heel prick? Arch Dis Child Fetal Neonatal Ed 
1995;72:F49-51. 
70. Rushforth JA, Levene MI. Behavioural response to pain in healthy neonates. 
Arc/; Dis Child 1994;70:F17 4-6. 
71. Ramenghi LA, Evans DJ, Levene JvU. "Sucrose analgesia": absorptive 
mechanism or taste perception? Arch Dis Child Fetal Neonatal Ed 1999;80:F146-
7. 
72. Benini F,Johnston CC, Faucher D, ArandaJV. Topical anesthesia during 
circumcision in newborn infants. JAMA 1993;270:850-3. 
References 123 
73. Barr RG. "Is this infant in pain?": Caveats from the clinical setting. Am Pain Soc 
1 1992;1:187-90. 
74. Fazzi E, Farinotti L, Scelsa B, Gerola 0, Bollani L. Response to pain in a group 
of healthy term newborns: behavioral and physiological aspects. Fttnct Neurol 
1996;11:35-43. 
75. Grunau RVE, Craig KD, Drummond JE. Neonatal pain behaviour and 
perinatal events: implications for research observations. Can J Nurs Res 
1989;21:7-17. 
76. Guinsburg R, Kopelman BI, Anand I<J, eta!. Physiological, hormonal, and 
behavioral responses to a single fentanyl dose in intubated and ventilated 
preterm neonates. J Pediatr 1998;132:954-9. 
77. Johnston CC, Stevens B, Yang F, Horton L. Developmental changes in 
response to heelstick in preterm infants: a prospective cohort study. Dev Med 
Child Neuro! 1996;38:438-45. 
78. Larsson BA, Tannfeldt G, Lagercrantz H, Olsson GL. Alleviation of the pain of 
venepuncture in neonates. Acta P aediatr 1998;87: 77 4-9. 
79. Pereira AL, Guinsburg R, de Almeida MF, eta!. Validity of behavioral and 
physiologic parameters for acute pain assessment of term newborn infants. Rev 
Paul Med 1999;117:72-80. 
80. Scott CS, Riggs K\Xl, Ling EW, et a!. Morphine pharmacokinetics and pain 
assessment in premature newborns.] Pediatr1999;135:423-9. 
81. Stevens BJ,Johnston CC, Horton L. Multidimensional pain assessment in 
premature neonates: a pilot study.]OGNl\11992;22:531-41. 
82. Taddio A, Katz], Ilersich AL, Koren G. Effect of neonatal circumcision on 
pain response during subsequent routine vaccination. Lancet 1997;349:599-603. 
83. Taddio A, Stevens B, Craig K, eta!. Efficacy and safety oflidocaine-ptilocaine 
cream for pain during circumcision. N Eng! J Med 1997;336:1197 -201. 
84. Lindh V, Wiklund U, Sandman PO, Hakansson S. Assessment of acute pain in 
preterm infants by evaluation of facial expression and frequency domain 
analysis of heart rate variability. Early Hum Dev 1997;48:131-42. 
85. Izard CE, Dougherty LM. Two complementary systems for measuring facial 
expressions in infants and children. In: Izard CE, ed. Measuring emotions in 
infants and children. Cambridge: Cambridge University Press, 1982:97-125. 
86. Ekman P, Oster H. Facial expression of emotion. Ann Rev Psycho! 1979;30:527-
54. 
124 References 
87. Izard CE. The Ma..'<imum Discriminative Facial Movement Coding System: 
University of Delaware, 1995. 
88. Prkachin KJ.\1, Mercer SR. Pain expression in patients with shoulder pathology: 
validity, properties and relationship to sickness impact. Pain 1989;39:257-65. 
89. Craig KD, Hyde SA, Patrick CJ. Genuine, suppressed and faked facial behavior 
during exacerbation of chronic low back pain. Pain 1991 ;46:161-71. 
90. Darwin C. The expression of the emotions in man and animals. Chicago: The 
university of Chicago press, 1965. 
91. Prechtl HF. The behavioural states of the newborn infant (a review). Brain Res 
1974;76:185-212. 
92. Stevens BJ, Johnston CC, Horton L. Multidimensional pain assessment in 
premature neonates: a pilot study. 1 Obstet Gynecol Neonatal Nurs 1993;22:531-41. 
93. Taddio A, Goldbach M, Ipp M, Stevens B, Koren G. Effect of neonatal 
circumcision on pain responses during vaccination in boys. Lancet 
1995;345:291-2. 
94. Grunau RVE, \XIhitfield MF, Petrie JH. Pain sensitivity and temperament in 
extremely low-birth-weight premature toddlers and preterm and full-term 
controls. Pain 1994;58:341-6. 
95. Gunnar MR, Porter FL, WolfCM, Rigatuso J, Larson MC. Neonatal stress 
reactivity: predictions to later emotional temperament. Child Dev 1995;66:1-13. 
96. Lander J, Brady-Fryer B, Metcalfe JB, Nazarali S, Muttitt S. Comparison of ring 
block, dorsal penile nerve block, and topical anesthesia for neonatal 
circumcision: a randomized controlled trial.1AlviA 1997;278:2157-62. 
97. Peters JWB, Meursing ABE, Tibboel D. Pre and postoperative application of 
EMLA cream is not a suitable replacement for caudal block in children 
undergoing circumcision: a randomised controlled trial. submitted. 
98. Mcintosh N. Pain in the newborn, a possible new starting point. Eur 1 Pediatr 
1997;156:173-7. 
99. Izard C. The face of emotion. New York: Appleton-Century Crofts, 1971. 
100. Anand KJS, Gronau RVE, Oberlander TF. Developmental character and 
long-term consequences of pain in infants and children. Child Ado! Psychiatr 
Clinics N Am 1997;6:703-24. 
101. Bandler R, Keay KA, Floyd N, Price J. Central circuits mediating patterned 
autonomic activity during active vs. passive emotional coping. Brain Res Bull 
2000;53:95-104. 
Reflrences 125 
102. Barker DP, Simpson], Pawuh M, et al. Randomised, double blind trial of two 
loading dose regimens of diamorphine in ventilated newborn infants. Arch Dis 
Child 1995;73:F22-6. 
103. Fitzgerald M, Millard C, Mcintosh N. Cutaneous hypersensitivity following 
peripheral tissue damage in newborn infants and its reversal with topical 
anaesthesia. Pain 1989;39:31-6. 
104. Barrier G, Atria], Mayer M?\, Amid-Tison C, Shnider SM. Measurement of 
post-operative pain and narcotic adrnlnisttation in infants using a new clinical 
scoring system. Intensive Care Med 1989;15:S37-9. 
105. Krechel SW, Bildner J. CRIES: a new neonatal postoperative pain 
measurement score. Initial testing of validity and reliability. Paediatr Anaesth 
1995;5:53-61. 
106. Blauer T, Gerstmann D. A simultaneous comparison of three neonatal pain 
scales during common 1\:ICU procedures. Ciin J Pain 1998;14:39-47. 
107. Ambuel B, Harulett KW, Marx CM, BlumerJL. Assessing distress in pediatric 
intensive care environments: the COMFORT scale. J Pediatr Psycho! 
1992;17:95-109. 
108. Buttner W, Finke W. Analysis of behavioural and physiological parameters for 
the assessment of postoperative analgesic demand in newborns, infants and 
young children: a comprehensive report on seven consecutive studies. Paediatr 
Anaesth 2000;10:303-18. 
1 09. Schade J G, Joyce BA, Gerkensmeyer J, Keck JF. Comparison of three 
preverbal scales for postoperative pain assessment in a diverse pediatric 
sample. J Pain Symptom Manage 1996;12:348-59. 
110. Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: A 
behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 
1997;23:293-7. 
111. Mills NM. Pain behaviors in infants and toddlers. J Pain Symptom Manage 
1989;4:184-90. 
112. Horgan M, Choonara IA. Measuring pain in neonates: an objective score. 
Paediatr Nurs 1996;8:24-7. 
113. Buchholz M, Karl HW, Pomietto M, Lynn AL\1. Pain scores in infants: a 
modified infant pain scale versus visual analogue. J Pain Symptom Manage 
1998;15:117-24. 
114. Lawrence J, Alcock D, McGrath PJ, et al. The development of a tool to assess 
neonatal pain. Neonatal Network 1993;12:59-66. 
126 Reftrences 
115. Taddio A, Nulman I, Koren BS, Stevens BJ, Koren G. A revised measure of 
acute pain in infants.] Pain Symptom Manage 1995;10:456-63. 
116. Stevens BJ,Johnston CC, Petryshen P, Taddio A. Premature Infant Pain 
Profile: development and initial validation. Clin J Pain 1996;12:13-22. 
117. Schultz AA, Murphy E, Morton J, et al. Preverbal, Early Verbal Pediatric Pain 
Scale (PEPPS): development and early psychometric testing. J Pediatr Nurs 
1999;14:19-27. 
118. Dijk van M, Boer de JB, Koot HM, et al. The reliability, stability and validity 
of the COMFORT scale as a postoperative pain instrument in 0 to 3-year-old 
infants. Pain 2000;84:367-77. 
119. Anand KJS, Aynsley-Green A. Measuring the severity of surgical stress in 
newborn infants. J Pediatr Surg 1988;23:297 -305. 
120. Beyer JE, McGrath PJ, Berde CB. Discordance between self-report and 
behavioral pain measures in children aged 3-7 years after surgery. J Pain 
Symptom Manage 1990;5:350-6. 
121. Johnston CC, Strada ME. Acute pain response in infants: a multidimensional 
description. Pain 1986;24:373-82. 
122. Gronau RVE, Craig KD. Facial activity as a measure of neonatal pain 
expression. In: Tyler DC, Krane EJ, eds. Advances in pain research and 
therapy. New York: Raven Press, 1990:147-55. 
123. Bouwmeester NJ, Anand I<JS, Dijk van C\1, et al. Hormonal and metabolic 
stress responses after major surgery in children aged 0 - 3 years: a double 
blind, randomized trial comparing the effects of continuous versus 
intermittent morphine. Br J Anaesth: in press. 
124. Tarbell SE, Cohen TI, MarshJL. The Toddler-preschooler postoperative pain 
scale: an observational scale for measuring postoperative pain in children aged 
1-5. Preliminary report. Pain 1992;50:273-80. 
125. McGrath PJ,Johnson G, GoodmanJT, et al. CHEOPS: A behavioral scale for 
rating postoperative pain in children. In: Fields HL, Dubner R, Cervero F, 
eds. Advances in Pain Research and Therapy. New York: Raven Press, 1985: 
395-402. 
126. Dijk van M, Boer de JB, Koot H.c\1!, et al. The association between 
physiological and behavioural pain measures in 0-to-3 years old infants after 
major smgery.J Pain Symptom Manage 2001;22:600-9. 
References 127 
127. Gibbons RD, Hedeker D, Elkin I, eta!. Some conceptual and statistical issues 
in analysis of longitudinal psychiatric data. Application to tbe NIMH 
treatment of depression collaborative research program dataset. Arch Gen 
Psychiatry 1993;50:739-50. 
128. I<Jeinbaum DG, Kupper LL, Muller KE. Applied regression analysis and otber 
multivariable metbods. Belmont: Du..,bury Press, 1988. 
129. Verbeke G, Molenberghs G, eds. Linear mixed models in practice. New York: 
Springer, 1997. 
130. Gilbert CA, Lilley CM, Craig KD, eta!. Postoperative pain expression in 
preschool children: validation of tbe child facial coding system. Clin 1 Pain 
1999;15:192-200. 
131. LeResche L, Dworkin SF. Facial expression accompanying pain. SocSciMed 
1984;19:1325-30. 
132. Prkachin KM. Dissociating spontaneous and deliberate expressions of pain: 
signal detection analyses. Pain 1992;51:57-65. 
133. Craig KD, Patrick CJ. Facial expression during induced pain. 1 Pers Soc Psycho! 
1985;48:1080-91. 
134. Craig KD, Gronau RVE. Neonatal pain perception and behavioral 
measurement. In: Anand KJS, McGratb PJ, eds. Pain in :Neonates. 
Amsterdam: Elsevier, 1993:67-106. 
135. Melzack R, Wall PD. Pain mechanisms: a new tbeory. Science 1965;150:971-8. 
136. Huijer Abu-Saad H, Bours GJJW, Stevens B, Hamers JPH. Assessment of 
pain in tbe neonate. Semin Perinato/1998;22:402-16. 
137. Hamers JP, Abu-Saad HH, Halfens RJ, Schumacher JN. Factors influencing 
nurses' pain assessment and interventions in children. 1 Adv Nurs 1994;20:853-
60. 
138. Seymour E, Fuller BF, Pedersen-Gallegos L, Schwaninger JE. Modes of 
tbought, feeling, and action in infant pain assessment by pediatric nurses. 1 
Pediatr Nttrs 1997;12:32-50. 
139. Shapiro CR. l\urses' judgements of pain in term and preterm newborns. 1 
Obstet Gynecol Neonatal Nurs 1993;22:41-7. 
140. Lynn &\1, Nespeca M, Bratton SL, Strauss SG, Shen DD. Clearance of 
morphine in postoperative infants during intravenous infusion: the influence 
of age and surgery. Anesth Ana{!; 1998;86:958-63. 
141. Lewis M, Thomas D. Cortisol release in infants in response to inoculation. 
Child Dev 1990;61:50-9. 
128 &ferences 
142. Lewis M, Ramsay DS. Developmental change in infants' responses to stress. 
Child Dev 1995;66:657-70. 
143. Anand KJS, Hickey PR. Halothane-morphine compared with high-dose 
sufentanil for anesthesia and postoperative analgesia in neonatal cardiac 
surgery. Ne~v Eng! J Med 1992;326:1-9. 
144. Quinn MW, Wild], Dean HG, eta!. Randomised double-blind controlled trial 
of effect of morphine on catecholamine concentrations in ventilated pre-term 
babies. Lancet 1993;342:324-7. 
145. Cabal LA, Siassi B, Artal R, et a!. Cardiovascular and catecholamine changes 
after administration of pancuronium in distressed neonates. Pediatrics 
1985;75:284-7. 
146. Stopfkuchen H, Racke K, Schworer H, Queisser-Luft A, Vogel K. Effects of 
dopamine infusion on plasma catecholarnines in preterm and term newborn 
infants. Eur J Pediatr1991;150:503-6. 
14 7. Berde CB. Pediatric postoperative pain management. Pediatr C!in North Am 
1989;36:921-941. 
148. Morton NS. Pain assessment in children. Paediatr Anaesth 1997;7:267 -72. 
149. Fitzgerald M, Anand KJS. Developmental neuroanatomy and neurophysiology 
of pain. In: Schechter NL, Berde CB, Y aster M, eds. Pain in infants, children 
and adolescents. Baltimore: Williams & Wilkins, 1993:11-31. 
150. Ruda MA, Ling QD, Hohmann AG, Peng YB, Tachibana T. Altered 
nociceptive neuronal circuits after neonatal peripheral inflammation. Science 
2000;289:628-31. 
151. Reynolds ML, Fitzgerald M. Long-term sensory hyperinnervation following 
neonatal skin wounds. J Comp .Neuro/1995;358:487-98. 
152. Andrews K Fitzgerald M. The cutaneous withdrawal reflex in human 
neonates: sensitization, receptive fields, and the effects of contralateral 
stimulation. Pain 1994;56:95-1 01. 
153. Fitzgerald M, Shaw A, Mcintosh N. Postnatal development of the cutaneous 
flexor reflex: comparative study of preterm infants and newborn rat pups. Dev 
Med Child Neuro/1988;30:520-6. 
154. Fitzgerald M, Millard C, Mcintosh N. Hyperalgesia in premature infants. 
Lancet 1988;1:292. 
155. Porter FL, Wolf CM, Miller JP. Procedural pain in newborn infants: the 
influence of intensity and development. Pediatrics 1999;104:E13. 
Riferences 129 
156. Gunnar MR. Reactivity of the hypothalamic-pituitary-adrenocortical system to 
stressors in normal infants and children. Pediatrics 1992;90:491-7. 
157. Johnston CC, Stremler R, Horton L. Effect of repeated doses of sucrose 
during heel stick procedure in preterm neonates. Bioi Neonate 1999;75:160-6. 
158. Grunau RVE, Oberlander TF, Whitfield MF, Fitzgerald C, Saul P. Prior pain 
experience and pain reactivity in former extremely low birtbweight infants and 
term born controls at corrected age 8 months. Pediatric Academic Societies 
and the American Association of Pediatrics; Joint Meeting 2000, Boston, 
Massachusetts. 
159. Grunau RVE, Whitfield MF, Petrie JH. Children's judgements about pain at 
age 8-10 years: do extremely low birtbweight ( < 1 OOOg) children differ from 
full birtbweight peers? J Child Psycho! Psychiatr 1998;39:587 -94. 
160. Sa\,o-al S, Feeny D, Rosenbaum P, et al. Self-perceived health status and health-
related quality of life of extremely low-birth-weight infants at adolescence. 
JAMA 1996;276:453-9. 
161. Taylor A, Fisk NM, Glover V. Mode of delivery and subsequent stress 
response. Lancet 2000;355:120. 
162. Ramsay DS, Lewis M. The effects of birth condition on infants' cortisol 
response to stress. Pediatrics 1995;95:546-9. 
163. Kirschbaum C, Strasburger CJ,Jammers W, Hellhammer DH. Cortisol and 
behavior: 1. Adaptation of a radioimmunoassay kit for reliable and 
inexpensive salivary cortisol detemaination. Pharmacol Biochem Behav 
1989;34:747-51. 
164. Keene AR, Cullen DJ. Therapeutic intervention scoring system: update 1983. 
Crit Care Med 1983;11:1-3. 
165. Malstam J, Lind L. Therapeutic Intervention Scoring System (TISS), a method 
for measuring workload and calculating costs in the I CU. Acta Anaesthesia/ 
S cand 1992;36:7 58-63. 
166. Smith L, Orts CM, O'Neil I, et al. TISS and mortality after discharge from 
intensive care. Intensive Care Med 1999;25:1 061-5. 
167. Ross DM, Ross SA. Childhood pain: current issues, research, and 
management. Baltimore: Urban & Schwarzenberg, 1988. 
168. Gunnar MR, Brodersen L, Krueger K, Rigatuso J. Dampening of 
adrenocortical responses during infancy: normative changes and individual 
differences. Child Dev 1996;67:877 -89. 
130 Riferences 
169. Little RJA. Missing-data adjustment in large surveys. Journal of Business and 
EconolJlic Statistics 1988;6:287-96. 
170. Anand KJ, Coskun V, Thrivikraman KV, Nemeroff CB, Plotsk-y PM. Long-
term behavioral effects of repetitive pain in neonatal rat pups. P!qysio! Behav 
1999;66:627-37. 
171. Woolf CJ, Thompson SW. The induction and maintenance of central 
sensitization is dependent on N-methyl-D-aspartic acid receptor activation; 
implications for the treatment of post-injury pain hypersensitivity states. Pain 
1991 ;44:293-9. 
172. Lander J, Fowler-Kerry S. TENS for children's procedural pain. Pain 
1993;52:209-16. 
173. Hammond DL, Ruda :MA. Developmental alterations in nociceptive threshold, 
immunoreactive calcitonin gene-related peptide and substance P, and fluoride-
resistant acid phosphatase in neonatally capsaicin-treated rats. J Comp Nettrof 
1991;312:436-50. 
17 4. McGrath PJ, McAlpine L. Psychological perspectives on pediatric pain. J 
Pediatr 1993;122:S2-8. 
17 5. Lacey JI. Somatic response patterning and stress: some revisions of activation 
theory. In: Appley ~.Trumbull R, eds. Psychological stress: issues in 
research. New York: Appleton-Century-Crofts, 1967:14-42. 
176. Huppi PS, Schuknecht B, Boesch C, eta!. Structural and neurobehavioral 
delay in postnatal brain development of preterm infants. Pediatr Res 
1996;39:89 5-901. 
177. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC. Pain affect 
encoded in human anterior cingulate but not somatosensory cortex. Science 
1997;277:968-71. 
178. Knight J C. Postoperative pain in children after day case surgery. Paediatr 
Anaesth 1994;4:45-51. 
179. Maunuksela EL, Korpela R. Double-blind evaluation of a lignocaine-prilocaine 
cream (EMLA) in children. Effect on the pain associated with venous 
cannulation. Br J Anaesth 1986;58:1242-5. 
180. Dalens B, Hasnaoui A. Caudal anesthesia in pediatric surgery: success rate and 
adverse effects in 750 consecutive patients. Anesth Ana[g 1989;68:83-9. 
181. Flandin-Blety C, Barrier G. Accidents following extradural analgesia in 
children. The results of a retrospective study. Paediatr Anaesth 1995;5:41-6. 
References 131 
182. Taddio A, Ohlsson A, Einarson TR, Stevens B, Koren G. A systematic review 
of lidocaine-prilocaine cream (EMLA) in the treatment of acute pain in 
neonates. Pediatrics 1998;10l:E 1. 
183. Tree-Trakarn T, Pirayavaraporn S. Postoperative pain relief for circumcision in 
children: comparison among morphine, nerve block, and topical analgesia. 
Anesthesiology 1985;62:519-22. 
184. Tree-Trakarn T, Pirayavaraporn S, Lertalyamanee J. Topical analgesia for 
relief of post-circumcision pain. Anesthesiology 1987;67:395-9. 
185. Lee JJ, Forrester P. EMLA for postoperative analgesia for day case 
circumcision in children. A comparison with dorsal nerve of penis block. 
Anaesthesia 1992;47:1081-3. 
186. Deshpande JK, Anand KJS. Basic aspects of acute pediatric pain and sedation. 
In: Deshpande JK, Tobias JD, eds. The pediatric pain handbook. StLouis: 
Mosby, 1996:1-48. 
187. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial 
measurements in medical research. BM] 1990;300:230-5. 
188. Lerman J. Study design in clinical research: sample size estimation and power 
analysis. Can] Anaesth 1996;43:184-91. 
189. Taddio A, Ohlsson K, Ohlsson A. Lidocaine-prilocaine cream for analgesia 
during circumcision in newborn boys. Cochrane Database Syst Rev 
2000:CD000496. 
190. Anand KJ. Consensus statement for the prevention and management of pain 
in the newborn. Arch Pediatr Ado/esc Med 2001;155:173-80. 
191. Setna NF, Koh JL. Regional anesthesia and analgesia. In: Anand KJS, Stevens 
BJ, McGrath PJ, eds. Pain in neonates, 2nd revised and enlarged edition. 
Amsterdam: Elsevier, 2000: 189-202. 
192. Bellini F,Johnston CC, Faucher D, Aranda JV. Topical anesthesia during 
circumcision in newborn infants. JAMA 1993;270:850-3. 
193. Johns RA, DiFazio CA, Longnecker DE. Lidocaine constricts or dilates rat 
arterioles in a dose-dependent manner. Anesthesiology 1985;62:141-4. 
194. Ljunghall K, Lillie borg S. Local anaesthesia with a lidocaine/ prilocaine cream 
(EMLA) for cautery of condylomata acuminata on the vulvar mucosa. The 
effect of timing of the application of the cream. Acta Derm Venereol 
1989;69:362-5. 
132 References 
195. Sutters KA, Levine JD, Dibble S, Savedra M, Miaskowski C. Analgesic efficacy 
and safety of single-dose intramuscular ketorolac for postoperative pain 
management in children following tonsillectomy. Pain 1995;61:145-53. 
196. Komblut AD. A traditional approach to surgery of the tonsils and adenoids. 
Oto!aryngo! C!in North Am 1987;20:349-63. 
197. Gallagher JE, Blauth J, Fomadley JA. Peri operative ketorolac tromethamine 
and postoperative hemorrhage in cases of tonsillectomy and adenoidectomy. 
Laryngoscope 1995;105:606-9. 
198. GunterJB, Varughese AJY!, HarringtonJF, et al. Recovery and complications 
after tonsillectomy in children: a comparison of ketorolac and morphine. 
Anesth Ana!g 199 5;81: 1136-41. 
199. Splinter WM, Rhine EJ, Roberts DW, Reid CW, McNeill HB. Preoperative 
ketorolac increases bleeding after tonsillectomy in children. Can 1 Anaesth 
1996;43:560-3. 
200. Watters CH, Patterson CC, Mathews HM, Campbell W. Diclofenac sodium 
for post-tonsillectomy pain in children. Anaesthesia 1988;43:641-3. 
201. Thiagarajan J, Bates S, Hitchcock M, Morgan-Hughes]. Blood loss following 
tonsillectomy in children. A blind comparison of diclofenac and papaveretum. 
Anaesthesia 1993;48:132-5. 
202. Bone ME, Fell D. A comparison of rectal diclofenac with intramuscular 
papaveretum or placebo for pain relief following tonsillectomy. Anaesthesia 
1988;43:277-80. 
203. Mather SJ, Peutrell JM. Postoperative morphine requirements, nausea and 
vomiting follovring anaesthesia for tonsillectomy. Comparison of intravenous 
morphine and non-opioid analgesic techniques. Paediatr Anaesth 1995;5:185-8. 
204. Mendham JE, Mather SJ. Comparison of diclofenac and tenoxicam for 
postoperative analgesia with and without fentanyl in children undergoing 
adenotonsillectomy or tonsillectomy. Paediatr Anaesth 1996;6:467 -73. 
205. Lindgren L, Saarnivaara L. Comparison of paracetarnol and aminophenazone 
plus diazepam suppositories for an.'<iety and pain relief after tonsillectomy in 
children. ActaAnaesthesiol Scand 1985;29:679-82. 
206. Gaudreault P, Guay J, Nicol 0, Dupnis C. Pharmacokinetics and clinical 
efficacy of intrarectal solution of acetaminophen. Can 1 Anaesth 1988;35:149-
52. 
207. Boelen-van der Loo WJ, Driessen FG. Prevention and control of pain in 
(adeno) tonsillectomy. Ned Tijdschr Geneeskd 1992;136:1409-13. 
Rejen11ces 133 
208. Rusy L\1, Houck CS, Sullivan LJ, et al. A double-blind evaluation ofketorolac 
tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and 
bleeding. Anesth Ana{g 1995;80:226-9. 
209. Anderson B, Kanagasundarum S, Woollard G. Analgesic efficacy of 
paracetamol in children using tonsillectomy as a pain model. Anaesth Intensive 
Care 1996;24:669-73. 
210. Hamers JPH: Postoperative pain in children: assessment and intervention. 
University of Maastricht; 1996 
211. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains 
the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 
1972;240:41 0-1. 
212. Rumack BH. Asparin versus acetaminophen: a comparative view. Pediatrics 
1978;62:943-6. 
213. CullenS, Kenny D, Ward OC, Sabra K. Paracetamol suppositories: a 
comparative study. Arch Dis Child 1989;64:1504-5. 
214. Keinanen S, Hietula M, Sirnila S, Kouvalainen K. Antipyretic therapy. 
Comparison of rectal and oral paracetamol. Ettr J Clin Pharmaco! 1977;12:77-
80. 
215. Windorfer A, Vogel C. Investigations concerning serum concentration and 
temperature following oral application of a new paracetamol preparation. K!in 
Padiatr 197 6;188:430-4. 
216. Anderson BJ, Woollard GA, Holford NH. Pharmacokinetics of rectal 
paracetamol after major surgery in children. Paediatr Anaesth 1995;5:237-42. 
217. Bjorkman R. Central antinociceptive effects of non-steroidal anti-
inflammatory drugs and paracetamol. Experimental studies in the rat. Acta 
Anaesthesia! S cand S upp! 199 5;103: 1-44. 
218. Dommerby H, Rasmussen OR. Diclofenac (Voltaren). Pain-relieving effect 
after tonsillectomy. Acta Otolaryngo! 1984;98:185-92. 
219. Rawlins MD, Henderson DB, Hijab AR. Pharmacokinetics ofparacetamol 
(acetaminophen) after intravenous and oral administration. Ettr J C!in 
Pharmaco! 1977;11:283-6. 
220. Wilson JT, Brown RD, Bocchini JA, Kearns GL. Efficacy, disposition and 
pharmacodynamics of aspirin, acetaminophen and choline salicylate in young 
febrile children. Ther Drng Monit 1982;4:14 7-80. 
134 References 
221. Moolenaar F, OlthofL, Huizingha T. Biopharmaceutics of rectal 
administration of drugs in man: 3. Absorption rate and bioavailability of 
paracetamol from rectal aqueous suspensions. Pharm Weekblad Sci Ed 
1979;1:25-30. 
222. Moolenaar F, Schoonen AJM, Everts A. Biopharmaceutics of rectal 
administration of drugs in man: 4. Absorption rate and bioavailability of 
paracetamol from fatty suppositories. Pharm Weekblad Sci Ed 1979;1:689-94. 
223. Shangraw RF, Walkling WD. Effect of vehicle dielectric properties on rectal 
absorption of acetaminophen. 1 Pharm Sci 1971;60:600-2. 
224. Pagay S"", Poust Rl, Colaizzi JL. Influence of vehicle dielectric properties on 
acetaminophen bioavailability from polyethylene glycol suppositories. 1 Pharm 
Sci 1974;63:44-7. 
225. Nahata MC, Powell DA, Durrell DE, Miller MA. Acetaminophen 
accumulation in pediatric patients after repeated therapeutic doses. Eur 1 C!in 
Pha1771aco/ 1984;27:57-9. 
226. Walson PD, Galletta G, Braden NJ, Alexander L. Ibuprofen, acetaminophen, 
and placebo treatment of febrile children. C!in Phamzaco/ Ther 1989;46:9-17. 
227. Hopkins CS, Underhill S, Booker PD. Pharmacokinetics of paracetamol after 
cardiac surgery. Arch Dis Child 1990;65:971-6. 
228. Kelley MT, Walson PD, Edge JH, Cox S, Mortensen ME. Pharmacokinetics 
and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile 
children. C!in Pham;acol Ther 1992;52:181-9. 
229. Montgomery]!':, Watson CB, Mackie .AJ.vL Anesthesia for tonsillectomy and 
adenoidectomy. Oto/aryngoi C!in North Am 1987;20:331-44. 
230. Kolloffel WJ, Driessen FG, Goldhoom PB. Plasma concentration proflles 
after pre-operative rectal administration of a solution of paracetamol in 
children. Pharm World Sci 1996;18:105-8. 
231. Montgomery CJ, McCormackJP, Reichert CC, Marsland CP. Plasma 
concentrations after high-dose ( 45 mg.kg-1) rectal acetaminophen in children. 
Can 1 Anaesth 1995;42:982-6. 
232. Jackson CH, McDonald NC, Cornett JW. Acetaminophen: a practical 
pharmacologic overview. Can Med Assoc 1 1984;131:25-32. 
233. Peterson RG, Rumack BH. Pharmacokinetics of acetaminophen in children. 
Pediatrics 1978;62:877 -9. 
Riferences 135 
234. Granry JC, Rod B, Boccard E, et al. Pharmacokinetics and antipyretic effects 
of an injectable pro-drug of paracetarnol (proparacetamol) in children. Paediatr 
Anaesth 1992;2:291-5. 
235. Linakes JG, Lovejoy FH. Antipyretics. In: Yaffe SJ, Aranda JV, eds. Pediatric 
pharmacology, therapeutic principles in practice. Philadelphia: W.B. Saunders 
Company, 1992: 335-44. 
236. Miller RP, Roberts RJ, Fischer LJ. Acetaminophen elimination kinetics in 
neonates, children, and adults. C!in Pharmacol Ther 1976;19:284-94. 
237. Alarn SN, Roberts RJ, Fischer LJ. Age-related differences in salicylamide and 
acetaminophen conju,o-ation in man. J Pediatr 1977;90:130-5. 
238. Kearns GL. Pharmacogenetics and development: are infants and children at 
increased risk for adverse outcomes? Curr Opin Pediatr 1995;7:220-33. 
239. Leeder JS, Keams GL. Pharmacogentics in pediatrics: implications for 
practice. Pediatr Clin North Am 1997;44:55-77. 
240. Peterson RG, Rumack BH. Age as a variable in acetaminophen overdose. Arch 
Intern Med 1981;141:390-3. 
241. Landsdorp D, Vree TB,Janssen TJ. Pharmacokinetics of rectal diclofenac and 
its hydro>.-y metabolites in man. Int J C!in Pharmacof Ther Toxicof 1990;28:298-
302. 
242. Riess W, Stierlin H, Degen P, et al. Pharmacokinetics and metabolism of the 
anti-inflammatory agent Voltaren. Scand J Rheumatof Stq?p/1978:17-29. 
243. John VA. The pharmacokinetics and metabolism of diclofenac sodium 
(Voltarol) in animals and man. Rheumatof Rehabif 1979:S22-37. 
244. Ryhanen P, Adamski], Puhakka K, et al. Postoperative pain relief in children. 
A comparison between caudal bupivacaine and intramuscular diclofenac 
sodium. Anaesthesia 1994;49:57 -61. 
245. Haapasaari J, Wuolijoki E, Ylijoki H. Treatment of juvenile rheumatoid 
arthritis with diclofenac sodium. Scand J Rheumatol 1983;12:325-30. 
246. Willis JV, Kendall MJ. Pharmacokinetic studies on diclofenac sodium in young 
and old volunteers. Scand J Rhettmatol Stq?pl 1978;18:36-41. 
247. Willis JV, Kendall MJ,Jack DB. A study of the effect of aspirin on the 
pharmacokinetics of oral and intravenous diclofenac sodium. Ettr J C!in 
Pharmacol 1980;18:415-8. 
248. Korpela R, Olkkola KT. Pharmacokinetics of intravenous diclofenac sodium 
in children. Eur J C!in Pharmaco! 1990;38:293-5. 
136 Rifr:rences 
249. Maggi CA, Lualdi P, :v!autone G. Comparative bioavailability of diclofenac 
hydrm:yethylpyrrolidine vs diclofenac sodium in man. Eur J Clin Pharmaco! 
1990;38:207 -8. 
250. Rane A Drug disposition and action in infants and children. In: Yaffe SJ, 
Aranda JV, eds. Pediatric pharmacology, therapeutic principles in practice. 
Philadelphia: W.B. Saunders Company, 1992: 10-21. 
251. Brocks DR,Jamali F. Clinical pharmacokinetics ofketorolac trometharnine. 
Clin Pharmacokinet 1992;23:415-27. 
252. Freie P. Antipyretic analgesics. In: Dukes MNG, ed. Myler's side effects of 
drugs. Amsterdam: Elsevier, 1996:191-203. 
253. Henretig PM, Selbst SM, Forrest C, eta!. Repeated acetaminophen 
overdosing. Causing hepatotoxicity in children. Clinical reports and literature 
review. Clin Pediatr 1989;28:525-8. 
254. Penna A, Buchanan N. Paracetamol poisoning in children and hepatotoxicity. 
Br J Clin Pha17J1aco!1991;32:143-9. 
255. Prescott LF. Paracetamol overdosage. Pharmacological considerations and 
clinical management. Drugs 1983;25:290-314. 
256. Rumack BH. Acetaminophen overdose in young children. Treatment and 
effects of alcohol and other additional ingestants in 417 cases. Am J Dis Child 
1984;138:428-33. 
257. Rivera-Penera T, Gugig R, Davis J, et a!. Outcome of acetaminophen 
overdose in pediatric patients and factors contributing to hepatotoxicity. J 
Pediatr 1997;130:300-4. 
258. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with 
acetaminophen: hepatoxicity after multiple doses in children. J Pediatr 
1998;132:22-7. 
259. Alonso EM, Sokol RJ, Hart J, eta!. Fulminant hepatitis associated with 
centrilobular hepatic necrosis in young children. J Pediatr 1995;127:888-94. 
260. Editorial. Acetaminophen use in children: more is not better. J Pediatr 
1997;130:175-7. 
261. Editorial. Acetaminophen overdose with therapeutic intent. J Pediatr 
1998;132:5-8. 
262. Bergman K, Muller L, Teigen S\V. Series: current issues in mutagenesis and 
carcinogenesis, 1\:o. 65. The genotoxicity and carcinogenicity of paracetamol: a 
regulatory (re)view. Mutat Res 1996;349:263-88. 
References 
263. Smilkstein :M), Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-
acetylcysteine in the treatment of acetaminophen overdose. Analysis of the 
national multicenter study (1976 to 1985). N Eng! 1 Med 1988;319:1557-62. 
264. Rumack BH, Peterson RG. Acetaminophen overdose: incidence, dia,onosis, 
and management in 416 patients. Pediatrics 1978;62:898-903. 
265. Prescott LF. Intravenous N-acetylcystine: the treatment of choice for 
paracetamol poisoning. BM1 1979;2:1 079-1100. 
137 
266. Prescott LF. Acetaminophen poisoning with intravenous acetyl cysteine. Arch 
Intern Med 1981;141:386-9. 
267. Smilkstein MJ, Bronstein AC, Linden C, eta!. Acetaminophen overdose: a 48-
hour intravenous N-acetylcysteine treatment protocoL Ann Emq; Med 
1991;20:1058-63. 
268. VeltriJC, Rollins DE. A comparison of the frequency and severity of 
poisoning cases for ingestion of acetaminophen, aspirin, and ibuprofen. Am 1 
Emq;Med 1988;6:104-7. 
269. Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen overdose. 
662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 
1981;141:380-5. 
270. Beierschmitt WP, Brady JT, Bartolone JB, eta!. Selective protein arylation and 
the age dependency of acetaminophen hepatotoxicity in mice. To:>.icoi Appl 
Pharmacoi1989;98:51 7-29. 
271. Lauterburg BH, Vaishnav Y, Stillwell WG, Mitchel! JR. The effects of age and 
glutathione depletion on hepatic glutathione turnover in vivo determined by 
acetaminophen probe analysis. 1 Pharmacal Exp Ther 1980;213:54-8. 
272. Adamson GM, Harman A W. A role for the glutathione peroxidase/ reductase 
enzyme system in the protection from paracetamol toxicity in isolated mouse 
hepatocytes. Biochem Pharmacol1989;38:3323-30. 
273. Adamson GM, Papaclimitriou JM, Harman AW. Postnatal mice have low 
susceptibility to paracetamol toxicity. Pediatr Res 1991;29:496-9. 
27 4. Davis DC, Potter WZ, J oil ow DJ, Mitchell JR. Species differences in hepatic 
glutathione depletion, covalent binding and hepatic necrosis after 
acetaminophen. Lift Sci 1974;14:2099-109. 
275. Small RE. Diclofenac sodium. Clin Pharm 1989;8:545-58. 
276. Willkens RF. Worldwide clinical safety experience with diclofenac. Semin 
Arthritis Rheum 1985;15: 105-10. 
138 Riferences 
277. Nordblaclh I, Oblander B, Bjorkman R. Analgesia in tonsillectomy: a double-
blind study on pre and post-operative treatment witb diclofenac. C!in 
Oto!aryngo/1991;16:554-8. 
278. Power I, Chambers WA, Greer IA, Ramage D, Simon E. Platelet function 
after intramuscular diclofenac. Anaesthesia 1990;45:916-9. 
279. Campbell WI, Kendrick R, Patterson C. Intravenous diclofenac sodium. Does 
its administration before operation suppress postoperative pain? Anaesthesia 
1990;45:763-6. 
280. Carmody D, Vamadevan T, Cooper SM. Post tonsillectomy haemorrhage.] 
Laryngol Oto/1982;96:635-8. 
281. Capper JW, Randall C. Post-operative haemorrhage in tonsillectomy and 
adenoidectomy in children. J Laryngol Oto/1984;98:363-5. 
282. Catitbers JS, Gebhart DE, Williams JA. Postoperative risks of pediatric 
tonsilloadenoidectomy. Laryngoscope 1987;97:422-9. 
283. Segal C, Berger G, Basker M, Marshak G. Adenotonsillectomies on a surgical 
day-clinic basis. Laryngoscope 1983;93:1205-8. 
284. Handler SD, Miller L, Richmond KH, Baranak CC. Post-tonsillectomy 
hemorrhage: incidence, prevention and management. Laryngoscope 
1986;96:1243-7. 
285. Tami TA, Parker GS, Taylor RE. Post-tonsillectomy bleeding: an evaluation of 
risk factors. Laryngoscope 1987;97:1307-11. 
286. Tewary AK, Curry AR. Same-day tonsillectomy. J Laryngol Oto/1993;107:706-8. 
287. Birmingham PK, Tobin MJ, Hentbom TK, eta!. Twenty-four-hour 
pharmacokinetics of rectal acetaminophen in children: an old drug witb new 
recommendations. Anesthesiology 1997;87:244-52. 
288. Hendrickson M, Myre L,Johnson DG, eta!. Postoperative analgesia in 
children: A prospective study of intermittent intramuscular injection versus 
continuous intravenous infusion of morphine. J Pediatr Snrg 1990;25:185-91. 
289. Ferrante F:\1:, Orav EJ, Rocco AG, Gallo J. A statistical model for pain in 
patient controlled analgesia and conventional intramuscular opioid regimens. 
Anesth Ana{g 1988;67:457 -61. 
290. Mackie AM, Coda BC, Hill HF. Adolescents use patient-controlled analgesia 
effectively for relief from prolonged oropharyngeal mucositis pain. Pain 
1991;46:265-9. 
Reftrences 139 
291. Bray RJ, Woodhams Ac\1, Vallis CJ, Kelly PJ, Ward-Platt MP. A double-blind 
comparison of morphine infusion and patient controlled analgesia in children. 
Paediatr Anaesth 1996;6:121-7. 
292. Skues MA, Watson DM, O'Meara M, Goddard JM. Patient-controlled 
analgesia in children. A comparison of two infusion tecbniques. Paediatr 
Anaesth 1993;3:223-8. 
293. Abu-Saad H. Assessing children's responses to pain. Pain 1984;19:163-71. 
294. PiagetJ, Inbelden B. The psychology of the child. New York: Basic Books, 
1969. 
295. Pocock SJ. Clinical trials: a practical approach. Chichester: John Wiley and 
Sons, 1987. 
296. Kirk-wood BR. Essentials of medical statistics. Oxford: Blad-well scientific 
publications, 1988. 
297. Gaukroger PB, Tomkins DP, van der Walt JH. Patient-controlled analgesia in 
children. Anaesth Intensive Care 1989;17:264-8. 
298. Owen H, Plummer JL, Armstrong I, Mather LE, Cousins MJ. Variables of 
patient-controlled analgesia. 1. Bolus size. Anaesthesia 1989;44:7-10. 
299. Owen H, Kluger MT, PlummerJL. Variables of patient-controlled analgesia 4: 
the relevance of bolus dose size to supplement a background infusion. 
Anaesthesia 1990;45:619-22. 
300. Taenzer P, Melzack R, Jeans ME. Influence of psychological factors on 
postoperative pain, mood and analgesic requirements. Perin 1986;24:331-42. 
301. Lim AT, Eclis G, Kranz H, et al. Postoperative pain control: contribution of 
psychological factors and transcutaneous electrical stimulation. Pain 
1983;17:179-88. 
302. Feinmann C, Ong M, Harvey W, Harris M. Psychological factors influencing 
post-operative pain and analgesic consumption. Br J Oral Maxi!!ofoc Smg 
1987;25:285-92. 
303. Ferrante FM. Patient Characteristics influencing effective use of patient 
controlled analgesia. In: Ferrante FM, Ostheimer GW, Covino BG, eds. 
Patient controlled analgesia. Cambridge: Black-well Scientific Publications, 
1990: 51-60. 
304. GillZ.\1, Ginsberg B, Muir M, Sullivan F, Williams DA. Patient controlled 
analgesia: the relation of psychological factors to pain and analgesic use in 
adolescents 'W1th postoperative pain. Clin J Pain 1992;8:215-21. 
140 
305. Johnson LR, Magnani B, Chan V, Ferrante FM. Modifiers of patient-
controlled analgesia efficacy. I. Locus of control. Pain 1989;39:17-22. 
Riferences 
306. Doyle E, Harper I, Morton NS. Patient-controlled analgesia with low dose 
background infusions after lower abdominal surgery in children. Br J Anaesth 
1993;71:818-22. 
307. Doyle E, Robinson D, Morton NS. Comparison of patient-controlled 
analgesia with and without a background infusion after lower abdominal 
surgery in children. Br J Anaesth 1993;71:670-3. 
308. Owen H, Szekely SM, Plummer JL, Cushnie JM, C'vfather LE. Variables of 
patient-controlled analgesia. 2. Concurrent infusion. Anaesthesia 1989;44:11-3. 
309. Doyle E, Mottart KJ, Marshall C, Morton NS. Comparison of different bolus 
doses of morphine for patient-controlled analgesia in children. Br J Anaesth 
1994;72:160-3. 
310. Glaser F, Sannwald GA, Buhr HJ, et a!. General stress response to 
conventional and laparoscopic cholecystectomy. Ann Smg 1995;221:372-80. 
311. Chernow B, Alexander HR, Smallridge RC, et a!. Hormonal responses to 
graded surgical stress. Arch Intern Med 1987;147:1273-8. 
312. Carr DB, Goudas LC. Acute pain. L:mcet 1999;353:2051-8. 
313. Fitzgerald M. Development of pain pathways and mechanisms. In: Anand 
KJS, McGrath PJ, eds. Pain in neonates. Amsterdam: Elsevier, 1993: 19-33. 
314. Yaffe SJ, ArandaJV. Pediatric pharmacology, therapeutic principles in 
practice. Philadelphia: W.B. Saunders Company, 1992. 
315. Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in 
neonates, infants and children based on a literature review: Part 1--
Pharmacokinetics. Paediatr Anaesth 1997;7:5-11. 
316. Wolf AR. Treat the babies, not their stress responses. Lzncet1993;342:319. 
317. Anand KJ, Barton BA, Mcintosh N, eta!. Analgesia and sedation in preterm 
neonates who reqnire ventilatory support: results from the NOP AIN trial. 
Neonatal outcome and prolonged analgesia in neonates. Arch Pediatr Ado/esc 
Med 1999;153:331-8. 
318. Gauthier JC, Fiuley GA, McGrath PJ. Children's self-report of postoperative 
pain intensity and treatment threshold: determining the adequacy of 
medication. Clin J Pain 1998;14:116-20. 
319. Demyttenaere S, Finley GA, Johnston C, McGrath PJ. Pain treatment 
thresholds in children following major surgery. J C!in Pain 2001;in press. 
Refirences 
320. Stevens B, Ohlsson A. Sucrose for analgesia in newborn infants undergoing 
painful procedures. Cochrane Database Syst Rev 2000:CD001069. 
321. Shah V, Ohlsson A. Venepuncture versus heel lance for blood sampling in 
term neonates. Cochrane Database Syst Rev 2000:CD001452. 
141 
322. Ohlsson A, Taddio A,Jadad AR, Stevens BJ. Evidenced-based decision 
making, systemic reviews and the cochrane collaboration: implications for 
neonatal analgesia. In: Anand KJS, Stevens BJ, McGrath PJ, eds. Pain in 
neonates, 2nd revised and enlarged edition. Amsterdam: Elsevier, 2000: 251-
68. 
323. Sacket DL. Evidence based medicine: what it is and what it isn't. BM1 
1996;312:71-2. 
324. Stang HJ, Snellman LW, Condon LM, et al. Beyond dorsal penile nerve block: 
a more humane circumcision. Pediatrics 1997;100:E3. 
325. Taddio A, Pollock)/, Gilbert-McLeod C, Ohlsson K, Koren G. Combined 
analgesia and local anesthesia to minimize pain during circumcision. Arch 
Pediatr Ado/esc Med 2000;154:620-3. 
326. Butler-O'Hara M, LeMoine C, Guillet R. Analgesia for neonatal circumcision: 
a randomized controlled trial of EMLA cream versus dorsal penile nerve 
block. Pediatrics 1998;101:E5. 
327. Lynn AM, Slattery JT. Morphine pharmacokinetics in early infancy. 
Anesthesiology 1987;66:136-9. 
328. Walson PD, Graves PS, Mortensen ME, Kern RA, Torch MA. Patient-
controlled versus conventional analgesia for postsurgical pain relief in 
adolescents. Dev PharmacoiTher 1992;19:32-9. 
329. Austin KL, Stapleton JV, Mather LE. Relationship between blood meperidine 
concentrations and analgesic response: a preliminary report. Anesthesiology 
1980;53:460-6. 
330. Bhat R, Chari G, Gulati A, et al. Pharmacokinetics of a single dose of 
morphine in preterm infants during the first week of life. 1 Pediatr 
1990;117:477-81. 
331. Koren G, Butt W, Chinyanga H, et al. Postoperative morphine infusion in 
newborn infants: assessment of disposition characteristics and safety. 1 Pediatr 
1985;107:963-7. 
332. Olkkola KT, Maunuksela E, Korpela R, Rosenberg PH. Kinetics and 
dynamics of postoperative intravenous morphine in children. C!in Pharmacal 
Ther 1988;44:128-36. 
142 References 
333. Olkkola KT, Hamunen K, Maunuksela EL. Clinical pharmacokinetics and 
pharmacodynamics of opioid analgesics in infants and children. C!in 
Phar/J1acokinet 1995;28:385-404. 
334. Korpela R, Korvenoja P, Meretoja OA. Morphine-sparing effect of 
acetaminophen in pediatric day-case surgery. Anesthesiology 1999;91:442-7. 
335. Lingen van RA, Quak CM, Deinum HT, et al. Effects of rectally administered 
paracetamol on infants delivered by vacuum extraction. Ettr J Obstet Gynecol 
2001;94:73-8. 
336. Lingen van RA, Deinum HT, Quak CM, Okken A, Tibboel D. :\fultiple-dose 
pharmacokinetics of rectally administered acetaminophen in term infants. Clin 
Pharmacol Ther 1999;66:509-15. 
337. Fitzgerald M, Shortland P. The effect of neonatal peripheral nerve section on 
the somadendritic growth of sensory projection cells in the rat spinal cord. 
Brain Res 1988;470:129-36. 
338. Fitzgerald M, Woolf CJ, Shortland P. Collateral sprouting of the central 
terminals of cutaneous primary afferent neurons in the rat spinal cord: 
pattern, morphology, and influence of targets. J Comp Nettro/1990;300:370-85. 
339. Fitzgerald M. Developmental biology of inflammatory pain. Br J Anaesth 
1995;75:177-85. 
340. Hammond DL, Ruda MA. Developmental alterations in nociceptive threshold, 
immunoreactive calcitonin gene-related peptide and substance P, and fluoride-
resistant acid phosphatase in neonatally capsaicin-treated rats. J Comp Nmrol 
1991;312:436-50. 
341. Bhutta AT, Rovnaghi C, Anand KJS. Interactions ofinflammatory Pain and 
Morphine in Infant Rats: Long-term Behavioral Effects. Physiol Behav: in press 
342. Gronau RVE, Whitfield MF, Petrie JH, Fryer LE. Early pain experience, child 
and family factors, as precursors of somatization: a prospective study of 
extremely premature and fullterm children. Pain 1994;56:353-9. 
343. Anand I<J. Effects of perinatal pain and stress. Prog Brain Res 2000;122:117-29. 
344. Franck LS, Greenberg CS, Stevens B. Pain assessment in infants and children. 




In the last decade the knowledge of and attitude towards the management of pain 
in hospitals have improved significantly. i\!owadays, it is generally acknowledged 
that even neonates and young infants do feel pain and that analgesics should be 
given before pain appears, i.e. pre-emptively and not on an if-necessary basis when 
pain is already present. This prevents the development of sensitisation, 
physiological and metabolic disturbances, pathologic complications, and long-term 
(behavioural) sequelae. 
After more than 10 years of progress, there are still many aspects open for 
improvement. This can be achieved either by means of improving the methods of 
pain assessment or by studying the efficacy of analgesics. Both subjects are 
addressed in this thesis. 
The gold standard to assess the presence of pain is what one reports about one's 
experience. Neonates and young infants lack this ability and for this reason one has 
to rely on nurses' and clinicians' skills to determine whether they are in pain or not. 
For this purpose the sensitivity and specificity of the face as a means to 
communicate pain is reviewed in chapter 2. A MEDLINE and PSYCLIT search 
from 1966 through 2000 was carried out. It was found that there are two coding 
systems to objectively code facial movements in neonates and infants: the Neonatal 
Facial Coding System (NFCS) and the Ma.'<imum Discriminative Facial Movement 
Coding System (MAX). The first was used in 34 of the 38 original studies found. In 
general, facial movements have only been studied in relation to acute pain, using 
needle pain as the gold-standard painful event. The facial response to acute pain 
has good sensitivity and specificity and is characterised by a constellation of seven 
well-defined facial actions that are different from e.'<pressions associated with anger, 
fear or sadness. Whether the face is of value for the assessment of subacute pain, 
such as postoperative pain or pain associated with neonatal illnesses, is not known. 
Chapter 3, therefore, examines the validity of the face, as coded by the NFCS, to 
assess pain in the postoperative period. A prospective observational study was 
carried out including 37 neonates and infants. All had undergone major abdominal 
or thoracic surgery. The i\!FCS was significantly related with other pain-related 
indices such as nurses' observational pain scores on the Visual Analogue Scale, 
COMFORT 'behaviour' scores, heart rate, and blood pressure. No relations were 
found between i\!FCS and catecholamine or morphine plasma concentrations. 
Furthermore, multidimensional scaling revealed that five facial actions form a 
constellation of pain. These five appeared to predict the pain-related indices as well 
as the complete NFCS. Moreover, this constellation of pain is similar as the one 
S!IUI/Jlt11)1 
defined for acute pain. It was concluded that the reduction of the J'\FCS to five 
facial actions increases the specificity for pain assessment without reducing the 
sensitivity and validity for detecting changes in pain. 
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Chapter 4 examines whether the administration of pre-emptive analgesia following 
major surgery prevents neonates and young infants from developing altered pain 
sensitivity. A case comparison study was carried out. Two groups of 50 toddlers 
each were compared: index and control group. Characteristics of the index group 
were major surgety in combination with pre-emptive morphine within the first 
three months of life. The control group consisted of matched controls. Both 
groups were subjected to routine immunisation at either 14 months (MMR 
immunisation) or 3 years and 9 months (DTT immunisation) of age. No 
differences were found in facial responsiveness, heart rates, or saliva cortisol 
concentrations between the index and control group. Intra-group analyses of the 
index group showed that following MMR, children with greater number of negative 
hospital e:,periences (e.g. length of stay in the hospital, number of operations, or 
TISS scores) displayed greater facial activity but less acceleration in heart rates than 
children with few negative hospital experiences. This effect was not observed after 
DTT immunisation. We concluded that major surgety in combination with pre-
emptive analgesia within the first months of life does not alter pain response to 
subsequent pain exposure in childhood. However, frequent exposure to negative 
hospital experiences influences the pain responses to subsequent pain. These 
effects, however, diminish after a prolonged period of non-exposure. 
In many cultures, boys are subjected to circumcision during infancy or childhood. 
Not only is this procedure painful, boys will suffer pain for some time thereafter. A 
fair amount of clinicians do not administer analgesics, either because they fear for 
side effects or because they are unfamiliar with anaesthetic techniques. Chapter 5 
therefore examines whether application of the topical anaesthetic EMLA cream can 
adequately replace caudal block for circumcision. A randomised clinical trial was 
carried out in 64 boys, aged 1 to 12 years, scheduled for elective circumcision in day 
care. In this study the efficacy of pre-operative as well as postoperative application 
of EMLA was compared with that of caudal block and placebo. Circumcision was 
carried out under standardised general anaesthesia. Those who had received 
placebo cream suffered most pain during circumcision. Children who had received 
caudal block needed less halothane during surgety than those receiving E:MLA. The 
first 120 minutes postoperatively, boys who had been given either EMLA or 
placebo cream were 6 and 14 times, respectively, more likely to receive rescue 
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analgesics compared with the Caudal group. It was concluded that EMLA cream 
can not be considered a suitable replacement for caudal block. 
There is still doubt about the optimal analgesic regimen for postoperative pain 
management following (adeno)tonsillectomy. Chapter 6, therefore, reviews the 
efficacy of paracetamol and diclofenac in children aged 3 to 12 years after 
(adeno)tonsillectomy. Pharmacokinetics and adverse effects of the two agents are 
also addressed. A MEDLI""E search from 1966 through 1998 was carried out. In 
general> systematic and practise-based research on these drugs for this indication is 
scarce. Paracetamol 20 mg.kg·1 administered orally 60 minutes preoperatively, 
paracetamol 40 mg.kg·1 administered rectally 2 to 3 hours preoperatively, and 
diclofenac 2 mg.kg1 administered rectally at induction seem to achieve satisfactory 
analgesia in the majority of children during the first few hours postoperatively. 
Evidence shows that morphine requirements in children following major surgery 
are also subjected to large intra-individual differences. Patient Controlled Analgesia 
is a technique that meets the prerequisites for effective pain relief, i.e. the opioid 
dosage is adjusted to the individual requirements, and plasma concentrations are 
maintained at a constant level. Chapter 7 examines the efficacy of PCA 
(background infusion of 15 mcg.kg.h·1 and bolus doses of 15 mcg.kg·1 with a 
lockout interval of 10 minutes) with that of continuous infusion of morphine (20 to 
40 mcg.kg.h.1) in terms of pain relief, morphine needs, and side effects. A stratified 
randomised clinical trial was carried out. Forty-seven children aged 5 to 18 years 
undergoing major elective lower/upper abdominal or spinal surgery were allocated. 
No differences were found between both groups in pain scores as assessed by self-
report using the Visual Analogue Scale. However, morphine intake in the PCA 
group was significantly higher than in the CM group. Greater morphine intake was 
also associated with higher surgical stress, independent of the technique of 
administration. Despite a greater morphine intake in the PCA group side effects did 
not differ between both groups. It was concluded that both techniques appear to 
provide sitrilar pain relief when in rest. Research is indicated whether this also 
holds good during activity such as nursing, therapy, or playing. 
Chapter 8 discusses the findings of this thesis in relation with the developments 
within the field of pain assessment in neonates, infants and children. Theoretical 
reflections are addressed and implications for further research are given. 
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Samenvatting 
In de laatste tien jaar zijn de kennis en attitude die ten grondslag liggen aan de visie 
op pijn en de bestrijding daarvan bij kinderen structureel veranderd. Het wordt 
onderkend dat ook pasgeborenen pijn kunnen voelen en dat pijn de kans op 
morbiditeit en mortaliteit vergroot. Tevens is algemeen erkend dat pijnbestrijdende 
middelen gegeven moet worden voordat de pijn optreedt. Deze strategie, ook we! 
"pre-emptive analgesia" genoemd, voorkomt behalve overgevoeligheid voor pijn, 
ook het optreden van fysiologische en pathologische complicacies. Tevens 
vermindert zij de hoeveelheid pijnbestrijdende middelen en mogelijke 
veranderingen in de pijngevoeligheid alsmede gedragsproblemen op de lange 
termijn. 
I'\ a meer dan tien jaar van vooruitgang ondergaan kinderen die op de afdeling 
neonatologie of de intensive care liggen nog steeds vee! pijnlijke procedures zonder 
enige vorm van pijnbestrijding, zoals de hielptik, het inbrengen van thora.'< drains 
of centrale lijnen. In vee! ziekenhuizen laat de pijnbestrijding bij besnijdenis en 
arnandelknippen te wensen over. Na grote operaties blijkt de behoefte aan morfine 
te varieren, tussen verschillende kinderen alsmede per kind. De vraag is dan ook 
hoe kan worden ingespeeld op deze verschillen in behoefte aan analgetica teneinde 
adequate pijnbestrijding te bewerkstelligen. Een andere vraag is of bij pasgeborenen 
de weefselbeschadiging die gepaard gaat met operaties, het ondergaan van pijnlijke 
procedures en het krijgen van pijnmedicatie consequenties hebben voor de 
ontwikkeling van de pijnbeleving en gevoeligheid op latere leeftijd. 
Dit proefschrift behandelt onderzoek naar pijnmeringen bij pasgeborenen en 
baby's. Tevens wordt in dezelfde leeftijdsgroep onderzoek beschreven naar 
mogelijke lange termijn effecten van grote operaties op latere leeftijd. De laatste 
hoofdstukken betreffen studies naar de effectiviteit van enkele 
pijnbestrijdingsmethoden na kleine en grote opera ties bij peuters, kleuters en 
kinderen. 
Over het algemeen wordt rapportage van de patient zelf als de beste methode 
gezien om de aanwe7igheid van pijn te achterhalen. Pasgeborenen en baby's 
kunnen dit niet, en zijn voor een goede pijnbestrijding afhankelijk van de 
vaardigheden van verpleegkundigen en artsen die hun gedragingen interpreteren. 
Onderzoek toont aan dat ouders en verzorgenden met name het ge--.dcht gebruiken 
om te bepalen of pijn aanwezig is. De sensitiviteit en specificiteit hiervan wordt 
beschreven in hoofdstuk 2; voor dit doe! werd een systematisch literatuur-
onderzoek uitgevoerd. Hiervoor werden o.a. de databestanden MEDLINE en 
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PSYCLIT geraadpleegd. Alle beschikbare literatuur die tussen 1966 en 2000 
verschenen is, werd opgenomen. In totaal werden er 38 publicaties gevonden. Er 
bestaan twee coderingsinstrumenten om bewegingen in het gezicht op een 
objectieve wijze te coderen, dit zijn de Neonatal Facial Coding System (NFCS) en 
de Ma.:illnum Discriminative Facial Movement Coding System (M&'(). In 34 van 
de 38 gevonden studies werd de NFCS gebruikt. Geconcludeerd werd dat 
pasgeborenen en baby's bij het ondergaan van pijnlijke procedures zoals een prik, 
reageren met een speci:fieke mimiek. Deze bestaat uit gefronste wenkbrauwen, 
dichtgeknepen ogen, aanwezigheid van de neus-lip groef, geopende overstrekte 
mond en een gespannen tong. Deze mimiek verschilt met die van boosheid, angst 
of droefheid. Het is niet bekend of kinderen deze mimiek Iaten zien als de pijn 
langer aanhoudt. 
Om deze reden is in hoofdstuk 3 een onderzoek ultgevoerd met als doe! te bepalen 
ofhet gezicht een valide meetrnethode is om bij pasgeborenen en baby's de 
aanwezigheid en mate van pijn te achterhalen gedurende de postoperatieve periode. 
In totaal werd dit bij 38 kinderen gedaan die allen een grote chirurgische 
abdominale of thoracale ingreep hadden ondergaan. De NFCS werd gebrulkt om 
veranderingen in het gezicht te coderen. Daamaast werden andere pijngerelateerde 
metingen verricht zoals COMFORT 'gedrag' en VAS, hartslag, adrenaline en 
noradrenaline. Morfineconcentraties in het bloed werden bepaald om te 
achterhalen of er een relatie is tussen hoeveelheid morfine in het bloed en mate van 
pijnbestrijcling. Een goede samenhang werd gevonden tussen i\!FCS, COMFORT 
'gedrag', VAS scores alsmede tussen NFCS scores, hartslag en bloeddruk. Er werd 
geen relatie gevonden tussen NFCS, adrenaline, noradrenaline en morfine plasma 
concentraties. Uit de analyses komt verder naar voren dat de mimiek voor 
postoperatieve pijn overeenkomt met die zoals beschreven is in hoofdstuk 2 bij 
pijnlijke procedures zoals een prik. 
Onderzoek ultgevoerd bij de mens en bij dieren toont aan dat weefselbeschadiging 
en pijn in de eerste levensperiode leiden tot een veranderde pijngevoeligheid op 
latere leeftijd. Het doe! van hoofdstuk 4 was te bepalen of het ondergaan van een 
grote opera tie in de eerste drie maanden van het leven, in combinatie met "pre-
emptive analgesia", leidt tot een veranderde pijngevoeligheid op latere leeftijd. Een 
tweede doe! was te achterhalen of het aantal opnamedagen in een ziekenhuls en het 
aantal stressvolle gebeurtenissen gedurende deze opnames van invloed is op de 
pijngevoeligheid op latere leeftijd. In dit onderzoek werd de reactie op vaccinatie 
van "V"ijftig peuters en kleuters, die in de eerste drie maanden van hun leven een 
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grote chirurgische ingreep hadden ondergaan, vergeleken met die van 50 gezonde 
op leeftijd gematchte controlekinderen. De kinderen !::regen of de BMR vaccinatie 
op de leeftijd van 14 maanden of de DTP vaccinatie op de leeftijd van 3 jaar en 9 
maanden. 
Er werd geen verschil tussen beide groepen gevonden; niet in rnimiek, hartslag of 
cortisolconcentraties. V erder h."V!am naar voren dat kinderen van 14 maanden oud 
met veel ziekenhuiservaringen, heftiger reageerden met hun rnimiek maar minder 
heftig met een stijging in de hartslag dan kinderen van dezelfde leeftijd die relatief 
kort waren opgenomen. Aangenomen wordt dat kinderen met veel 
ziekenhuiservaringen vee! pijn hebben geleden. Dit effect werd niet gezien bij 
kinderen van 3 jaar en 9 maanden. Dit onderzoek lijkt aan te tonen dat adequate 
pijnbestrijding tijdens en na een grate operatic verandering in pijngevoeligheid 
voorkomt. Excessieve blootstelling aan pijnlijke procedures en stress leidt tot een 
verhoogde pijngevoeligheid die, na een lange periode van niet blootgesteld zijn aan 
pijn, lijkt af te nemen. 
In de hoofdstukken 5 tot en met 7 werden enkele pijnbestrijdingsmethoden op hun 
effectiviteit getest. In hoofdstuk S werd bepaald of bij besnijdenis het aanbrengen 
van EMLA een even goede pijnbestrijding geeft als het relatief moeilijk uit te 
voeren caudaal blok. EMLA is een zalf die de huid verdooft. Vierenzestig jongens 
van 1 tot 12 jaar namen dee! aan dit onderzoek. Voor de ingreep !::regen zij 6f 
EMLA 6f placebo creme, 6f een caudaal blok. Behalve zij die een caudaal block 
hadden gekregen, !::regen allen na de besnijdenis nogmaals hetzij EMLA hetzij 
placebo creme. De besnijdenis werd uitgevoerd onder algehele anesthesie. Zoals 
verwacht reageerden de jongens die placebo creme voor de ingreep hadden 
gekregen het heftigst op de besnijdenis. EMLA verminderde de pijn tijdens de 
besnijdenis, echter de effectiviteit hiervan was niet zo goed als die van het caudaal 
blok. Het aantal jongens dat na de ingreep extra pijnbestrijding nodig had was vee! 
grater bij de groepen die na de besnijdenis placebo of EMLA creme hadden 
gekregen dan bij de groep met het caudaal blok. Geconcludeerd werd dat EMLA 
geen altematief is voor het caudaal blok. 
Over het algemeen geven Nederlandse artsen paracetamol tegen de pijn na 
amandelknippen, met wisselend resultaat. Hoofdstuk 6 heeft daarom ten doe! te 
achterhalen welk rniddel in welke closeting het meest effectief is voor de pijn na 
amandelknippen. Een systematisch literatuuronderzoek werd uitgevoerd naar zowel 
de effectiviteit, farmacokinetiek als veiligheid van kleine ana]getica zeals 
paracetamol of diclofenac die bij amandelknippen gegeven worden in Nederland. 
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Hiervoor werden o.a. de databestanden :\.fEDLINE en PSYCLIT geraadpleegd. 
Aile literatuur die tussen 1966 en 1998 verschenen is, werd geraadpleegd. In totaal 
werden er 10 effectiviteitsstudies gevonden waarin paracetamol of diclofenac 
gegeven werd. Geconcludeerd werd dat paracetamol drank in een closeting van 20 
mg.kt1 gegeven 60 minuten voor de ingreep, paracetamol zetpillen 40 mg.kg·1 
ingebracht 2 tot 3 uur voor de ingreep, of cliclofenac zetpillen in een dosering van 2 
mg.kg·1 gegeven vlak voor de ingreep, leiden tot adequate pijnbestrijding na 
amandelknippen bij de meeste kinderen. 
Goede pijnbestrijding heeft tot doel de hoeveelbeid analgetica af te stemmen op de 
behoefte van de patient. Het meest ideale is dat de patient bier zelf controle over 
heeft, hetgeen mogelijk is met behulp van Patient Controlled Analgesia (PCA). Dit 
is een techniek die de patient zelf de mogelijkbeid biedt om zichzelf kleine 
hoeveelbeden morfine toe te dienen. PCA kan met en zonder achtergrond infuus 
van morfine worden toegepast. Het doe! van hoofdstuk 7 was te bepalen of PCA in 
combinatie met een achtergrond infuus een betere pijnbestrijding geeft dan aileen 
een continu infuus van morfine. Zevenenveertig kinderen van 5 tot 18 jaarwerden 
in \J.lillekeurige volgorde toegewezen aan een van deze twee methoden. De mate 
van pijnbestrijding was matig bij beide technieken. Kinderen die PCA hadden 
gekregen gebruikten veel meer morfine; d.it leidde echter niet tot een hogere 
incidentie van bijwerkingen. Geconcludeerd werd dat meer onderzoek nodig is om 
te achterhalen welke factoren verantwoordelijk zijn voor het feit dat kinderen die 
zichzelf e.'Ctra morfine kunnen toedienen toch pijn lijden. 
In hoofdstuk 8 worden de bovengenoemde bevindingen in een breder verband 
geplaatst en besproken in het Iicht van ontwikkelingen op het terrein van 
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(neonatal) intensive care unit 
appearance changes 
American Society of Anesthesiologists 
brow bulge 
continuous background infusion of morphine 
mean blood pressure 
variability in blood pressure 
confidence interval 
continuous infusion of morphine 
systemic clearance 
ma.-ximum plasma concentration 
central nervous system 
chin quiver 
diastolic blood pressure 
diphtheria, tetanus, and trivalent polio immunisation 
application of EMLA cream pre- and postoperatively 
extremely low birtb weight 
eutectic mi.;;:ture of local anaesthetics 
eye, nose and cheek root region 
application of EMLA cream preoperatively and placebo cream 
postoperatively 
eye squeeze 
forehead, eyebrows, and nasal root region 
horizontal mouth stretch 
heart rate 
mean heart rate at baseline 
difference between mean heart rate at baseline and mean heart 
rate during observation period 
mean heart rate 
variability in heart rate 
intertuittent morphine administration 
lip purse 




























microgram per kilogram 
microgram per litre 
mouth, lips, and chin root region 
measles, mumps, and rubella immunisation 
N-acetylcystcine 
N-acetyl-p-benzoquinone 
neonatal facial coding system 
pain score based on tbe duration of five facial actions 
pain score based on tbe duration of ten facial actions 
naso-labial furrow 
nonsteroidal anti-inflammatory drugs 
open lips 
patient controlled analgesia 
patient controlled analgesia with a continuous background 
infusion of morphine 
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patient controlled analgesia witbout a continuous background 
infusion of morphine 
application of placebo cream preoperatively and EMLA cream 
postoperatively 
respiratory rate 
systolic blood pressure 
aspartate transaminase serum values 
severity of surgical stress 
elimination half-life 
therapeutic intervention scoring system 
time to ma.-cimum concentration 
tongue protruding 
taut tongue 
visual analogue scale 
distribution volume 
vertical moutb stretch 

